fbpx

Marijuana policy reading

Marijuana policy reading

Drafting a pamphlet: “What North Carolinians Need To Know About Marijuana Money.” Here’s what I’m thinking for background reading references:  

For marijuana issues generally, I don’t know a better place to start than Mark Kleiman’s Marijuana Legalization:  What Everyone Needs to Know (2d ed. 2016, with Caulkins and Kilmer, under $20), which inspired the title here.  A more technical 2015 analysis by Kleiman and others for the State of Vermont is in the public domain at https://www.rand.org/pubs/research_reports/RR864.html.

Kleiman’s work is a little dated; a recent multi-author issue of the B.U. Law Review provides a good update in the public domain. https://www.bu.edu/bulawreview/2021/07/14/volume-101-number-3-may-2021/.

For an ideological prohibitionist view, the group Smart Approaches to Marijuana, https://learnaboutsam.org, provides online material and offers a book for sale.  

An anti-prohibition view is thought through in a free online book by the U.K. Transform Drugs Foundation: https://transformdrugs.org/publications/how-to-regulate-cannabis-a-practical-guide


#CBD #Hemp
Marijuana policy reading
September 25, 2021 2:25 pm

Hemp Cake As An Alternative Ingredient For Sustainable Meat?

Hemp Cake As An Alternative Ingredient For Sustainable Meat?

The hemp plant is one of the most versatile plants on earth, with humans having made use of the hemp plant for centuries for many purposes.

As hemp advocates will be quick to point out, the hemp plant has the ability to clothe, feed, and in many cases heal. It’s a truly amazing crop.

Hemp grows much faster than most trees and can even be used to decontaminate soil, especially soil that is contaminated with heavy metals.

Food-products made from hemp are particularly popular among consumers, including hemp milk and hemp seed. 

The results of a recent study could one day lead to hemp being in even more things that we eat.

Evolving Consumer Demands

Many consumers are becoming more conscious about what they eat, and understandably so. What we eat plays a very important role in our overall health.

Sustainability is another major concern, and so it is no coincidence that consumers are increasingly looking for sustainable meat products.

Sustainable meat is specifically created via regenerative practices and processes with the goal of lowering meat’s carbon footprint.

Producing sustainable meat involves the addition of various ingredients for storage purposes to help preserve the meat, among other things. Hemp is one of those ingredients.

Hemp Cake As A Sustainable Meat Ingredient?

Researchers recently conducted a study in which they examined hemp cake, a by-product of cold pressing oil from hemp seeds, as an alternative ingredient in sustainable meat.

They specifically looked at hemp cake’s impact “on the physicochemical and textural properties, oxidation, and sensory acceptance of cooked and vacuum-packed meatballs during refrigerated storage”

“The addition of 7.4% hemp cake enhanced the amount of dry matter and reduced the content of water. Lightness (L*) and redness (a*) values reduced significantly with higher levels of hemp supplementation.” the researchers stated.

“The results indicate that hemp cake, a material considered mainly as waste, may be destined for food purposes and be an alternative ingredient for the production of sustainable meat products.” the authors concluded.


#CBD #Hemp
https://cannatechtoday.com/hemp-cake-as-an-alternative-ingredient-for-sustainable-meat/
September 24, 2021 11:00 am

Lean Management in a Cannabis Lab

Lean Management in a Cannabis Lab

Lean management or Lean thinking is a process for continuous improvement that can be applied to any business. Most frequently Lean is attributed to the manufacturing sector due to its origins in Japan at the Toyota Motor Company. Lean originated in post-war Japan where resources were scarce as the country rebuilt itself after World War II. The scarcity of resources forced the Japanese to do more with less which manifested itself within the Toyota organization as the Toyota Production System from which Lean originated.

Today, Lean thinking is being applied to every industry and we believe that the cannabis industry, and in particular laboratories, can benefit tremendously from its principals.

What Is Lean and How Does it Apply to Cannabis?

Lean thinking is a set of powerful tools for any business or organization that wants to be the best in their industry and deliver superior value their customers. This is especially relevant to the fast-growing cannabis and hemp testing industry where customers demand fast turnaround times and error-free results.

The reason that Lean applies to all businesses and especially the cannabis industry is because of its focus is on eliminating waste. Waste comes in many forms including defects, waiting time, extra motion, excess inventory, transportation, over production, over processing and underutilized talent.

Companies that adopt Lean management eliminate waste using a wide variety of tools that help surface issues and eliminate the root causes. When companies eliminate waste, they simultaneously improve both their speed and quality, two attributes that customers really care about. Given the fast-changing nature of the cannabis industry and differences state by state, we believe that using Lean thinking to eliminate waste is critical to being a top performing business in the cannabis industry.

One important tool that many businesses begin with is known as 5S or 6S. At our laboratory we recently implemented 6S to organize both our office and laboratory spaces. 6S is a process improvement tool that stands for Sort, Set in Order, Shine, Standardize, Sustain and Safety. The process involves each technician or analyst assessing their areas and asking critical questions such as: Can I easily reach everything I need for this test or process? Is there wasted motion due to the placement of items within the lab? Can I easily tell how much consumable inventory I have on hand at a glance?

This process also helps improve safety because the workspace is better organized, easier to navigate and designed with safety in mind. Each person is responsible for maintaining their workspace and regular audits by rotating teammates, helping drive continuous improvement to our 6S. It is a fundamental process for any business starting to adopt Lean thinking.

Another very helpful process that any cannabis business can implement is the Gemba walk. Gemba is the Japanese word for “actual place” and refers to the place in a business where value is created for the customer. Value in our cannabis business is created in our testing lab. By improving everything in our testing lab we improve our quality and speed for our customers. In our laboratory we begin the Gemba walk as a team reviewing our key performance indicators (KPIs). From there, the management team visits each station to review additional KPIs and discuss any issues that group may be having. We try to surface issues, however small they may be, so that they are solved and hopefully eliminated. This process is key to helping us keep a pulse on the lab, engaging employees and better understand the improvements that need to be made.

How to Implement Lean Processes

labsphoto
Without quality results, a testing laboratory does not really have a product or service to offer

Lean thinking is a very accessible set of tools. Unfortunately, it is quite difficult to implement because of the dedication that it requires. Implementing Lean and changing the culture requires a significant amount of time, investment in training and management commitment. Time and capital for training can be scarce at some businesses in the cannabis industry. For the businesses with capital, it is extremely important that management commit to implementing Lean and changing their culture. Without the support of the executive team most businesses stop implementing new procedures and revert to how they are used to operating. It is also common for changes in management to result in lean becoming deprioritized in place of a new initiative.

If the executive team is inexperienced in Lean management, it will be important to find a Lean consultant that can guide the training and events. A Lean consultant should be able to provide you with thorough training on each tool and help your business implement them in real time to improve the business. The training and knowledge gained during these events are extremely valuable and practical tools that every employee can use.

Results From Implementing a Lean Organization

If a business is able to successfully implement Lean management the results for their customers can be dramatic. In the laboratory setting, turnaround times will be reduced, and more importantly, will remain consistent despite fluctuations in sample volume. Faster turnaround times for cannabis companies means that they can bring inventory to market faster which can be critical for supply constrained businesses.

Additionally, implementing Lean helps reduce the number of errors, rework and retests so the quality of the results for the customer is dramatically improved. Root cause issues are solved, processes are updated and then shared with the entire team so that everyone can learn and benefit from the improvement. Without quality results, a testing laboratory does not really have a product or service to offer so it is critical to get it right every time.

All areas of the cannabis industry are becoming more competitive, and it is important for every business to make sure they can stay competitive considering changing market dynamics. Lean management has helped businesses in other industries stand apart from the rest and we believe that the cannabis industry will be no different. Academic literature has studied and documented the positive impact that Lean has on businesses globally. Lean management has repeatedly shown that businesses that can truly implement Lean thinking in everything that they do will have an inherent advantage because they’ll be faster, more agile, higher quality, more efficient and focused entirely on creating value for their customer.

The post Lean Management in a Cannabis Lab appeared first on Cannabis Industry Journal.


#CBD #Hemp

Lean Management in a Cannabis Lab


September 22, 2021 3:41 pm

Now Seeking Leaders in Sustainability

Now Seeking Leaders in Sustainability

There’s no argument that the cannabis industry has made some serious global strides in the past few years. 

For many people, the act of purchasing cannabis out in the open in dispensaries that resemble Apple stores is still hard to comprehend. 

While it’s an exciting time, it’s an industry that needs sustainable solutions for many of its sectors. Cultivation, packaging, and retail businesses all have room to improve their environmental stewardship.

Fortunately, the cannabis industry is still fairly young. According to research conducted by New Frontier Data, the legal cannabis market will continue to grow and is expected to reach $43 billion by 2025. 

This industry is only going to get larger, which means there’s an opportunity to make positive, sustainable changes that will impact the world. 

Seeking Sustainable Leaders

The cannabis plant is incredibly eco-friendly, so how can we reflect that with more responsible production practices? One company working for change is Tiny E Paper Company.

Tiny E Paper produces 100% pure hemp paper from hemp stalks and pre- and post-extraction waste from CBD. During a presentation at the Emerge Virtual Cannabis Conference, Founder and CEO Erica Halverson emphasized the importance of sustainable leadership.

“We have a really awesome opportunity and responsibility right now, and we cannot squander that by doing it the wrong way. We have a chance to really be a model for the world right now in what sustainability means, and what it means in practice, rather than just saying it,” said Halverson. 

We are still very much a budding industry. By carrying out sustainable practices we can help build global trust and cleaner medicine, while also helping the world.

The 2021 Sustainable Leadership Awards

Cannabis & Tech Today partnered with Regennabis for this year’s Sustainable Leadership Awards to highlight individuals and businesses making sustainable practices foundational for their work in the industry.

We’re using the United Nation’s Sustainable Development Goals as a guide to help define what it means to build a sustainable business model.

The awards are seeking applicants using sustainable practices in several sectors, from water conservation and eco-friendly packaging to social impact and the cannabis event with the smallest carbon footprint. 

Nine different categories showcase how broad the term sustainability is and how a company can make an impact in a variety of ways. 

Categories include: water conservation, energy use, innovation, packaging, stewardship, event impact, ESG, social impact, and SDGs. Learn more with this link.

Companies Changing the Game

Since starting the Sustainable Leadership Awards in 2019, we have showcased innovative, game-changing companies, taking what it means to “go green” to another level. 

During the 2019 award ceremony, which took place MJBizCon in Las Vegas, Cannabis & Tech Today CEO Charles Warner explained why the awards were created.

“We realized that sustainability is something that is incredibly important for this burgeoning industry and it’s up to us to take charge and lead the way, because if we don’t do it, it’s going to be forced upon us in regulations. It’s our sandbox to really push the envelope towards sustainability,” said Warner. 

We have had a lot of amazing winners over the years, many of whom have continued to excel since being awarded their custom engraved plaque. 

Companies like LumiGrow, Surna Packaging, Polyscience, and Solar Therapeutics – just to name a few.

If those names look familiar, it’s because not only are they doing amazing work, they’ve been featured in an issue of Cannabis & Tech Today, another prize awarded to each award winner. 

Solar Therapeutics Director of Marketing and Communications Derek Gould offered advice to operators looking to become more sustainable after the company’s win. If overwhelmed, take it step-by-step. 

“You don’t have to go all-in on sustainability right off the bat. There’re a lot of low-hanging fruit and very easily implemented, inexpensive ways, and procedures that can make your facility at least start to be a little bit more sustainable. It’s imperative we start really considering this approach to cultivating cannabis,” said Gould. 

How to Apply

If your company deserves to be recognized for mastering eco-friendly practices, giving back to your community, or being an example of conservation, we would love to learn more about you. 

Any cannabis business operating in accordance with state and local regulations in North America may apply. 

All applications must be submitted by October 10, 2021. Apply here.

Each entry is $199. One entry per category. 

Winners will be awarded a custom plaque, a profile in Cannabis & Tech Today, and a spotlight session at our Emerge Virtual Cannabis Conference & Expo. 

Being sustainable is a team effort and the pandemic only made it more evident how well this industry works together.

We can’t wait to see which inspiring companies will apply for this year’s Cannabis & Tech Today Sustainable Leadership Awards. Sign up for the Cannabis & Tech Today newsletter to stay up to date.


#CBD #Hemp
https://cannatechtoday.com/cannabis-techs-sustainability-leadership-awards-taking-applications/
September 21, 2021 11:00 am

Leaders in Cannabis Formulations: Part 4 – LifeTonic

Leaders in Cannabis Formulations: Part 4 – LifeTonic

Russell is the CEO of NES Technology Holdings, a technology development and marketing company that operates Vapor Distilled and LifeTonic Brands. NES Technology Holdings has invented a technology portfolio of more than 160 granted and pending patents that cover inventions across several high-value industries, including cannabis, beverage, fragrance and nutraceuticals. The company is currently in license acquisition diligence processes with 7 of world’s 10 largest fragrance companies and has received a joint venture offer from a $3 billion fragrance company to produce perfumes with its extraction technology. It is also launching ionized cannabis beverage products that provide effects as quickly as alcohol in Nevada and Colorado this fall.

Vapor Distilled invented and commercialized an evaporative extraction process with 40 international patents granted and pending that, along with CO2 extraction, is one of only two fundamentally new extraction processes invented in the last 50 years. Instead of using solvents or hydrocarbons to extract oils from plants, evaporative extraction directly evaporates essential oils from plants and condenses the evaporated compounds into an extract. The process takes less than two seconds to complete and extracts higher levels of volatile terpenes than existing extraction methods. Vapor Distilled has built a fleet of commercial-scale extraction machines and has supplied some of the cannabis industry’s largest brands. The company is currently licensing its evaporative extraction technology within the perfume industry and is marketing an aroma hop extract to replace the dry hopping step when making beer.

LifeTonic invented a drug delivery technology with 56 patents pending and granted, that turns oil-based plant compounds like CBD and THC into electrically charged cannabinoid ions that dissolve completely in water without emulsifiers or additives. When cannabinoids are ionized, absorption is significantly enhanced and their effects can be felt in minutes. The effects of a LifeTonic ionized CBD beverage can be felt by most people in less than 5 minutes, whereas the effects of a LifeTonic ionized THC beverage can be felt by most people in less than 8 minutes. For reference, typical onset times for cannabis beverages are 30 minutes or longer. LifeTonic beverage technology will allow cannabis beverages to work as quickly as alcohol, enabling cannabis to become a social drink.

Russell Thomas, CEO of Vapor Distilled and LifeTonic

We spoke with Russell Thomas, CEO of Vapor Distilled and LifeTonic about his cannabinoid evaporation process and rapid onset beverage technologies. Thomas is a career entrepreneur and inventor with 21 years of experience inventing and protecting intellectual property. Russell’s team has generated more than 160 granted and pending patents. Prior to entering the cannabis industry, Thomas worked in the cleantech industry.

Aaron Green: How did you get involved in the cannabis industry?

Russell Thomas: I came to the cannabis industry from the cleantech industry where I worked on technologies that improved the fuel economy of vehicles. I saw opportunities in the cannabis industry to improve cannabis extraction, which was one of the most important supply chain verticals in cannabis. Every product, from edibles to beverages and vape products, requires a cannabis extract. Any product that needs to be accurately dosed requires an extract. The old way of making edible products with cannabis butter was simply not viable as the industry matured, and most people were rapidly moving away from smoking cannabis and embracing vape products. Even with the entire industry almost completely dependent on extraction, no fundamental innovation was occurring. The primary ways that cannabis was being extracted were chemically intensive. The cleaner methods, such as CO2 extraction, were slow and expensive for terpene recovery. I saw this as a great opportunity to provide a better solution within a primary funnel of the cannabis supply chain.

We commercialized an extraction technology that evaporates cannabinoids directly from plant material in the form of vapor, and then recondenses that vapor back into an essential oil. The entire process takes less than two seconds to complete and preserves fragile terpenes. That technology, called Evaporative Extraction, is the foundation of Vapor Distilled.

Green: What timeframe was that roughly?

Thomas: We capitalized our company in 2015 and began selling wholesale extracts in 2017.

Green: Can you talk more about the evaporative extraction process?

Thomas: Our process works in a similar way to a cannabis vaporizer, but on a massive scale. Our extract is literally recondensed cannabis vapor. In one step, we extract, refine, and activate cannabinoids. On one end, plant material goes in the machine, and on the other end, extract and depleted plant material comes out. Our total extraction time is less than two seconds if you measure the time from when the plant material goes into the extractor and when the extract is condensed.

The LifeTonic logo

A continuous feed of dry plant material is introduced into a heated air stream. The air stream pneumatically conveys the plant material through a series of turbulent, heated evaporation chambers. Upon entering the evaporation chambers, volatile plant compounds are instantaneously distilled from the plant material. A centrifugal separator removes the depleted plant material from the air stream. The air stream is rapidly cooled, causing the volatile plant compounds to condense into an essential oil.

We achieve nearly total activation of THCA to THC simultaneously during extraction and, on average, we extract approximately two to four times more terpenes than a conventional extraction process. The cannabis industry is rampant with exaggeration about terpenes, but we are the only cannabis company negotiating a joint venture with a $3 billion fragrance company to produce perfumes, and I think that says a lot about our process.

Green: Is the extract coming out then as an oil?

Thomas: Our extract comes out of our machines as a fully-activated, high-terpene content, full spectrum oil. Unlike the THC crude that emerges from other processes, our extract requires no further distillation, activation or refinement. You can put it straight into a product.

Green: How about terpene recovery?

Thomas: This is by far what we do best. We excel with the recovery terpenes and volatile compounds from plant material. From day one, we noticed that our evaporative extraction process yields about two to four times more terpenes by mass compared to traditional extraction methods.

While we started as a cannabis company, we recently received a compelling joint venture offer from a $3 billion fragrance company to produce perfume products with our technology. We are also under NDA with 7 of the world’s 10 largest fragrance companies to complete diligence processes to license our extraction technology.

As part of our licensing diligence process, we are performing paid fragrance extraction research for three multi-billion-dollar fragrance companies. Our evaporative extracted fragrance extracts are presenting a broader and more complete range of volatile compounds compared reference samples. We are also seeing substantially improved yield of volatile fragrance compounds. Combined, this gives us the advantage of being able to produce more extract at a lower cost, while also producing a superior product. This combination is how licensees can take market share away from any fragrance company that does not have access to our technology, and it is why we are seeing so much rapid traction in this area.

We have also extracted hops with our technology. If you’ve ever smelled a traditional hops resin, it smells good, but the smell doesn’t fill the room. If you put just a drop of our hops extract on any surface, the entire room will smell strongly of a premium IPA beer. It’s so potent you don’t want to get it on your hands or clothes because you will smell like beer for hours. It’s powerful and wonderful stuff!

Green: What is your business model?

Thomas: At our core, we are a technology development and licensing company. We first identify what we believe to be critical verticals and bottlenecks in high-value industries, then we develop and patent highly differentiated and disruptive technology solutions that we believe exist nowhere else. We then demonstrate both market fit and viability at scale through proof-of-concept sales of branded and high-profile, white-labeled products produced with our unique technologies. Finally, we systematically license and exit the various portions our IP portfolio though the orchestration of highly competitive bidding processes that promote both defensive and strategic acquisitions of our technologies. We are currently at the final phase of our model with licensing our extraction technology, and we are receiving offers as part of a competitive bidding process.

Green: Okay, let’s change gears here and start talking more about LifeTonic and your cannabinoid ionization technology. Can you talk high level about the onset times of cannabinoids in different matrices and media?

Thomas: Through LifeTonic, we invented 56 international patents granted and pending cannabinoid ionization technology that compresses the normal onset time of cannabis beverages from 30 minutes down to just a few minutes. Our cannabinoid ionization technology can also be used as a rapid onset vape alternative when sold in a breath spray format. We are currently selling hemp-based versions of these products through LifeTonic.com, and we are bringing THC versions of these products to market in Nevada and Colorado this fall and winter under the brand name LifeTonic.

All conventional and even nano-emulsified cannabis edibles and beverages take a long time to work. A cannabis chocolate can take 45 minutes to two hours before the effects kick in. Cannabis gummies are faster, but it still takes half an hour to 45 minutes to feel the effects. The very best nano-emulsified cannabis beverages take about a half an hour to work on average, if you are lucky. That long of a time delay effectively eliminates the social aspect of consuming cannabis, so most people instead choose to vaporize or smoke cannabis.

If you look at the largest investments that have been made across cannabis, some of the most prominent have been made by alcohol companies. Constellation Brands invested nearly $4 billion into Canopy Growth, with a mission to find an alternative to alcohol in cannabis. Molson Coors has partnered with Hexo and AB InBev has partnered with Tilray, both with that same mission. Even after all this effort and investment, cannabis beverages represent just a sliver of the market because current cannabis-based beverages take too long to work. The fastest ones on the market, on average, take around a half hour to kick in.

Imagine going to a bar and knowing that every time you got a shot of tequila or a shot of whiskey it’s going to take thirty minutes or more for the effects to even begin to kick in. That would be terrible. That would be the end of social drinking. Unfortunately, that is how a conventional cannabis beverage works.

You can’t really get a social drinking experience with cannabis yet, so most people vape it because it’s fast. But a lot of people don’t want to smoke something; in fact, they don’t want to inhale at all. So, we saw beverages as a huge opportunity. How do we make cannabis beverages work as fast as alcohol? That’s what our ionization technology delivers. From all the people we’ve surveyed – hundreds of people – they say that they reliably feel an onset within about seven to eight minutes with our technology. That is just about as fast as a shot of tequila or whiskey.

“With our partners, we will be featuring LifeTonic beverage products on tap in a cannabis cocktail lounge right off the Las Vegas strip, where social consumption rules are welcoming.”What we’ve done is very different from available nanoemulsion technologies. All those technologies try to mix oil and water, and oil and water don’t mix. In a nanoemulsion, you mix cannabis, a carrier oil, an edible detergent and water, and then you run it all through an ultrasonic homogenizer that breaks the cannabinoids and oil into microscopic droplets suspended in water. There are a lot of styles of nanoemulsions, from spray-dried nanoemulsions to liquid liposomal encapsulations, and they all confer certain absorption benefits when compared to straight-up oil absorption. But still, even the microscopic oil droplets suspended in water are quite large compared to what we have done, and still take quite a long time to digest.

We looked at the cannabis molecule and we said, “You know what? If we can put a strong negative charge on it, if we can ionize it, then we can make it behave more like a dissolvable salt instead of an oil.” When we treat it this way, the cannabis molecule dissolves completely in the water without emulsifiers or additives. When something is dissolved, there is no nano-emulsion droplet size. It is single molecules dissolved water. A single ionized cannabinoid molecule is about 1,000 times smaller than an average nano-emulsion droplet – and this greatly enhances absorption. The onset speed of ionized cannabinoids compared to nanoemulsions is measurable as just a few minutes instead of a half hour or more.

We have 56 granted and pending patents on LifeTonic’s ionization technology. We can ionize THC, CBD, CBG and CBD – most cannabinoids are compatible. There are also several herbal products that are compatible with our ionization technology, like the curcuminoids in turmeric, which are normally very hard to get into water. We can also ionize the eugenol that is in cloves. Ionized eugenol is an intoxicant, so we have big plans for alcohol alternatives outside of cannabis.

We’re using this technology to enter the Nevada cannabis market with one of the largest dispensary chains and cannabis product manufacturers in Nevada. With our partners, we will be featuring LifeTonic beverage products on tap in a cannabis cocktail lounge right off the Las Vegas strip, where social consumption rules are welcoming. We’ll craft every kind of cocktail you can imagine, only without alcohol. All these beverages will work in a matter of minutes to provide the first true social drinking experience with cannabis. After you enjoy a beverage, you may purchase a package of ionized THC beverage powder sachets in the cannabis cocktail lounge or at any of the dispensaries within our distribution network. You can pour the powder into any beverage, and it becomes a friendly, fast-acting THC beverage that will get you high, but not leave you with a hangover. We will also be selling a breath-spray format that works almost as quickly as vaping.

Green: What kind of validation studies have you done?

Thomas: We have conducted several broad market studies for our ionized products and almost all people report a profound onset within a few minutes. We have not completed a formalized clinical trial, but we are closing a major funding round that will allow us to do so. We plan to begin controlled pre-clinical trials focused mainly on ionized CBD because it’s far easier to get FDA approval for clinical trials on CBD than for THC. Our studies will monitor a couple dozen volunteers with a functional MRI and watch the change in the brain using our oral spray and beverage products compared against a standard CBD tincture control. We know that we’re going to see fast action because everybody who uses it says that a feeling develops in minutes.

Green: What geographies are you active in and exploring?

Thomas: CBD and hemp products from our extraction technology have been sold in every US state and parts of Europe. Additionally, hemp-based CBD and CBG versions of our ionized products and ionized turmeric products have been sold in several states through our LifeTonic.com, our ecommerce site. We have also sold white labeled versions of our ionized products through partner brands. We will be launching THC versions of our ionized products with our partners Nevada this fall. We expect THC versions to also be available in Colorado this winter.

Green: So, you are creating the powders on site?

Thomas: Yes. We manufacture ionized CBD, CBG, eugenol and turmeric beverage powders on site. We also manufacture and fast acting ionized sprays. These products are sold through our own retail site and we white label for other brands. Per our long-term licensing strategy, these sales establish market viability through sales. Selling products and establishing market viability prior to licensing significantly increases the value of our licenses and exits. It’s very important to answer the question: Do people buy it and do people love it? So far, we like the feedback!

On the THC side, we manufacture ionized products through partners in each cannabis state that we enter. We manufacture the ionizing base here in Colorado, then we ship it to other states where our partners add the THC and package it in LifeTonic-branded packaging. The analogy is that we sell a proprietary Coca-Cola formula without the caffeine, then our partners add the caffeine and bottle it in Coca-Cola branded bottles. In this way, we ensure that the hardest part of our process is controlled house to ensure consistency and quality across all states. It also allows us to be a non-plant touching business, since we only sold upstream base products that did not contain THC. We pick the best manufacturing and distribution partner in each cannabis state and grow from there.

Green: What’s the one thing you’re most interested in learning about?

Thomas: Increasing the bioavailability of cannabis. I have been most passionate about making cannabis work as quickly as alcohol and giving people an alternative to inhaling it through smoking or vaping. That’s definitely what we’ve been most excited about as a company.

Green: Okay, great. That concludes the interview!

Thomas: Thank you Aaron!

The post Leaders in Cannabis Formulations: Part 4 – LifeTonic appeared first on Cannabis Industry Journal.


#CBD #Hemp

Leaders in Cannabis Formulations: Part 4 – LifeTonic


September 20, 2021 8:48 pm

3 Tips for Partnering With a Hemp Inspection Lab

3 Tips for Partnering With a Hemp Inspection Lab

After spending their early careers in a third-generation, family-owned testing laboratory for commodity grains, Kia Adams-Mikesh and Mark Adams, along with their father and grandfather, Mike and Steve Adams, turned their attention toward hemp.

They realized there was a need for unbiased third-party testing laboratories and decided to bring their expertise to the budding hemp industry.

The brother-sister team launched Adams Independent Testing (AIT) in 2019 with a focus on providing Certificates of Analysis (COAs) to buyers and sellers of hemp, testing for potency, pesticides, heavy metals, mycotoxins, terpenes, microbials, and more. 

Especially in the hemp industry, quick turnaround times and attention to customer service are essential.

Existing wait times for results were often between one and four weeks — unacceptable for formulators, processors, and farmers who cannot afford to let biomass languish in a barn or warehouse, waiting for their COA.

When preparing for your hemp inspection, here are three things to look for:

Understand your state’s regulations.

Buyers and sellers of any commodity often choose to pursue certificates to prove their product is free from contaminants such as pesticides, heavy metals or mold.

The USDA has laid the foundation for hemp regulation, such as making sure the THC level is below 0.3%.

Still, variances are common when it comes to state regulations. Some states only have regulations for finished products, while others only regulate smokable hemp.

Other states have no regulations at all.

In such a new industry, the rules are always changing. Choosing to test for as many contaminants as possible helps ensure the highest quality product from start to finish.

Sample your product correctly.

While there are standard regulations for grain sampling, hemp sampling best practices lag behind.

One common example has to do with biomass stored in large plastic totes.

Many people will simply scoop biomass from the top of one tote, which does not give a representative sample.

Instead, use a probe or other sampling apparatus to get all the way to the bottom of the tote, then the middle, and finally the top.

The other key is to sample from multiple totes, which might represent different fields or strains.

This “bottom, middle, top” method works for extracts, too.

Know how to read your COA.

It’s one thing to receive a COA and another thing to decipher it. There’s no governing standard for consistency among testing results, and different labs handle and represent data differently. 

Hemp buyers and sellers must look at the “limits of quantification,” which refers to how closely laboratories test for particular analytes, such as THC.

One lab may set 0.01% as the limit of quantification, while another may use 1% for the same analyte.

The second lab wouldn’t detect a reading for anything under 1%, even if the THC measured above the USDA’s limit of 0.3%.

The test isn’t technically fraudulent, but it’s a red flag.

Cannabis labs, for example, likely don’t usually set limits of quantification as low as 0.3%.

In this type of situation, partnering with an unbiased third-party lab offers an important advantage. ϖ

Learn more at https://hempinspection.com or follow on Instagram at @hempinspection.


#CBD #Hemp
https://cannatechtoday.com/3-things-to-know-when-partnering-with-a-hemp-inspection-lab/
September 17, 2021 11:00 am

5 Cosas que Debe Saber Sobre el Delta-8 Tetrahidrocannabinol – Delta-8 THC

5 Cosas que Debe Saber Sobre el Delta-8 Tetrahidrocannabinol – Delta-8 THC 5 Cosas que Debe Saber Sobre el Delta-8 Tetrahidrocannabinol – Delta-8 THC Anonymous (not verified) Thu, 09/16/2021 – 12:02

Detailed Description
Los productos de Delta-8 THC no están aprobados por la FDA y pueden ponerle en riesgo.

Audience

Topics
Public Awareness

English

El delta-8 tetrahidrocannabinol, también conocido como Delta-8 THC, es una sustancia psicoactiva que se encuentra en la planta de Cannabis sativa, de la que la marihuana y el cáñamo son dos variedades. El Delta-8 THC es uno de más de 100 cannabinoides producidos naturalmente por la planta de cannabis, pero no se encuentra en cantidades significativas en la planta de cannabis. Por ello, las cantidades concentradas de Delta-8 THC se fabrican normalmente a partir de cannabidiol (CBD) derivado del cáñamo.

Es importante que los consumidores sepan que los productos de Delta-8 THC no han sido evaluados ni aprobados por la FDA para su uso seguro en ningún contexto.  Pueden comercializarse de forma que ponen en peligro la salud pública y, sobre todo, deben mantenerse fuera del alcance de los niños y las mascotas. 

A continuación, se presentan 5 cosas que debe saber sobre el Delta-8 THC para mantenerse a usted y a sus seres queridos protegidos de productos que pueden suponer graves riesgos para la salud:

1. Los productos de Delta-8 THC no han sido evaluados ni aprobados por la FDA para su uso seguro y pueden comercializarse de forma que ponen en riesgo la salud pública.

La FDA está consciente de la creciente preocupación sobre los productos de Delta-8 THC que se venden actualmente en línea y en las tiendas. Estos productos no han sido evaluados ni aprobados por la FDA para su uso seguro en ningún contexto. Algunas de las preocupaciones incluyen la variabilidad en las formulaciones y las etiquetas de los productos, el contenido de otros cannabinoides y terpenos, y las concentraciones variables de Delta-8 TCH. Además, algunos de estos productos pueden estar etiquetados simplemente como “productos de cáñamo”, lo que puede confundir a los consumidores que asocian “cáñamo” con “no psicoactivo”. Además, la FDA está preocupada por la proliferación de productos que contienen Delta-8 THC y se comercializan para usos terapéuticos o médicos, aunque no hayan sido aprobados por la FDA. La venta de productos no aprobados con afirmaciones terapéuticas sin fundamento no sólo constituye una infracción de la ley federal, sino que también puede poner en riesgo a los consumidores, ya que no se ha demostrado que estos productos sean seguros o eficaces. Esta comercialización engañosa de tratamientos no probados plantea importantes problemas de salud pública porque los pacientes y otros consumidores pueden utilizarlos en lugar de las terapias aprobadas para tratar enfermedades graves e incluso mortales.

2. La FDA ha recibido informes de eventos adversos relacionados con productos que contienen Delta-8 THC.

Desde diciembre de 2020 hasta julio de 2021, la FDA recibió informes de eventos adversos tanto de consumidores como de las fuerzas policiales que describían a 22 pacientes que consumieron productos con Delta-8 THC; de ellos, 14 se presentaron en un hospital o sala de emergencias para recibir tratamiento después del consumo. De los 22 pacientes, 19 experimentaron efectos adversos tras consumir productos alimenticios que contenían Delta-8-THC (por ejemplo, brownies, gomitas). Los eventos adversos incluyeron vómitos, alucinaciones, problemas para mantenerse en pie y pérdida de conciencia.  

Los centros nacionales de control de envenenamiento recibieron 661 casos de exposición a productos con Delta-8-THC entre enero de 2018 y el 31 de julio de 2021, 660 de los cuales ocurrieron entre el 1 de enero de 2021 y el 31 de julio de 2021. De los 661 casos de exposición:

  • El 41% implicó una exposición no intencional al Delta-8-THC y el 77% de estas exposiciones no intencionales afectaron a pacientes pediátricos menores de 18 años.
  • El 39% afectó a pacientes pediátricos menores de 18 años.
  • El 18% requirió hospitalizaciones, incluyendo niños que requirieron ingreso en la unidad de cuidados intensivos (ICU, por sus siglas en inglés) tras la exposición a estos productos.

3. El Delta-8 THC tiene efectos psicoactivos y embriagantes.

El Delta-8 THC tiene efectos psicoactivos y embriagantes, similares a los del Delta-9 THC (es decir, el componente responsable del “subidón” que pueden experimentar las personas al consumir cannabis). La FDA está al tanto de los informes de los medios de comunicación sobre productos con Delta-8 THC que hacen que los consumidores estén “drogados”.  La FDA también está preocupada por el hecho de que los productos con Delta-8 THC probablemente expongan a los consumidores a niveles de la sustancia mucho más elevados que los que se dan de forma natural en los extractos crudos de cáñamo. Por lo tanto, no se puede confiar en el uso histórico del cannabis para establecer un nivel de seguridad para estos productos en los seres humanos.   

4. Los productos de Delta-8 THC a menudo implican el uso de productos químicos potencialmente dañinos para crear las concentraciones de Delta-8 THC que se afirman en el mercado.

La cantidad natural de Delta-8 THC en el cáñamo es muy baja, y se necesitan productos químicos adicionales para convertir otros cannabinoides del cáñamo, como el CBD, en Delta-8 THC (es decir, conversión sintética). Las preocupaciones con este proceso incluyen:

  • Algunos fabricantes pueden utilizar productos químicos domésticos potencialmente nocivos para fabricar Delta-8 THC mediante este proceso de síntesis química. Se pueden utilizar productos químicos adicionales para cambiar el color del producto final. El producto final de Delta-8 THC puede tener subproductos potencialmente dañinos (contaminantes) debido a los productos químicos utilizados en el proceso, y hay incertidumbre con respecto a otros contaminantes potenciales que pueden estar presentes o producirse dependiendo de la composición de la materia prima inicial. Si se consumen o inhalan, estas sustancias químicas, incluidas algunas utilizadas para fabricar (sintetizar) el Delta-8 THC y los subproductos creados durante la síntesis, pueden ser perjudiciales.
  • La fabricación de productos de Delta-8 THC puede llevarse a cabo en entornos no controlados o antihigiénicos, lo que puede dar lugar a la presencia de contaminantes nocivos u otras sustancias potencialmente dañinas.   

5. Los productos de Delta-8 THC deben mantenerse fuera del alcance de los niños y las mascotas.

Los fabricantes están envasando y etiquetando estos productos de forma que puedan resultar atractivos para los niños (gomitas, chocolates, galletas, dulces, etc.).  Estos productos pueden comprarse en línea, así como en una variedad de establecimientos, incluyendo tiendas de conveniencia y gasolineras, donde puede que no haya límites de edad sobre quién puede comprar estos productos. Como se ha comentado anteriormente, se han producido numerosas alertas de centros de control de envenenamiento que implican a pacientes pediátricos que estuvieron expuestos a productos que contienen Delta-8-THC. Además, los centros de control de envenenamiento de animales han indicado un fuerte aumento general de la exposición accidental de las mascotas a estos productos. Mantenga estos productos fuera del alcance de los niños y las mascotas.

¿Por qué está notificando la FDA al público sobre el Delta-8 THC?

Una combinación de factores ha llevado a la FDA a proporcionar a los consumidores esta información. Estos factores incluyen:

  • Un aumento de los informes de eventos adversos a la FDA y a los centros de control de envenenamientos del país.
  • La comercialización, incluida la comercialización en línea de productos que resulta atractiva para los niños.
  • Preocupación por la contaminación debida a los métodos de fabricación que en algunos casos pueden utilizarse para elaborar productos comercializados de Delta-8 THC. 

La FDA está trabajando activamente con socios federales y estatales para seguir abordando las preocupaciones relacionadas con estos productos y vigilando el mercado en busca de quejas sobre los productos, eventos adversos y otros productos emergentes derivados del cannabis de potencial preocupación. La FDA advertirá a los consumidores sobre problemas de salud pública y seguridad, y tomará medidas, cuando sea necesario, cuando los productos regulados por la FDA infrinjan la ley.

Cómo reportar quejas y casos de exposición accidental o eventos adversos:

Si cree que tiene un efecto secundario grave que supone un peligro inmediato para su salud, llame al 9-1-1 o la sala de emergencias de su localidad. Se alienta a los profesionales de la salud y a los pacientes a que comuniquen las quejas, los casos de exposición accidental y los acontecimientos adversos al programa MedWatch de Información de Seguridad y Reporte de Eventos Adversos de la FDA:

Para más información sobre el Delta-8 THC:  RED DE ALERTA DE SALUD DE LOS CDC (HAN, POR SUS SIGLAS EN INGLÉS) – añada el enlace cuando esté disponible

La Asociación Americana de Centros de Control de Envenenamientos (AAPCC, por sus siglas en inglés) mantiene el Sistema Nacional de Datos sobre Envenenamientos (NPDS, por sus siglas en inglés), que alberga registros de casos no identificados de información recopilada de las personas que llamaron durante la gestión de la exposición, y llamadas de información sobre envenenamientos gestionadas por los centros de control de envenenamientos del país (PCC, por sus siglas en inglés).  Los datos del NPDS no reflejan todo el universo de exposiciones a una sustancia concreta, ya que puede haber exposiciones adicionales que no se reporten a los PCC; por lo tanto, no debe interpretarse que los datos del NPDS representen la incidencia completa de las exposiciones a cualquier sustancia en los EE. UU.  Las exposiciones no representan necesariamente un envenenamiento o sobredosis, y la AAPCC no puede verificar completamente la exactitud de cada informe.  Las conclusiones basadas en los datos del NPDS no reflejan necesariamente las opiniones de la AAPCC.
 

Image
el Delta-8 THC Tiene Graves Riesgos Para la Salud

Communication Type

Short Title
5 Cosas que Debe Saber Sobre el Delta-8 Tetrahidrocannabinol – Delta-8

Source Organization

Short Description
Los productos de Delta-8 THC no están aprobados por la FDA y pueden ponerle en riesgo.

Publish Date
Thu, 09/16/2021 – 18:05

Review Date
Fri, 09/16/2022 – 12:00

Last Reviewed Date
Thu, 09/16/2021 – 12:00

Site Structure

Next Review Date
1 Year

Navigational Page
Off

Bulk Approved
Off

Display Short Description
Off

First Publish Date
Thu, 09/16/2021 – 12:26

Generic Boolean
Off

Language

Number of Related Information to Display
3

Add Subscription Box
On

Description
Haga clic en “Consumer Health Info” y luego marque “Artículos en español”

Email Subscription List

Header
Subscríbase a los Artículos para el Consumidor en español

#CBD #Hemp http://www.fda.gov/consumers/articulos-en-espanol/5-cosas-que-debe-saber-sobre-el-delta-8-tetrahidrocannabinol-delta-8-thc September 16, 2021 4:02 pm

FDA Issues Warnings on Delta-8 THC Products

FDA Issues Warnings on Delta-8 THC Products

On September 14, the FDA published a consumer update on their website, seeking to educate the public and offer a public health warning on delta-8 tetrahydrocannabinol, otherwise known as delta-8 THC.

For the uninitiated, delta-8 THC is a cannabinoid that can be synthesized from cannabidiol (CBD) derived from hemp. It is an isomer of delta-9 THC, the more commonly known psychoactive cannabinoid found in cannabis. Delta-8 THC does produce psychoactive effects, though not quite as much as its better-known cousin, delta-9 THC.

FDAlogoDue to loopholes in federal and state laws, namely the 2018 Farm Bill specifying that hemp must contain less than 0.3% Delta-9 THC, delta-8 THC is technically legal across the country. It grew in popularity across the United States very quickly over the past year, largely due to online sales.

Following the surge in sales, a number of states including Colorado, Alaska, Arizona, Arkansas, Delaware, Idaho, Iowa, Mississippi, Montana, Rhode Island, Utah and Washington have implemented some form of regulation or outright ban on products containing delta-8 THC. Christopher Hudalla, president and chief scientific officer of ProVerde Laboratories, told Chemical & Engineering News that he has a lot of safety concerns about the whole delta-8 THC craze. Hudalla says he’s more concerned about the processing involved to produce it in large quantities. “These are pretty aggressive synthetic conditions that use strong acids,” Hudalla says. “They might be using strong bases to neutralize. They can use metal catalysts. I hear different people doing it different ways.”

The FDA’s consumer update included this picture at the top of the page

The FDA shares similar concerns. Their fourth point in the consumer update mentions that delta-8 THC products “often involve use of potentially harmful chemicals” in its production. They even claim that some manufacturers might be using unsafe household chemicals to synthesize delta-8 THC. “The final delta-8 THC product may have potentially harmful by-products (contaminants) due to the chemicals used in the process, and there is uncertainty with respect to other potential contaminants that may be present or produced depending on the composition of the starting raw material,” reads the FDA report.

In their consumer update, they note that between December 2020 and July 2021, they received 22 adverse event reports. Of the 22 reports, 14 were hospitalized following ingesting a delta-8 THC product. Notably, those reports included reactions consistent with symptoms from overconsumption of delta-9 THC, such as vomiting, hallucinations, trouble standing, and loss of consciousness.

The chemical structure of Delta 8 THC.

The FDA says that national poison control centers received 661 cases of delta-8 THC products, with 41% being unintentional exposure, 39% involved pediatric patients and 18% required hospitalization.

In the consumer update, they tell the public that delta-8 THC products have not been evaluated by the FDA and that they “may be marketed in ways that put the public health at risk.” This includes marketing it as a hemp product, which it is. Still though, many consumers associate hemp products with somewhat innocuous things, like CBD oil, which is mostly harmless.

The FDA also mentions in the update that delta-8 THC does have psychoactive and intoxicating effects. The FDA says they are notifying the public about the delta-8 THC due to an uptick in adverse event reports, marketing that is appealing to children and concerns regarding manufacturing with unsafe chemicals and contaminants.

The post FDA Issues Warnings on Delta-8 THC Products appeared first on Cannabis Industry Journal.


#CBD #Hemp

FDA Issues Warnings on Delta-8 THC Products


September 15, 2021 9:30 pm

GPS and GCNC Join Forces to Build a Stronger Cannabis Industry

GPS and GCNC Join Forces to Build a Stronger Cannabis Industry

Gateway Proven Strategies (GPS.Global), a team of sustainable cannabis, hemp, and CBD consultants, recently acquired the Global Cannabis Network Collective (GCNC). 

The GCNC, founded by Chris Day and Jillian Reddish, is a growing network of cannabis professionals working to accelerate international cannabis trade.

While Day and Reddish will continue to operate the GCNC, they will also be overseeing GPS executive positions and joining the GPS Board of Directors.

Day and Reddish will assume the titles of Chief Marketing Officer and Senior Vice President for Communications, respectively. 

“The GCNC is known for a culture of C-Suite members who understand the value in knowledge shared across sectors and cultures. That understanding is also an essential ingredient in the collaborative client relationships that GPS is known for. By expanding this ecosystem of cannabis leaders, everybody wins,” said Day.

“The GCNC will continue to operate as it has but this acquisition provides more support and depth of expertise to serve the goals of GCNC members worldwide.”

Prior to founding the GCNC, Day created Project Evolve, which is a marketing think tank for small or emerging businesses to gain marketing leadership skills, business expertise, and hands-on experience within the cannabis space.

On the GCNC’s website, Day said he spent years creating trusted partnerships and now wants to collectively build an industry, supporting other businesses in the process. With the GPS partnership, Day will be doing just that.

This acquisition will open new pathways for GPS to further support the development of cannabis as an economic accelerator.

The company will be working with sizable and modest companies, well-capitalized individuals, capital fund managers, and global governments to minimize risk and responsibly maximize return.


#CBD #Hemp
https://cannatechtoday.com/gps-and-gcnc-join-forces-to-build-a-stronger-cannabis-industry/
September 15, 2021 9:00 am

Royal Blend CBD Gummies Reviews – 10 Shocking Reasons To Use It

Royal Blend CBD Gummies Reviews – 10 Shocking Reasons To Use It

Royal Blend CBD Gummies are a clinically-tested product made of natural ingredients to assist consumers in treating their stress, depression, anxiety, mental pain, chronic pain, melancholy, and other diseases of the body. 

The daily consumption of this product will boost the overall mental health of the consumers naturally. 

This product comes in the form of tasty gummies, which consumers will have to chew daily by following all the terms and conditions of the product. 

These chewable gummies are made of a natural extract of pure hemp CBD and other natural components so that users of the product can easily reduce their stress, depression, anxiety, acne, and other mental torments. 

These tasty gummies come in different colors, sizes, and shapes. 

What To Know More Click Here Royal Blend CBD Gummies

What Are Royal Blend CBD Gummies?

This is a scientifically tested formula that is composed of a variety of natural ingredients so that various mental torments of the consumers can be addressed easily and naturally. 

This CBD gummy product will provide various therapeutic benefits to the consumers so they can easily improve overall health and get rid of all kinds of pains and inflammation of the body. 

This CBD gummy is an all-natural product, which is made of natural ingredients with the help of which users can overcome all kinds of mental torments of the body. 

Royal Blend CBD Gummies are made of gelatin and various other natural substances to give a natural boost to the overall health and fitness of consumers.

 Check here Available Discount Price Royal Blend CBD Gummies

What Natural Ingredients Are Used In Making These Royal Blend CBD Gummies?

All the components used in making these CBD gummies are known to be pain-curing, effective, natural, safe, pure, and 100% free from all kinds of adulterated and toxic components. 

With the daily consumption of these CBD gummies, consumers of this product will not get high and they will not be suffering from any psychoactive effects. 

These CBD-based gummies will boost the overall health and fitness of the consumers. 

This CBD gummy product will make sure that consumers do not suffer from any sort of mental pain, stress, depression, acne, high and low blood pressure, hypertension, skin diseases, and so on. 

Royal Blend CBD Gummies are made of natural ingredients that are helpful in treating several mental and physical health ailments of the consumers naturally.

 

What Are The Health Benefits Of Consuming These Royal Blend CBD Gummies?

  • The daily consumption of these CBD-based gummies will surely treat depression, stress, anxiety, mental pain, headache, and other health issues. These CBD gummies will not let consumers go through these mental torments anymore in their life.
  • Royal Blend CBD Gummies are useful for treating insomnia and other sleeping disorders. These tasty gummies will cause sleepless nights and sleeping disorders naturally and easily. 
  • These CBD-infused gummies are prepared with natural and pain-curing ingredients. And consumers can easily deal with all their mental torments. These CBD delicious gummies will boost the overall health of the consumers easily.
  • The consumption of these gummies will make sure that consumers do not suffer from pain and inflammation of the joints. As per the makers of these gummies, with the daily consumption of these gummies, the health of joints and muscles will also improve with no side effects.
  • The daily use of these CBD gummies will enhance the overall health and fitness of the consumers. These CBD gummies will cure the overall mental health of the consumers with no side effects.
  • These CBD gummies cure the problem of high and low blood pressure by maintaining the blood circulation of the body naturally. These CBD gummies will easily address the blood flow of the body. 
  • The metabolism of the body will also be cured and boosted naturally. These CBD gummies will easily take care of the metabolic rate of the body with no side effects. These CBD gummies will also boost the immunity of the body due to which consumers become able to fight stress, depression, viruses, infections, and other health problems.
  • The daily consumption of these CBD gummies will also deal with respiratory diseases such as breathing problems, etc. These CBD-infused gummies will easily take care of the overall health and fitness of the consumers. 
  • As per the makers of these gummies, the daily utilization of this CBD gummy product will deal with cancer and hazardous diseases of the consumers. 

 

What Is The Procedure Of Consuming These Royal Blend CBD Gummies?

To use these CBD-infused gummies, consumers of this product will have to use the product daily and under the guidance of the doctor. With the doctor’s permission, consumers will have to use this CBD gummy product daily and once in the morning and once in the evening by complying with all terms and conditions of the product. 

Royal Blend CBD Gummies will deliver various therapeutic benefits to consumers. 

This CBD gummy product will easily and naturally remove stress, depression, anxiety, high and low blood pressure, acne, and other mental torments of the consumers.

Where To Buy These Royal Blend CBD Gummies?

To buy these Royal Blend CBD Gummies, consumers can make a visit to the official site of the product and from the site, they can easily buy this CBD gummy product with no side effects. 

These CBD-infused gummies will be available at some cheap and affordable prices. On the official site, consumers will have to fill the form by filling in all the required details such as name, address, city, and so on. 

Once the form is filled with all the basic information then, the product will be delivered within a week. 

In case, consumers find any difficulty in filling the form or if they want to know about the product then getting in touch with the customer care of the product would be the most effective and most suitable option.

 Order Now Royal Blend CBD Gummies Official Website

 

Who Is Not Eligible To Consume These Royal Blend CBD Gummies?

  • Royal Blend CBD Gummies are not made to be consumed by people who are below the age of 18. If you are a person who is under the age of 18 then, you are not allowed to use this CBD gummy product.
  • If you are a pregnant lady and breastfeeding mother then the consumption of these CBD gummies will not be good for your health and body. And that’s why do not forget to take the advice of the doctor.
  • If you are suffering from big diseases then consumption of these CBD gummies will not be effective in this case also.
  • If you are addicted to smoking and drinking then the consumption of these gummies will also not be good in this case as well.

The Ultimate Words On Royal Blend CBD Gummies:

With the daily consumption of these gummies, consumers can get rid of all kinds of mental and physical health issues such as stress, depression, anxiety, acne, hypertension, mental pain, and so on. 

This CBD gummy product will easily let consumers improve their overall health and fitness and all kinds of mental torments are cured naturally. 

These little size gummies are useful for alleviating stress, depression, mental pain, acne, and other issues. 

Royal Blend CBD Gummies are made for men and women who are above the age of 18 and comply with all the terms and conditions of the product. 

These CBD-infused gummies will take care of the entire health and lifestyle of the consumers.  


#CBD #Hemp
https://cannatechtoday.com/royal-blend-cbd-gummies-reviews-10-shocking-reasons-to-use-it/
September 7, 2021 11:00 am

Leaders in Cannabis Formulations: Part 3 – RealSleep

Leaders in Cannabis Formulations: Part 3 – RealSleep

Sleep health is a large and growing global market. According to Statista, the global market value of the sleep market was $432B in 2019 with an expected CAGR of 6.3% from 2019 to 2024. Supplements are a growing category of popular sleep health products with common ingredients including melatonin, valerian root, and more recently cannabinoids such as CBD and CBN.

RealSleep is a cannabinoid formulation company developing personalized products to improve sleep outcomes. RealSleep’s product strategy has been developed by top scientists and sleep experts, and clinically tested to aid individuals seeking to fall asleep faster, sleep deeper and cut down on sleep disturbances. Their studies have shown that 90% of people taking RealSleep have reported experiencing better sleep immediately

We spoke with Michael Kamins, co-founder and partner of OpenNest Labs and RealSleep, about RealSleep’s innovation in personalized formulations for better sleep. Kamins founded RealSleep as an incubated company under OpenNest Labs, where he is also a founding partner. Michael is the Chief Community Officer of the Wholistic Research and Education Foundation, and just led the world’s largest study on CBD and general health with Wholistic and Radicle Science, where he is also an advisor. Prior to RealSleep, Michael worked in tech where he was an early employee at Musical.ly (now TikTok) building brand partnerships.

Aaron Green: How did you get involved in the cannabis industry?

Michael Kamins, co-founder and partner of OpenNest Labs and RealSleep.

Michael Kamins: I got into the industry professionally about two and a half years ago, but my relationship with the plant goes back to high school. Prior to jumping into this space, I was working primarily in digital media. I was an early employee at Musical.ly, (eventually rebranded as TikTok), leading global music partnerships and growth. I helped grow that business by leveraging the social capital of music artists and celebrities and doing partnerships with record labels. At the end of 2018, I really saw the opportunity in the cannabis space. One of my best friends in Los Angeles, Dr. Jeff Chen, someone I did my MBA with at UCLA, became the founder and executive director of cannabis research at UCLA Medical. Seeing all the clinical research that he was doing and the objective health outcome data coming out of that research was really a huge inspiration to me. I saw a massive whitespace and opportunity to help build that bridge between the medical community and the cannabis marketplace. There’s been almost a century of cannabis prohibition setting back our scientific understanding of the plant. We know more about the rivers and plants in the Amazon than we do about the composition and compounds within the cannabis plant with regards to their wellness benefits.

I met my partners, Tyler Wakstein, Kris Bjornerud and Max Goldstein and we started a cannabis venture studio called OpenNest Labs, which is building out a diversified portfolio of cannabis consumer brands. We are focused on leveraging our collective experience at building ventures and communities and rallying those communities around a brand.

Over the last two and a half years, it’s been super exciting building brands that you see on shelves. We’re still in the early stages right now of building brand loyalty. A lot of cannabis consumers are still going into dispensaries and asking, “what is the cheapest product that I can buy with the highest potency?”

Green: Tell me about RealSleep, how did you come up with the idea and what is the basic concept for the end user?

Kamins: RealSleep comes from the passion that I had developed for medicinal aspects of the cannabis and hemp plant, thinking about not only THC and CBD – which are two major cannabinoids in the plant – but also thinking about the other 120 plus cannabinoids, each with their own unique properties.

It turns out that half the world’s population suffers from one poor night of sleep a week, and sleep issues lead to the highest rate of other comorbidities. We were thinking about the addressable sleep market, with ourselves being a part of that market, and wanting to build products that would help not only ourselves, but the countless other people around the world that suffer from poor sleep too, as it impacts their daily lives.

I’ve had issues with sleep myself. I have a genetic hearing condition called tinnitus. It’s a ringing in your ears that other people can experience environmentally from exposure to loud noises. I’ve had loud ringing in my ears my entire life even in quiet situations, like right before I go to sleep. I’ll often be lying in bed awake for an hour or two unable to sleep with the ringing. Everyone else on the team has had their own sleep issues and realized the profound negative impact of lack of sleep on other areas of health and wellness, whether it be next day energy or immunity.

We felt that by leveraging our access to the medical research community and even running clinical research on our own to validate the efficacy of the product relative to other products on the shelves, we could create a product that was safe and effective. We came across a clinical trial on insomnia and CBD by one of our research partners, the Wholistic Research and Education Foundation. What we saw from a lot of that anecdotal data was that CBD, and hemp in general, really helps to provide restful and restorative sleep.

CBD and CBN are two highly effective compounds for sleep and melatonin is by far the most widely researched and used over the counter sleep aid. We are sourcing clinical research on other ingredients such as valerian root, L-Theanine and GABA, and the list of ingredients goes on. We were interested in formulating a product that incorporates these safe and effective ingredients.

We noticed from our research and our access that sleep is as unique to an individual as their fingerprint. Take brainwave patterns when you are sleeping as an example. No one person’s patterns are the same. You could essentially identify an individual based on those patterns. One solution, or one product, is not going to help everyone. So, we worked with UCLA and the head of their laboratory of sleep and circadian medicine, a gentleman by the name of Dr. Chris Colwell, to understand the science of sleep. He is one of the most renowned sleep researchers in the world and is the head of our scientific advisory board for RealSleep. We’ve done clinical studies with over 900 people and 10,200 nights of sleep and used this data to develop a personalization engine in the form of a quiz that takes 90 seconds and allows us to map ingredients to specific answer selections. From these answers we deliver products that are customized to the individual consumer specific to their unique needs

We’re proud of the journey that we’ve gone on to understand the science and research behind sleep and to develop this personalization engine variations of products that work for each individual and their unique needs.

Green: Tell me how the questionnaire and personalization engine works. I understand the ingredient profile will change based on the customer’s responses?

Kamins: Sleep impacts an individual’s general health and wellness. For me, if I don’t sleep well, my next day is filled with anxiety, and that anxiety leads to worse sleep; it’s a vicious cycle. For other people, it could be a metabolic issue that leads to poor sleep or poor sleep that leads to weight issues. The list of other health issues and diseases linked to poor sleep goes on. So, while we’re looking at combating sleep to prevent other health issues down the road, one person who’s looking to get better sleep to improve one aspect of their life could be different from another person and the area of life they are looking to improve upon.

The quiz is essentially a combination of validated, reliable and flexible measures of patient reported outcomes. We use a combination of gold standard patient reported sleep questionnaires, one of which is called the Pittsburgh Sleep Quality Index, another being the RAND MOS scale, and others. We also work with our scientific advisory board and machine learning experts to advise us on customizing these questions with logic. We then use the responses to generate the appropriate formulations for our customers.

The questions cover everything from very specific questions on sleep, like sleep latency (the time it takes to get the bed) or sleep fragmentation (the number of times you wake up in the middle of the night) sleep duration, sleep quality, and then other areas of health that you’re looking to improve upon. Examples include metabolism, cardiovascular health, skin health, anxiety and stress. So, all these things factor into the different ingredients that we layer into the formulation.

Let’s say you don’t have a problem getting to sleep, but you wake up a lot of times in the middle of the night. Your formulation might be very different from someone who has trouble getting to sleep, but they don’t wake up in the middle of the night. Overall, one of our big goals with the formulation of all these products is that they increase your next day cognitive alertness by giving you that high sleep quality and restorative sleep. We don’t want to make anyone groggy the next day. Because overall, what you’re trying to achieve with sleep is you want to be ready to go the next day and be able to perform at your peak.

Green: So, you mentioned CBD, CBN and melatonin already as ingredients. Are there any other ingredients?

Kamins: Depending on what your answer selections are for the quiz, we will layer in L-Theanine, valerian root, Ashwagandha and even some of the other novel cannabinoids like CBC (cannabichromene). We have about 24 different ingredients that we can layer in, so it just depends. When you look at all the permutations and combinations of formulations and dosages, it’s in the trillions. From a supply chain standpoint, we’ve simplified it in a way that makes it very easy to funnel people into one of many predefined combinations of ingredients and dosage levels.

Our algorithm is an unstructured machine learning algorithm. The more people that take the quiz and the more people that provide feedback on their sleep score makes our programming and our personalization engine smarter.

Green: How does your manufacturing and packaging work?

Kamins: We have a strong relationship with a pharmaceutical partner that we have been growing even before RealSleep. It is a pharmaceutical manufacturing facility underneath a regional health care provider in the state of California. Everything they do is incredible. It’s a state-of-the-art facility and focused on complete transparency and building the products with the highest efficacy and safety profiles. They’re based in LA, and they’ve been such a pleasure to build our supply chain with.

Green: What kind of trends are you looking at in the formulation space?

Kamins: From a cannabinoid side, there’s been a bit more of a look towards some of the novel cannabinoids that have traditionally catered to a niche consumer base that is educated on cannabis. From being inside the industry, it’s very easy for me to talk about all the different cannabinoids, but a lot of people still don’t even know the difference between THC and CBD.

Our goal overall is to build efficacious products and educate people on all the different formulations and the different ingredients going in. Outside of cannabis, this year we’ve seen a large boom in consumer demand for Ashwagandha. There’s just so much hype around it in terms of how it impacts stress and energy and even libido, which is interesting. It’s probably the hottest non-cannabinoid ingredient that we’ve seen. Specific to sleep, the combination of L-Theanine and GABA and how they potentiate each other is impactful. Then there’s valerian root, which has been a big one over the last few years for sleep.

Green: Last question. What are you most interested in learning about?

Kamins: A personal interest of mine over the last few years is understanding from a scientific perspective, each of the cannabis compounds in greater detail. I think part of it is just really the curiosity to know the unknown. We’re at a point in the industry where there are still so many unknowns on the science-side of cannabinoids.

My passion for science has led me to support medical researchers in the space, so much so that I am an advisor and chief community officer to a nonprofit medical research organization called the Wholistic Research and Education Foundation, which to date has funded over six and a half million dollars in human clinical trials with cannabinoid rich therapeutics. One we’re currently conducting at UC San Diego is studying the impact of CBD on autism and other neurological conditions. That’s given me incredible exposure to research in the space. I am also a strategic advisor to a for profit medical research organization called Radicle Science, which is a very swiftly running clinical research for CBD and other cannabis brands in the space.

All in all, I’m driven by the possibilities that come with continuing to unlock the science behind the plant. By doing so, we can innovate products with efficacy and can educate people who are uninformed about the therapeutic benefits of cannabis, which will in turn benefit the industry and society. Striving for research breakthroughs and being transparent about our findings is going to help us destigmatize cannabis and legitimize the industry. 

Green: That concludes the interview. Thanks, Michael!

Kamins: Thanks, Aaron.

The post Leaders in Cannabis Formulations: Part 3 – RealSleep appeared first on Cannabis Industry Journal.


#CBD #Hemp

Leaders in Cannabis Formulations: Part 3 – RealSleep


September 3, 2021 5:39 pm

Leaders in Cannabis Formulations: Part 3 – RealSleep

Leaders in Cannabis Formulations: Part 3 – RealSleep

Sleep health is a large and growing global market. According to Statista, the global market value of the sleep market was $432B in 2019 with an expected CAGR of 6.3% from 2019 to 2024. Supplements are a growing category of popular sleep health products with common ingredients including melatonin, valerian root, and more recently cannabinoids such as CBD and CBN.

RealSleep is a cannabinoid formulation company developing personalized products to improve sleep outcomes. RealSleep’s product strategy has been developed by top scientists and sleep experts, and clinically tested to aid individuals seeking to fall asleep faster, sleep deeper and cut down on sleep disturbances. Their studies have shown that 90% of people taking RealSleep have reported experiencing better sleep immediately

We spoke with Michael Kamins, co-founder and partner of OpenNest Labs and RealSleep, about RealSleep’s innovation in personalized formulations for better sleep. Kamins founded RealSleep as an incubated company under OpenNest Labs, where he is also a founding partner. Michael is the Chief Community Officer of the Wholistic Research and Education Foundation, and just led the world’s largest study on CBD and general health with Wholistic and Radicle Science, where he is also an advisor. Prior to RealSleep, Michael worked in tech where he was an early employee at Musical.ly (now TikTok) building brand partnerships.

Aaron Green: How did you get involved in the cannabis industry?

Michael Kamins, co-founder and partner of OpenNest Labs and RealSleep.

Michael Kamins: I got into the industry professionally about two and a half years ago, but my relationship with the plant goes back to high school. Prior to jumping into this space, I was working primarily in digital media. I was an early employee at Musical.ly, (eventually rebranded as TikTok), leading global music partnerships and growth. I helped grow that business by leveraging the social capital of music artists and celebrities and doing partnerships with record labels. At the end of 2018, I really saw the opportunity in the cannabis space. One of my best friends in Los Angeles, Dr. Jeff Chen, someone I did my MBA with at UCLA, became the founder and executive director of cannabis research at UCLA Medical. Seeing all the clinical research that he was doing and the objective health outcome data coming out of that research was really a huge inspiration to me. I saw a massive whitespace and opportunity to help build that bridge between the medical community and the cannabis marketplace. There’s been almost a century of cannabis prohibition setting back our scientific understanding of the plant. We know more about the rivers and plants in the Amazon than we do about the composition and compounds within the cannabis plant with regards to their wellness benefits.

I met my partners, Tyler Wakstein, Kris Bjornerud and Max Goldstein and we started a cannabis venture studio called OpenNest Labs, which is building out a diversified portfolio of cannabis consumer brands. We are focused on leveraging our collective experience at building ventures and communities and rallying those communities around a brand.

Over the last two and a half years, it’s been super exciting building brands that you see on shelves. We’re still in the early stages right now of building brand loyalty. A lot of cannabis consumers are still going into dispensaries and asking, “what is the cheapest product that I can buy with the highest potency?”

Green: Tell me about RealSleep, how did you come up with the idea and what is the basic concept for the end user?

Kamins: RealSleep comes from the passion that I had developed for medicinal aspects of the cannabis and hemp plant, thinking about not only THC and CBD – which are two major cannabinoids in the plant – but also thinking about the other 120 plus cannabinoids, each with their own unique properties.

It turns out that half the world’s population suffers from one poor night of sleep a week, and sleep issues lead to the highest rate of other comorbidities. We were thinking about the addressable sleep market, with ourselves being a part of that market, and wanting to build products that would help not only ourselves, but the countless other people around the world that suffer from poor sleep too, as it impacts their daily lives.

I’ve had issues with sleep myself. I have a genetic hearing condition called tinnitus. It’s a ringing in your ears that other people can experience environmentally from exposure to loud noises. I’ve had loud ringing in my ears my entire life even in quiet situations, like right before I go to sleep. I’ll often be lying in bed awake for an hour or two unable to sleep with the ringing. Everyone else on the team has had their own sleep issues and realized the profound negative impact of lack of sleep on other areas of health and wellness, whether it be next day energy or immunity.

We felt that by leveraging our access to the medical research community and even running clinical research on our own to validate the efficacy of the product relative to other products on the shelves, we could create a product that was safe and effective. We came across a clinical trial on insomnia and CBD by one of our research partners, the Wholistic Research and Education Foundation. What we saw from a lot of that anecdotal data was that CBD, and hemp in general, really helps to provide restful and restorative sleep.

CBD and CBN are two highly effective compounds for sleep and melatonin is by far the most widely researched and used over the counter sleep aid. We are sourcing clinical research on other ingredients such as valerian root, L-Theanine and GABA, and the list of ingredients goes on. We were interested in formulating a product that incorporates these safe and effective ingredients.

We noticed from our research and our access that sleep is as unique to an individual as their fingerprint. Take brainwave patterns when you are sleeping as an example. No one person’s patterns are the same. You could essentially identify an individual based on those patterns. One solution, or one product, is not going to help everyone. So, we worked with UCLA and the head of their laboratory of sleep and circadian medicine, a gentleman by the name of Dr. Chris Colwell, to understand the science of sleep. He is one of the most renowned sleep researchers in the world and is the head of our scientific advisory board for RealSleep. We’ve done clinical studies with over 900 people and 10,200 nights of sleep and used this data to develop a personalization engine in the form of a quiz that takes 90 seconds and allows us to map ingredients to specific answer selections. From these answers we deliver products that are customized to the individual consumer specific to their unique needs

We’re proud of the journey that we’ve gone on to understand the science and research behind sleep and to develop this personalization engine variations of products that work for each individual and their unique needs.

Green: Tell me how the questionnaire and personalization engine works. I understand the ingredient profile will change based on the customer’s responses?

Kamins: Sleep impacts an individual’s general health and wellness. For me, if I don’t sleep well, my next day is filled with anxiety, and that anxiety leads to worse sleep; it’s a vicious cycle. For other people, it could be a metabolic issue that leads to poor sleep or poor sleep that leads to weight issues. The list of other health issues and diseases linked to poor sleep goes on. So, while we’re looking at combating sleep to prevent other health issues down the road, one person who’s looking to get better sleep to improve one aspect of their life could be different from another person and the area of life they are looking to improve upon.

The quiz is essentially a combination of validated, reliable and flexible measures of patient reported outcomes. We use a combination of gold standard patient reported sleep questionnaires, one of which is called the Pittsburgh Sleep Quality Index, another being the RAND MOS scale, and others. We also work with our scientific advisory board and machine learning experts to advise us on customizing these questions with logic. We then use the responses to generate the appropriate formulations for our customers.

The questions cover everything from very specific questions on sleep, like sleep latency (the time it takes to get the bed) or sleep fragmentation (the number of times you wake up in the middle of the night) sleep duration, sleep quality, and then other areas of health that you’re looking to improve upon. Examples include metabolism, cardiovascular health, skin health, anxiety and stress. So, all these things factor into the different ingredients that we layer into the formulation.

Let’s say you don’t have a problem getting to sleep, but you wake up a lot of times in the middle of the night. Your formulation might be very different from someone who has trouble getting to sleep, but they don’t wake up in the middle of the night. Overall, one of our big goals with the formulation of all these products is that they increase your next day cognitive alertness by giving you that high sleep quality and restorative sleep. We don’t want to make anyone groggy the next day. Because overall, what you’re trying to achieve with sleep is you want to be ready to go the next day and be able to perform at your peak.

Green: So, you mentioned CBD, CBN and melatonin already as ingredients. Are there any other ingredients?

Kamins: Depending on what your answer selections are for the quiz, we will layer in L-Theanine, valerian root, Ashwagandha and even some of the other novel cannabinoids like CBC (cannabichromene). We have about 24 different ingredients that we can layer in, so it just depends. When you look at all the permutations and combinations of formulations and dosages, it’s in the trillions. From a supply chain standpoint, we’ve simplified it in a way that makes it very easy to funnel people into one of many predefined combinations of ingredients and dosage levels.

Our algorithm is an unstructured machine learning algorithm. The more people that take the quiz and the more people that provide feedback on their sleep score makes our programming and our personalization engine smarter.

Green: How does your manufacturing and packaging work?

Kamins: We have a strong relationship with a pharmaceutical partner that we have been growing even before RealSleep. It is a pharmaceutical manufacturing facility underneath a regional health care provider in the state of California. Everything they do is incredible. It’s a state-of-the-art facility and focused on complete transparency and building the products with the highest efficacy and safety profiles. They’re based in LA, and they’ve been such a pleasure to build our supply chain with.

Green: What kind of trends are you looking at in the formulation space?

Kamins: From a cannabinoid side, there’s been a bit more of a look towards some of the novel cannabinoids that have traditionally catered to a niche consumer base that is educated on cannabis. From being inside the industry, it’s very easy for me to talk about all the different cannabinoids, but a lot of people still don’t even know the difference between THC and CBD.

Our goal overall is to build efficacious products and educate people on all the different formulations and the different ingredients going in. Outside of cannabis, this year we’ve seen a large boom in consumer demand for Ashwagandha. There’s just so much hype around it in terms of how it impacts stress and energy and even libido, which is interesting. It’s probably the hottest non-cannabinoid ingredient that we’ve seen. Specific to sleep, the combination of L-Theanine and GABA and how they potentiate each other is impactful. Then there’s valerian root, which has been a big one over the last few years for sleep.

Green: Last question. What are you most interested in learning about?

Kamins: A personal interest of mine over the last few years is understanding from a scientific perspective, each of the cannabis compounds in greater detail. I think part of it is just really the curiosity to know the unknown. We’re at a point in the industry where there are still so many unknowns on the science-side of cannabinoids.

My passion for science has led me to support medical researchers in the space, so much so that I am an advisor and chief community officer to a nonprofit medical research organization called the Wholistic Research and Education Foundation, which to date has funded over six and a half million dollars in human clinical trials with cannabinoid rich therapeutics. One we’re currently conducting at UC San Diego is studying the impact of CBD on autism and other neurological conditions. That’s given me incredible exposure to research in the space. I am also a strategic advisor to a for profit medical research organization called Radicle Science, which is a very swiftly running clinical research for CBD and other cannabis brands in the space.

All in all, I’m driven by the possibilities that come with continuing to unlock the science behind the plant. By doing so, we can innovate products with efficacy and can educate people who are uninformed about the therapeutic benefits of cannabis, which will in turn benefit the industry and society. Striving for research breakthroughs and being transparent about our findings is going to help us destigmatize cannabis and legitimize the industry. 

Green: That concludes the interview. Thanks, Michael!

Kamins: Thanks, Aaron.

The post Leaders in Cannabis Formulations: Part 3 – RealSleep appeared first on Cannabis Industry Journal.


#CBD #Hemp

Leaders in Cannabis Formulations: Part 3 – RealSleep


September 3, 2021 5:39 pm

Colorado to Bolster Hemp Testing Rules, Rollout Delayed

Colorado to Bolster Hemp Testing Rules, Rollout Delayed

Earlier this year, the Colorado Department of Public Health and Environment (CDPHE) announced a plan to introduce new testing rules for the state’s growing hemp industry. Under the new regulations, hemp products must be tested for residual solvents, heavy metals and pesticides, in addition to making sure they contain less than 0.3% THC.

The CDPHE are planning on a gradual rollout to prevent any supply chain issues or a lab testing bottleneck, similar to what we’ve seen in other states launching new testing requirements in years past, such as Arizona or California. Well, the Colorado rollout appears to be hitting similar snags and because of supply chain issues related to instruments and consumables in laboratories, the implementation of those testing rules is somewhat delayed. What was originally supposed to be implemented over the summer was pushed back to an October 1 deadline, and that deadline has now been pushed back to 2022.

The pesticide testing list to be implemented January 1, 2022

As a result of supply chain shortages and the learning curve to test for such a wide range of pesticides, Colorado is opening hemp testing to out-of-state labs in an effort to stay on schedule with the rollout. Dillon Burns, lab manager at InfiniteCAL, a cannabis testing company with locations in California and Michigan, just completed an audit with the CDPHE in their work to get certified and start conducting hemp testing for businesses in Colorado.

Burns says they’re well-acquainted with the list of pesticides because of how similar the list is to California’s requirements. “For the pesticide testing rules that were supposed to go into effect on August 1st, it’s basically the same list as California just with slightly different action levels,” says Burns. “I would say these action limits are generally stricter – they have much lower LOQs [limits of quantification].”

The pesticide testing list (continued) to be implemented January 1, 2022

Come January 1, 2022, they are expecting an additional 40 pesticides to be required under the new rules. “But currently, it’s still unclear when these regulations will actually go into effect,” says Burns. The full pesticide testing list is currently slated to be implemented on April 1, 2022.

The supply chain issues referenced above have a lot to do with what the state is asking labs to test for. Previously, most of the pesticides tested for under Colorado’s adult use and medical cannabis programs could be analyzed with an LC/MS. A handful of pesticides on the new list do require GC/MS, says Burns. It’s entirely possible that a lot of labs in Colorado just don’t have a GC/MS or are in the process of training staff and developing methods for using the new instrument. “Cleanliness of these instruments is such a priority that it takes time to acquire the right skill set for it,” says Burns.

Dillon Burns, Lab Manager at InfiniteCAL

The new testing rollout isn’t just another compliance hurdle for the cannabis industry; these rules are about protecting public health. Dillon Burns said he’s seen hiccups in California with the amount of new hemp farmers getting into the space. “The hemp products we’ve tested in California often fail for pesticides,” says Burns. It’s a lot easier in most states to get a license for growing hemp than it would be for growing adult use cannabis. “You’ll see a lot more novice growers getting into hemp farming without a background in it. They’ll fail for things they just haven’t considered, like environmental drift. We see a lot of fails in CA. Hemp is bioaccumulating so it presents a lot of problems. If they’re not required to look for it, they weren’t monitoring it.”

When asked how the market might react to the new rules, Burns was confident that Colorado knows what they’re doing. “I don’t anticipate that [a testing bottleneck] happening here. The regulators are reasonable, supportive of the industry and opening it up to out-of-state labs should help in preventing that.”

The post Colorado to Bolster Hemp Testing Rules, Rollout Delayed appeared first on Cannabis Industry Journal.


#CBD #Hemp

Colorado to Bolster Hemp Testing Rules, Rollout Delayed


September 2, 2021 4:22 pm

Ad valorem excise taxes are not the way to go for marijuana. 

Ad valorem excise taxes are not the way to go for marijuana. 

Ad valorem excise taxes are not the way to go for marijuana.  Ideological adversaries agree on that, if on little else!  The left-leaning Institute for Taxation and Economic Policy warned, in a detailed report, that ad valorem price-based “ad valorem” taxes on marijuana are a recipe for trouble when prices go down – as they do in every jurisdiction where legalization takes hold. https://itep.org/taxing-cannabis/  

More recently, the right-leaning Tax Foundation has joined the warning:  “states risk losing out on forecasted revenue if prices continue to go down.” https://taxfoundation.org/safe-banking-act-state-marijuana-revenues/

We needn’t use ad valorem taxes at all for marijuana.  The bill phases ad valorem taxes out, but keeps them too long, then compounds the error by de facto freezing them.  

The draft sticks precisely to the early 2017 design of the old Blumenauer-Wyden bill, with ad valorem taxes for five years before switching to “specific” (non-ad valorem) taxes, only at that late date taxing flower by weight and concentrates by THC.  See http://thehill.com/blogs/pundits-blog/economy-budget/327694-marijuana-legalization-grows-closer-with-senate-tax

2017 is a long time ago for a drug that was first legalized in 2012; we’ve come a long way in what we know since then.

That five-year delay may have had some possible justification in 2017, but not now.  But even then, ad valorem taxes were outdated.  Sure, no one was taxing anything by THC content then – but several states had already worked out taxing raw plant matter by weight, the state of the art tax system in 2017.  In the intervening four years since the 2017 bill, Canada, legalizing in 2018, moved straight into taxing flower by weight immediately, and concentrates by THC content about a year later.  No five-year delay!  The system up north seems to be humming.  Lots of states tax by weight already, and Canada has the gold standard using both bases, weight and THC.  I don’t know why we don’t just go ahead and copy it — now.

Taxing by price means that when the pre-tax price goes down, taxes do, too. So do after-tax prices.  Low taxes and cheap weed are not on some people’s wish list, but not everyone’s. After legalization, pre-tax prices are bound to wither.  Fully legal marijuana won’t sell for hundreds or even dozens of dollars per ounce, pre-tax.

But price taxes create another problem. In case of “vertical integration” like a farm-to-market operation, the bill shies away from taxing the actual price the consumer pays, so it imagines an artificial — and probably arbitrary — “constructive sale price” in section 5903.   This is the amount one person, who is both retail clerk and farmer, supposedly pays his farmer self as a wholesale price.  Shenanigans galore!  Colorado has this kind of unworkable producer price tax on the books but, finding it doesn’t work, has quietly given up. Colorado taxes producers by weight instead of by the de jure price-based ad valorem method in related party transactions.  Nevada taxes producers by weight instead of the de jure price-based ad valorem tax on its statute books, last I heard – in all transactions.

— Sent to sponsors of U.S. Senate marijuana bill.


#CBD #Hemp
Ad valorem excise taxes are not the way to go for marijuana. 
September 1, 2021 7:03 pm

6 Trends Influencing the Cannabidiol (CBD) Market Forecast Through 2027

6 Trends Influencing the Cannabidiol (CBD) Market Forecast Through 2027

The rise in the number of optimistic regulatory frameworks instigated by various regional governments will positively anchor the forecast for the cannabidiol (CBD) market. The growing awareness regarding the benefits and effects of the product as an alternative treatment method has accelerated its preference among consumers and suppliers. Moreover, the continued advancements in the approval processes by various authorities worldwide have also made way for numerous opportunities supporting CBD market growth.

According to a report by Global Market Insights, Inc, the global CBD market size could exceed $108.8 billion by 2027.

Growing presence in cosmetics

The overall industry share from creams and roll-on products is poised to hit a 35.8% CAGR up to 2027. This is owing to the increasing scope of CBD in cosmetic applications as it is highly effective in treating skin conditions. This, as well as its anti-inflammatory characteristics from a medicinal perspective, are leading to increased demand for CBD products like creams and roll-ons.

Scope in the treatment of mental health

Some of the many infused products on the market today.

CBD market value from anxiety/stress applications exceeded USD 1.5 billion in 2020 due to the growing need for helping mental health. The World Health Organization reported that over 4.5% of the total population in Europe suffers from depression. This escalating anxiety and stress rate has encouraged healthcare practitioners to increasingly make use of CBD-based medications.

Higher demand for oral administration

Demand for oral cannabidiol administration held nearly 45% of the industry proportion in 2020 due to its growing preference considering the gradual relief of pain compared to other disorders. The increasing dependency on the oral administration route for product development by several manufacturers will add positive impetus to market growth.

Medical benefits of cannabis

Annual revenue of the CBD market from the segment of the market dealing with THC (and CBD) products is expected to cross USD 30.1 billion by 2027. This is largely due to its increasing penetration across various countries and regions on account of its legal status. Furthermore, the relatively higher THC content of the compound has led to its growing usage to combat medical conditions, including Alzheimer’s and Parkinson’s disease, among others.

Online distribution to see a considerable footprint

Ads for CBD products online regularly perform very well

The online CBD industry was responsible for more than 46% of the market in 2020. This is mainly due to the numerous advantages of online channels, like on-time delivery and adequate inventory, compared to their offline counterparts. Besides, this distribution platform minimizes the operational costs related to the maintenance of brick and mortar retail.

Australia to lead the regional landscape

Australia dominated the Asia Pacific CBD market by holding over 25% of the market share owing to the expanding geriatric population and the liberal stance of the regulating bodies in the region. The permittance to the medicinal and cosmetic use of CBD products is likely to spur regional adoption. The rising amendments in regulatory scenarios have also triggered awareness regarding the potential benefits of the product in the country. For instance, in April 2020, the Australian government released a new proposal for over-the-counter CBD in a bid to relax its narcotic scheduling whilst making it a Schedule 3 substance.

Providers of various CBD products are actively indulging in numerous growth strategies, like acquisitions and partnerships, to reinforce their market presence. For example, Mota Ventures Corp., in January 2020, acquired Spanish producer and online retailer, Sativida OU in a USD 2.2 million deal. The acquisition expanded the company’s presence in Europe and Latin America.

Although the demand for CBD is likely to experience certain hesitation from consumers in the short term, the market will witness lucrative growth in the long run. However, counterfeit and substandard quality products may potentially restrain industry expansion to some extent.

The post 6 Trends Influencing the Cannabidiol (CBD) Market Forecast Through 2027 appeared first on Cannabis Industry Journal.


#CBD #Hemp

6 Trends Influencing the Cannabidiol (CBD) Market Forecast Through 2027


September 1, 2021 6:21 pm

Hold Hearings before legalizaing marijuana federally

Hold Hearings before legalizaing marijuana federally

Here’s one of my messages to sponsors of federal marijuana legalization bill:

Dear Senators and Staffers,

On the joint Congressional Committee that devoted four full days of public hearings to liquor taxes alone in December 1933 were a future Supreme Court Justice (Vinson), a future Speaker of the House (McCormack), and a future Vice President (Barkley).  That kind of work might well help Congress today.  The 1933 hearings were hardly a political graveyard for those who took time to listen and study tricky issues.

Those four days covered only taxes, and only liquor – not beer, not wine.  Marijuana legalization needs more work than liquor taxes did in 1933. Unlike with cannabis, we had already had lots of experience taxing liquor.  But Congress studied liquor taxation thoroughly anyway.

Hearings in the Senate Finance Committee on taxes would help, I’d say, as a tax scholar and a former staffer there.  The tax structure in the draft is going to receive severe criticism, only some of it from me, and things have changed dramatically from the Wyden-Blumenauer bill of 2017, whose tax provisions the CAOA basically copies.  Canada has started taxing THC in concentrates, for instance, and New York and Connecticut are going to try to tax it in flower.  These are new developments since 2017 – and warrant a new tax structure.  But what structure?  No one knows. 

There is lot of work for Senators and your staffs to do – and plenty of time to do it in, I suspect, as marijuana legalization will not happen overnight.

In 1933, the Committee heard input from staff, the executive branch, academics, and interested private parties (once known as special interests, now known as stakeholders).  The Ways & Means and Finance Committees reported out a bill in short order, and President Roosevelt signed it in January.  A success story — the result of listening and working.

Here’s the source material, attached. [Newrevenue readers — ask by email for a google drive copy of the large file if you want.]

 Tax on Intoxicating Liquor, Joint Hearings Before the Committee on Ways and Means, House of Representatives and the Committee on Finance, United States Senate, 73d Congress, Interim, 1st and 2d Sessions, Dec. 11-14, 1933, at 309.  


#CBD #Hemp
Hold Hearings before legalizaing marijuana federally
August 29, 2021 9:51 pm

Technical tax comment on federal marijuana bill

Technical tax comment on federal marijuana bill

Comment on the Cannabis Administration and Opportunity Act draft submitted to the Act’s authors:

I don’t understand what (B) is doing in new 26 U.S.C. 5902(a)(2).  

‘‘(2) THC-MEASURABLE CANNABIS PRODUCT.—

The term ‘THC-measurable cannabis product’ means any cannabis product—

‘‘(A) with respect to which the Secretary has made a determination that the amount of tetrahydrocannabinol in such product (or any particular category of products which includes such product) can be measured with a reasonable degree of accuracy—

 ‘‘(i) consistent with good commercial practice, and

 ‘‘(ii) sufficient to protect the revenue and the public, or

 ‘‘(B) which is not cannabis flower and the concentration of tetrahydrocannabinol in which
is significantly higher than the average such concentration in cannabis flower.

+++

 If (A) is satisfied, OK, we know how to measure THC in this product.  Case closed.

If (A) is not satisfied, THC can’t be accurately measured, so at first blush, tax should not be calculated by THC.  

But maybe (B) taxes by THC content something where THC can’t be certifiably accurately measured.  I don’t understand.  (A) alone, without (B), seems to do the job.

(B) seems unnecessary and confusing.  What is (B) supposed to do?  I don’t know.

Thank you.


#CBD #Hemp
Technical tax comment on federal marijuana bill
August 28, 2021 3:43 pm

The profit motive and medical marijuana in North Carolina

The profit motive and medical marijuana in North Carolina

Here are comments on North Carolina SB711 sent to Senators on the Health Committee.

++++

John D. Rockefeller, Jr., was a Baptist teetotaler who opposed alcohol and a Republican businessman who liked the profit motive.  When prohibition was repealed in 1933, Rockefeller didn’t want profit-maximizers retailing liquor.  For health and temperance, he said, let the states themselves sell liquor—and that’s the North Carolina way.  

This bill would let just 10 big companies sell medical cannabis.  If the recreational kind is legalized, those companies will say, “Hooray,” and line up to control the recreational market.  That’s the profit motive.

There’s a more restrictive way than SB711, proven in Canada: Sell medical cannabis only through government retailers—online only, delivered to the patient’s door.  No glitzy storefronts, no marketing to tempt the weak.  No lawsuits claiming cartoons and advertising are protected free speech under the North Carolina Constitution.

Marijuana sellers will say state-run sales are a nonstarter because marijuana is federally illegal, but that’s a diversion.  The federal government simply doesn’t care.  The State of Louisiana has been openly growing and selling marijuana for years – with impunity.  The federal government hasn’t batted an eye.

How about the voters?  In a 2013 North Carolina poll, state marijuana sales beat private sales by 3-to-1.  The full poll with cross-tabs is at https://newtax.files.wordpress.com/2013/03/nc-marijuana-polling-march-2013.pdf.

Sure, if state sales are inept and bureaucratic, the illegal market will step up.  But the kind of licensing proposed in SB711 creates a host of problems.  Medicine will be delayed as folks who didn’t get licenses go to court to protest.  Out-of-state interests will go to court to say the bill’s residence restrictions are unconstitutional.  Winning licensees will go to court to say the bill’s advertising rules improperly restrict free speech under the North Carolina Constitution.  Winning licensees may “flip” valuable licenses for huge sums – and shareholders in winning corporate licensees may “flip” their ownership interests to new shareholders – all for huge windfalls.  And naturally enough, winning licensees will aim to maximize sales and profits.

State sales are no easy answer, but they can be safe, quiet, and restrictive.  The profit motive has its place, but for marijuana, maybe North Carolina can restrict it.

+++

Thank you for this opportunity, and for listening to me and others.  


#CBD #Hemp
The profit motive and medical marijuana in North Carolina
August 28, 2021 2:25 pm

ACS Laboratory Launches Tested Safe Certified Seal Program

ACS Laboratory Launches Tested Safe Certified Seal Program

ACS Laboratory, a cannabis and hemp testing lab based outside of Tampa Bay, Florida, announced the launch of their “Tested Safe Certified Seal” program. The program is designed to help raise standards and put more consumer trust in safe, tested products.

The “Tested Safe Certified Seal” on a hemp oil product

ACS Laboratory is an ISO 17025-accredited and DEA-licensed cannabis testing company founded in 2008. Last year they were certified by the Florida Department of Health to perform cannabis testing for state-licensed cannabis companies. In addition, the company acquired Botanica Testing, Inc. in 2020, adding more than 500 hemp and CBD clients to their portfolio. They now perform hemp testing for clients in more than 44 states.

The “Tested Safe Certified Seal” program allows companies to adorn their products with the trademarked seal following testing, informing consumers that their product has met safety standards and a full panel of compliance tests. “Unlike a mandated QR code that links to a Certificate of Analysis (COA) with detailed test results, the Seal shows visual proof at a glance that consumers can trust a brand,” reads the press release.

The program is also endorsed by the American Cannabinoid Association (ACA). “It is exciting to see our industry legally providing cannabis and cannabis-derived products on a commercial scale,” says Matthew Guenther, founder of the ACA. “As with any consumer product, safety and quality control remain our absolute priority.”

To earn the seal, companies send their products to the ACS lab for a full panel of safety and potency tests. ACS has a scope of services that includes: potency testing for 21 cannabinoids, 38 terpene profiles, 42 residual solvents, screening for 105 pesticides, moisture content, water activity, microbiology panels, heavy metals screening, flavonoid testing for 16 profiles, micronutrient testing, mycotoxins, Vitamin E acetate, shelf life & stability, plant regulators (PGRS), PAH testing and Pharmacokinetic Studies (PK) aka human trials.

The post ACS Laboratory Launches Tested Safe Certified Seal Program appeared first on Cannabis Industry Journal.


#CBD #Hemp

ACS Laboratory Launches Tested Safe Certified Seal Program


August 26, 2021 2:21 pm

ACS Laboratory Launches Tested Safe Certified Seal Program

ACS Laboratory Launches Tested Safe Certified Seal Program

ACS Laboratory, a cannabis and hemp testing lab based outside of Tampa Bay, Florida, announced the launch of their “Tested Safe Certified Seal” program. The program is designed to help raise standards and put more consumer trust in safe, tested products.

The “Tested Safe Certified Seal” on a hemp oil product

ACS Laboratory is an ISO 17025-accredited and DEA-licensed cannabis testing company founded in 2008. Last year they were certified by the Florida Department of Health to perform cannabis testing for state-licensed cannabis companies. In addition, the company acquired Botanica Testing, Inc. in 2020, adding more than 500 hemp and CBD clients to their portfolio. They now perform hemp testing for clients in more than 44 states.

The “Tested Safe Certified Seal” program allows companies to adorn their products with the trademarked seal following testing, informing consumers that their product has met safety standards and a full panel of compliance tests. “Unlike a mandated QR code that links to a Certificate of Analysis (COA) with detailed test results, the Seal shows visual proof at a glance that consumers can trust a brand,” reads the press release.

The program is also endorsed by the American Cannabinoid Association (ACA). “It is exciting to see our industry legally providing cannabis and cannabis-derived products on a commercial scale,” says Matthew Guenther, founder of the ACA. “As with any consumer product, safety and quality control remain our absolute priority.”

To earn the seal, companies send their products to the ACS lab for a full panel of safety and potency tests. ACS has a scope of services that includes: potency testing for 21 cannabinoids, 38 terpene profiles, 42 residual solvents, screening for 105 pesticides, moisture content, water activity, microbiology panels, heavy metals screening, flavonoid testing for 16 profiles, micronutrient testing, mycotoxins, Vitamin E acetate, shelf life & stability, plant regulators (PGRS), PAH testing and Pharmacokinetic Studies (PK) aka human trials.

The post ACS Laboratory Launches Tested Safe Certified Seal Program appeared first on Cannabis Industry Journal.


#CBD #Hemp

ACS Laboratory Launches Tested Safe Certified Seal Program


August 26, 2021 2:21 pm

CBD Use Associated With Improved Emotional Wellness

CBD Use Associated With Improved Emotional Wellness

We are living in the midst of some truly hard times. Due to the ongoing pandemic and many other factors, emotional wellness is something that many people struggle with.

It was estimated that roughly one out of every seven people globally struggled with mental health as of 2017, and it’s likely a safe bet that the problem has only gotten worse.

Emotional wellness is a subset of overall mental health, and is often described as a person’s ability to successfully navigate the stresses that come with life, and to be able to adapt to change during difficult times.

Depression has increased during the pandemic all over the world, as have anxiety and emotional exhaustion, and people are looking for ways to reduce that depression

According to the results of a new study, CBD may be able to help.

CBD And Emotional Wellness

A team of researchers in Brazil recently conducted a clinical trial to explore CBD’s relationship with depression, emotional exhaustion, and anxiety.

The clinical trial conducted by researchers with the University of São Paulo in Brazil involved a cohort of 120 ‘frontline health care professionals’ half of which were administered 300mgs of CBD daily and the other half having not used CBD.

“This randomized clinical trial found that the efficacy and safety of daily treatment with CBD, 300 mg, for 4 weeks combined with standard care was superior to standard care alone for reducing the symptoms of emotional exhaustion, anxiety, and depression among frontline health care professionals working with patients with COVID-19,” the study’s authors stated.

“Cannabidiol may act as an effective agent for the reduction of burnout symptoms among a population with important mental health needs worldwide.” the researchers concluded.

Talk To Your Doctor

It is worth noting that 5 of the cohort subjects that participated in the previously cited study had to drop out of the study due to adverse effects of the CBD products that were used.

That fact should serve as a reminder to people that they should always check with a medical professional prior to incorporating CBD into their treatment regimens, and cease use of CBD if complications arise.

With that being said, CBD helps far more people than it hurts, and there will always be someone that is allergic to just about anything, including certain cannabinoids.

Do your research, evaluate your own situation, and talk to a medical professional to make sure that CBD, or any other cannabinoid, is right for you.


#CBD #Hemp
https://cannatechtoday.com/cbd-use-associated-with-improved-emotional-wellness/
August 25, 2021 11:00 am

Growing a Competitive Advantage from Cultivation to Consumption

Growing a Competitive Advantage from Cultivation to Consumption

There are an increasing number of publicly-traded companies in the evolving North American cannabis sector, all vying for attention.

Yet for this industry to grow, it must embrace the principles of Environmental, Social, and Corporate Governance (ESG) Frameworks and navigate the risks and opportunities inherent in ESG issues.  

Corporations embrace ESG standards for a variety of reasons including access to capital, enhanced risk mitigation and value creation, greater social “license to operate,” customer acquisition, and employee retention.

Greater recognition of the competitive advantage linked to this approach is increasingly making ESG a business fundamental for companies across industry sectors. 

The risks of climate change have brought environmental management to the forefront as a business imperative.

For the cannabis industry, energy and water stewardship are two critical environmental issues all companies must be actively managing.

Estimated at approximately 40% of operational expenses, the energy required for plant cultivation, temperature control, and product manufacturing makes energy management a vital cost consideration.

As global temperatures and the frequency of severe weather events rise, so will the risks associated with energy stewardship and resilience.

Similarly, global water scarcity and its material impact on a wide range of industries make water stewardship a vital component to controlling costs and ensuring business continuity in the future.

Cannabis companies must implement a systematic approach to environmental management and resource stewardship across the value chain, from seed to storefront. 

As the multi-industrial applications for cannabis and hemp become better understood, the range of social risks and opportunities increase.

From a human capital perspective, companies will need employees with a broad range of skill sets and backgrounds to capitalize on the range of potential opportunities.

Developing a clear talent acquisition and retention strategy will become increasingly important.

Similarly, engagement and collaboration across stakeholder groups provide a range of opportunities.

From advancing economic inclusion for marginalized populations to revitalizing distressed rural farming communities, focused stakeholder engagement can mitigate reputational challenges while addressing operational needs and product commercialization.

Cannabis companies need a methodical and consistent approach to governance, especially given the rapid evolution of the industry and its regulatory landscape. A focus on governance prioritizes long-term business continuity amongst managing these risks. To manage the complexity inherent in engaging ESG issues across an enterprise, the composition of the board and management team, and their associated experiences, credentials, and effectiveness, can have a profound impact on ensuring ESG becomes a source of competitive advantage. 

Regennabis and Summit Strategy Group have partnered to provide a range of services that address the most pressing risks and opportunities facing the cannabis industry and the changing business landscape at large. The approach is based on a series of specific steps that all companies should follow when developing an effective ESG program; fig. 1 highlights some of the most critical: (see Fig 1. ESG Framework: a 5-Step Process). ϖ

To learn more, please contact [email protected].  

Fig 1

1. Understanding why ESG is critical to commercial success

• Identify the relevancy of ESG trends to your business model, industry, and stakeholder groups.

• Assess the competitive landscape and expectations from your key stakeholder groups.

2. Mapping an ESG journey that leads to desired business outcomes  

• A materiality assessment uncovers ESG threats that present financial risk to the business and opportunities to strengthen engagement with stakeholders.   

• Assess and understand what you are already doing to address these issues and clearly articulate your desired objectives moving forward.

• Create a shared vision of success and engage the stakeholders most relevant to this success to participate in the process.

3. Gauge how you are being perceived

• Evaluate how you are being assessed on ESG performance.

• What is your current reputation with stakeholders?  What are the potential risks associated with these stakeholders?

• Assess what is working well with your current reputation, what could be developed to support both perceptions of investment risk and ESG maturity, and the actions that must be taken and communicated to your key stakeholder groups.  

4. Develop an ESG strategy 

• Integrate material ESG issues into corporate strategy and risk management, ensuring clear targets and performance indicators are established, and the internal systems are in place to track that progress.

• Embed the ESG strategy into daily operations and stand up an internal governance structure to oversee enterprise implementation.

5. Communicate and Disclose

• Determine your priority audiences and the most important stakeholders to your business.

• Determine the right messages and methods for communicating this progress that speaks to the relevant issues and in the language known to your stakeholders.  Identify and align around the disclosure frameworks and communications cadence preferable to your key stakeholders.

• Communications, specifically with credible disclosure frameworks like SASB and TCFD, ensures the ESG strategy and accompanying narrative is clear, credible, and accurate, which in turn fortifies stakeholder trust and positively impacts corporate reputation and valuation.


#CBD #Hemp
https://cannatechtoday.com/growing-a-competitive-advantage-from-cultivation-to-consumption/
August 24, 2021 11:00 am

Growing a Competitive Advantage from Cultivation to Consumption

Growing a Competitive Advantage from Cultivation to Consumption

There are an increasing number of publicly-traded companies in the evolving North American cannabis sector, all vying for attention.

Yet for this industry to grow, it must embrace the principles of Environmental, Social, and Corporate Governance (ESG) Frameworks and navigate the risks and opportunities inherent in ESG issues.  

Corporations embrace ESG standards for a variety of reasons including access to capital, enhanced risk mitigation and value creation, greater social “license to operate,” customer acquisition, and employee retention.

Greater recognition of the competitive advantage linked to this approach is increasingly making ESG a business fundamental for companies across industry sectors. 

The risks of climate change have brought environmental management to the forefront as a business imperative.

For the cannabis industry, energy and water stewardship are two critical environmental issues all companies must be actively managing.

Estimated at approximately 40% of operational expenses, the energy required for plant cultivation, temperature control, and product manufacturing makes energy management a vital cost consideration.

As global temperatures and the frequency of severe weather events rise, so will the risks associated with energy stewardship and resilience.

Similarly, global water scarcity and its material impact on a wide range of industries make water stewardship a vital component to controlling costs and ensuring business continuity in the future.

Cannabis companies must implement a systematic approach to environmental management and resource stewardship across the value chain, from seed to storefront. 

As the multi-industrial applications for cannabis and hemp become better understood, the range of social risks and opportunities increase.

From a human capital perspective, companies will need employees with a broad range of skill sets and backgrounds to capitalize on the range of potential opportunities.

Developing a clear talent acquisition and retention strategy will become increasingly important.

Similarly, engagement and collaboration across stakeholder groups provide a range of opportunities.

From advancing economic inclusion for marginalized populations to revitalizing distressed rural farming communities, focused stakeholder engagement can mitigate reputational challenges while addressing operational needs and product commercialization.

Cannabis companies need a methodical and consistent approach to governance, especially given the rapid evolution of the industry and its regulatory landscape. A focus on governance prioritizes long-term business continuity amongst managing these risks. To manage the complexity inherent in engaging ESG issues across an enterprise, the composition of the board and management team, and their associated experiences, credentials, and effectiveness, can have a profound impact on ensuring ESG becomes a source of competitive advantage. 

Regennabis and Summit Strategy Group have partnered to provide a range of services that address the most pressing risks and opportunities facing the cannabis industry and the changing business landscape at large. The approach is based on a series of specific steps that all companies should follow when developing an effective ESG program; fig. 1 highlights some of the most critical: (see Fig 1. ESG Framework: a 5-Step Process). ϖ

To learn more, please contact [email protected].  

Fig 1

1. Understanding why ESG is critical to commercial success

• Identify the relevancy of ESG trends to your business model, industry, and stakeholder groups.

• Assess the competitive landscape and expectations from your key stakeholder groups.

2. Mapping an ESG journey that leads to desired business outcomes  

• A materiality assessment uncovers ESG threats that present financial risk to the business and opportunities to strengthen engagement with stakeholders.   

• Assess and understand what you are already doing to address these issues and clearly articulate your desired objectives moving forward.

• Create a shared vision of success and engage the stakeholders most relevant to this success to participate in the process.

3. Gauge how you are being perceived

• Evaluate how you are being assessed on ESG performance.

• What is your current reputation with stakeholders?  What are the potential risks associated with these stakeholders?

• Assess what is working well with your current reputation, what could be developed to support both perceptions of investment risk and ESG maturity, and the actions that must be taken and communicated to your key stakeholder groups.  

4. Develop an ESG strategy 

• Integrate material ESG issues into corporate strategy and risk management, ensuring clear targets and performance indicators are established, and the internal systems are in place to track that progress.

• Embed the ESG strategy into daily operations and stand up an internal governance structure to oversee enterprise implementation.

5. Communicate and Disclose

• Determine your priority audiences and the most important stakeholders to your business.

• Determine the right messages and methods for communicating this progress that speaks to the relevant issues and in the language known to your stakeholders.  Identify and align around the disclosure frameworks and communications cadence preferable to your key stakeholders.

• Communications, specifically with credible disclosure frameworks like SASB and TCFD, ensures the ESG strategy and accompanying narrative is clear, credible, and accurate, which in turn fortifies stakeholder trust and positively impacts corporate reputation and valuation.


#CBD #Hemp
https://cannatechtoday.com/growing-a-competitive-advantage-from-cultivation-to-consumption/
August 24, 2021 11:00 am

Quick Hits: This Week in Cannabis News

Quick Hits: This Week in Cannabis News

Seizures 

Humboldt County, a region infamously synonymous with the Shangri-la of cannabis cultivation, was caught in the crosshairs when law enforcement seized over 64,000 unregulated marijuana plants. 

According to a news release from the Humboldt County Sheriff’s Office, deputies from their Marijuana Enforcement Team (MET) conducted multiple investigations during the week of August 9-12 into illegal cannabis cultivation in watersheds determined to be critical spawning streams for various salmon, trout, and other types of fish. 

MET investigated numerous parcels during the service of the search warrants in the South Fork Trinity River, East Branch, Steelhead Creek, Mad River, Van Duzen, and Little Larrabee Creek/Van Duzen watersheds. 

None of the parcels investigated possessed the required county permit and state license to cultivate cannabis commercially.

In total, deputies eradicated over 64,000 illegally grown cannabis plants and documented approximately 79 environmental violations, including 42 water diversion violations, 24 depositing trash into waterway violations, and 13 water pollution violations. 

During the service of the search warrants, environmental scientists and law enforcement found and documented severe damage to the watersheds. 

Environmental scientists found numerous deceased wildlife and located Coastal Giant Salamander larvae in a water diversion pool.

Full story from the Times-Standard.  

Cannabis Grants 

In other Humboldt County news, Isabella Vanderheiden of the Times-Standard reports that Humboldt County announced more than $2 million in grant funding through Project Trellis, the county’s cannabis micro-grant, marketing, and local equity program. 

The grants are designated to assist the local cannabis community with entering into the commercial cannabis marketplace. 

Those eligible can apply for up to $10,000 “per service” per Humboldt County’s eligibility requirements for Project Trellis.

Applicants may download an application for the grant funding at the county’s website and send the application to [email protected].

Potential applicants may request a hard copy by contacting Project Trellis at +1 (707)-445-7745. 

Hard copies can be mailed or delivered to the County of Humboldt CAO’s Office of Economic Development, Attn: Project Trellis, 825 Fifth Street No. 112, Eureka, CA 95501.

Applications must be received or postmarked no later than 5 p.m. on September 17.

M & A 

Ayr Wellness, a vertically integrated cannabis multi-state operator (MSO), or dispensary chain, has entered into a binding letter of intent (LOI) to acquire Cultivauna, the owner of the Levia branded cannabis-infused seltzers and water-soluble tinctures. 

Both companies expect the acquisition to close by the fourth quarter (Q4) of 2021, with a purchase price of $20 million. 

Ayr intends to purchase 100% of the equity interests of Cultivauna, LLC. 

The transaction terms include $20 million in upfront consideration, comprising up to $10 million in cash with the remainder in stock. 

Ayr will provide an earn-out payment of up to an additional $40 million in shares based on achieving revenue targets in 2022 and 2023.

“Ayr Wellness is excited to join the rapidly-growing infused beverage segment through our Levia acquisition. We believe the opportunity to unlock a new consumer base through the beverage market is endless, and we look forward to continuing to make cannabis more approachable and sessionable through our high-quality products,” said Jonathan Sandelman, CEO of Ayr. 

Levia is currently available in Massachusetts in three flavors: “Achieve” Raspberry Lime (Sativa), “Celebrate” Lemon Lime (Hybrid), and “Dream” Jam Berry (Indica)

Each flavor is available in 12-ounce skinny cans that contain 5mg of THC

Levia is also available in water soluble tinctures in the same formulations.

Even though cannabis beverages have been hyped for years as the next exploding marketplace trend, beginning with Constellation Brands’ – makers of Corona beer– acquisition of Canadian cannabis company Canopy Growth, the market still hasn’t taken off according to various analysts’ predictions. 

While the category is growing, with unique brands including House of Saka, and Cannacraft’s Gem + Jane, the category as a whole, has yet to rival alcohol or cannabis flower for significant market share. 

Prohibition of Interstate cannabis commerce and the lack of state-by-state bottling plant manufacturing contracts currently hinder national launches of cannabevs. 

The market might see an explosion in this category once national distribution becomes available. 

In 2019, shrewd cannabis company Caliva acquired plant-based beverage company, Zola, to preeminently access its established beverage-to-supermarket distribution network and expand into the cannabis and hemp-based CBD (hCBD) beverage market.

Cannabis Trade Shows

The Cannabis Edibles Expo (CEE), presented by the Beverage Trade Network, is an excellent place to check out emerging cannabevs and infused confectionaries. 

Taking place in San Francisco on November 12, 2021, at the South San Francisco Conference Center, and in Chicago on November 16, 2021, at the Midwest Conference Center, the CEE gives MSOs and local dispensary buyers the chance to connect with established and emerging edibles brands. 


#CBD #Hemp
https://cannatechtoday.com/quick-hits-this-week-in-cannabis-news/
August 20, 2021 11:00 am

Kaycha Labs Joins NIST’s CannaQAP

Kaycha Labs Joins NIST’s CannaQAP

Kaycha Labs, a cannabis lab testing company headquartered in Fort Lauderdale, Florida, has announced their participation in the National Institute of Standards and Technology’s (NIST) Cannabis Quality Assurance Program (CannaQAP).

The NIST is an organization under the U.S. Department of Commerce that promotes innovation through standards, technology and advancing science. The NIST’s CannaQAP platform works with cannabis labs to help improve competence in analytical science and standardization.

The program requires participating labs to conduct exercises that help inform the NIST about current industry standards and capabilities for hemp and cannabis testing. One of the goals of the program is aiding in the design and characterization of cannabis reference materials.

Kaycha Labs took part in two exercises for the CannaQAP study. Exercise 1 included testing for potency with 17 cannabinoids in hemp oil and Exercise 2 included potency, heavy metals and moisture content testing in plant materials.

Chris Martinez, president of Kaycha Labs, says the program can benefit the entire industry when it comes to regulatory compliance testing. “As a leading cannabis lab company with a network of labs in multiple states, it is imperative we demonstrate that our labs apply compliant and consistent testing methodologies,” says Martinez. “Assuring all industry participants, including State and Federal government regulators, that precise and consistent testing data is the norm will benefit the entire industry.”

Kaycha Labs, while based in Fort Lauderdale, actually has cannabis testing labs in California, Colorado, Florida, Massachusetts, Nevada, Oklahoma, Oregon and Tennessee, making them an ideal candidate for CannaQAP.

Exercise 1 has been completed in its entirety and published here. Exercise 2 has completed the participation and data submission legs of the study and NIST is preparing it for publication. On their website, it says that announcements about their upcoming Exercise 3 are coming soon.

The post Kaycha Labs Joins NIST’s CannaQAP appeared first on Cannabis Industry Journal.


#CBD #Hemp

Kaycha Labs Joins NIST’s CannaQAP


August 19, 2021 6:30 pm

ASTM Proposes New Standard on Change Control Process Management

ASTM Proposes New Standard on Change Control Process Management

Change control, when it comes to quality management systems in manufacturing, processing and producing products such as cannabis edibles or vape pens, is a process where changes to a product or production line are introduced in a controlled and coordinated manner. The purpose of change control process management is to reduce the possibility of unneeded changes disrupting a system, introducing errors or increasing costs unnecessarily.

ASTM International, the international standards development organization, is developing a new standard guide that will cover change control process management for the cannabis and hemp market. The guide is being developed through the D37 cannabis committee.

The WK77590 guide will establish a standardized method for change control process management for cannabis companies so that they can document and track important decisions in manufacturing and quality systems.

For example, an edibles manufacturer would utilize change control process management if they want to use a different type of processing equipment or introduce a new shape or design of their product. Without change control process management, that edibles producer might switch to a new piece of processing equipment without knowing that it requires more energy or uses different raw materials, thus making production unexpectedly more expensive.

While that’s a very cursory example, the premise is simple: Before you undergo a change to your process, plan it out, analyze it, review it, test it out, implement it and make sure it works.

Change control process management can often be summarized in six steps:

Food processing and sanitation
Change control is designed to coordinate changes to manufacturing so they don’t disrupt a process. 
  1. Plan/Scope
  2. Assess/Analyze
  3. Review/Approval
  4. Build/Test
  5. Implement
  6. Close

Maribel Colón, quality assurance consultant and vice chair of the ASTM subcommittee on cannabis quality management systems, says producers and testing labs will benefit the most from the guide. “As the cannabis industry grows, the quality, expectations, and control challenges grow within,” says Colón. “The creation and implementation of this standard guide will increase cannabis business efficiency and minimize risk, time, and potential cost of poorly managed changes.”

According to a press release, ASTM International is open to collaboration on this as well. Specifically, they are looking for professionals with change control who might be interested in helping advance and develop this guide.

The post ASTM Proposes New Standard on Change Control Process Management appeared first on Cannabis Industry Journal.


#CBD #Hemp

ASTM Proposes New Standard on Change Control Process Management


August 18, 2021 9:05 pm

Improving the Medical Cannabis Production Commission in North Carolina

Improving the Medical Cannabis Production Commission in North Carolina

Draft statement of Pat Oglesby, Center for New Revenue, for the North Carolina Senate Judiciary Committee meeting August 18 at 2 p.m.

Medical marijuana is coming to North Carolina, like it or not.  Like most people, I’m for that.

But Senate Bill 711 could be improved in a lot of ways, I think.

Here’s one.

New N.C.G.S. section 90-113.122 would say the Medical Cannabis Production Commission is to have two industry representatives among its nine members.  The industry doesn’t need representatives on the Commission. Marijuana sellers can lobby the Commission quite readily, just as they can present their views to the North Carolina Senate without being Senators.

The industry naturally wants to maximize profits, and maximize sales.  That’s the American way.  But why should industry representatives vote about how to regulate themselves?  That’s regulatory capture.  The Commission needs to serve the general public interest.  We don’t mandate power companies on the Utilities Commission.  We don’t mandate liquor companies and bar owners on the North Carolina Alcoholic Beverage Control Commission.  We mandate professors on the UNC Board of Governors.  The way the bill is written now, the Commission is of the marijuana sellers, by the marijuana sellers, for the marijuana sellers.  

Let’s not put any foxes on the Henhouse Commission.


#CBD #Hemp
Improving the Medical Cannabis Production Commission in North Carolina
August 18, 2021 2:21 pm

The International Cannabis Business Conference is Coming Back to Germany

The International Cannabis Business Conference is Coming Back to Germany

The International Cannabis Business Conference is coming back to Berlin, Germany on August 25-27, 2021. 

Offering world-class industry networking opportunities, the Berlin International Cannabis Business Conference is the largest B2B cannabis trade event in Europe and is also the longest running cannabis B2B conference on the continent. 

The conference will once again feature a unique blend of cannabis policy, advocacy, industry, and networking.

“We are particularly excited about this year’s conference in Berlin. It is going to be extra special for our team to be able to get back to offering world-class cannabis industry and policy education, networking, and entertainment to attendees.” says Alex Rogers, founder of the International Cannabis Business Conference.

In addition to the Berlin B2B event the International Cannabis Business Conference will also offer a one-day Global Investment Forum (GIF). 

The ICBC Global Investment Forum in Berlin will feature ten hand-picked cannabis companies participating in a pitch session in front of top investors on the ICBC Main Stage. 

It is a tremendous opportunity for cannabis companies in the emerging cannabis industry to showcase their products/services in front of seasoned industry investors. 

The pitch session is also open to service providers looking for reliable and high-end clients.

Germany is home to the largest economy in the European Union and is poised to serve as the cannabis industry capital of Europe going forward. 

The cannabis industry is evolving rapidly in Germany, with the country’s medical cannabis program increasing in size with every passing day.

Cannabis industry opportunities that are popping up in Germany and on the European continent have tremendous profit potential, and the Global Investment Forum is the perfect place for entrepreneurs to try to secure capital to take their pursuits to the next level. 

It is also an unparalleled opportunity for investors to learn more about pre-vetted investment opportunities and for industry service providers to find reliable and high-end clients.

“We know how hard it is for quality investors to link up with vetted cannabis industry companies offering valuable investment opportunities,” Rogers stated. “That is why we are bringing the Global Investment Forum to Berlin. It will be a prime networking opportunity for cannabis industry investors, entrepreneurs, and industry service providers alike.”

The International Cannabis Business Conference is the leading B2B cannabis event series on earth. 

Events have been held in the United States, Canada, Spain, Germany, and Switzerland. Additional locations in other countries are being identified and will be announced in the future.

Event festivities begin on August 25 with the start of the Global Investment Forum at the amazing Vienna House Andel’s Berlin. 

Speakers and the official GIF schedule will be announced soon. 

Attendance at the International Cannabis Business Conference Global Investment Forum in Berlin will be limited to 200 attendees.

The following morning the 2-day curriculum portion of the conference will begin with a conference overview from Alex Rogers, founder and Executive Producer of the International Cannabis Business Conference. 

Rogers will welcome conference attendees and provide an overview of the schedule, including the panels and speakers that will be providing presentations and interviews. 

Attendees at the conference portion of the event will be limited to 1,000 people.

Topics that will be covered at the conference include:

  • European cannabis regulations
  • Mergers and acquisitions
  • Novel Food
  • CBD
  • Imports and exports
  • Extractions
  • Branding

The topics covered at the conference via panels and presentations will be led by the top cannabis experts in the global cannabis space. 

The International Cannabis Business Conference in Berlin, Germany will include (but is not limited to) the following speakers:

  • Peter Homberg – Partner, Dentons
  • Finn Age Hänsel – Founder & Managing Director, Sanity Group
  • Erwin Rüddel – Member of the German Bundestag, Christian Democratic Union
  • Niema Movassat – Member of the German Bundestag, spokesperson for Die Linke
  • Daniel Gauci – Chief Business Development Officer, Juicy Fields
  • Jan Peter Witte – Managing Director, Vayamed, and Director, Medical Sanity Group
  • Sita Schubert – Secretary General, European Medicinal Cannabis Association
  • Cornelius Maurer – Founder, Demecan
  • Georg Wurth – German Hemp Association (DHV)
  • Tim Feike – CEO WEECO
  • Luc Richner – CEO and Founder, Cannavigia

International Cannabis Business Conference events are attended by leading policymakers, executives, and entrepreneurs from all over the world, with over 60 countries being represented at previous events. 

The event series is the best way for innovators and inventors to get their products or services in front of the top influencers and decision-makers in the cannabis space, as well as for investors to network with aspiring entrepreneurs.

The conference series consistently features world-class speakers that cannabis entrepreneurs, advocates, and consumers from all backgrounds can learn from and be entertained by. 

International Cannabis Business Conference events include after-party festivities that feature some of the most entertaining musical acts and celebrities from across the globe.

A cannabis industry revolution is sweeping Europe, and Germany is at the center of it. If you’re serious about succeeding in the cannabis industry, check out the International Cannabis Business Conference’s flagship program in Berlin this month. 

Leading cannabis entrepreneurs and policymakers from around the world will be in attendance and the networking and educational opportunities will be unparalleled.
You can secure tickets now at: https://internationalcbc.com/icbc-buy-tickets/#berlinb2b


#CBD #Hemp
https://cannatechtoday.com/the-international-cannabis-business-conference-is-coming-back-to-germany/
August 18, 2021 11:00 am

AOAC Approves Two New Microbiological Assays

AOAC Approves Two New Microbiological Assays

On August 11, PathogenDx announced that they received an AOAC Performance Tested Methods Certificate for their QuantX total yeast and mold test. Six days later, on August 17, Medicinal Genomics announced that AOAC approved their PathoSEEK 5-Color Aspergillus Multiplex Assays under the same AOAC Performance Tested Methods program.

Both assays are specifically designed with cannabis and hemp testing in mind and designed to expedite and simplify microbiological testing. PathogenDx’s QuantX quantifies the total amount of yeast and mold in a sample while also measuring against safety standards.

In addition to the total yeast and mold count test, PathogenDx has also introduced a 96-well plate, improved sample preparation and new data reporting with a custom reporting portal for compliance testing.

The Medicinal Genomics platform can detect four species, including A. flavus, A. fumigatus, A. niger, and A. terreus in both flower and infused edibles. The PathoSEEK microbial testing platform uses a PCR-based assay and provides an internal plant DNA control for every reaction.

This technique verifies the performance of the assay when detecting pathogens, allegedly minimizing false negative results commonly due to set up errors and experimental conditions.

AOAC International is a standards organization that works in the cannabis testing space through their CASP program to evaluate and approve standard testing methods for the industry.

The post AOAC Approves Two New Microbiological Assays appeared first on Cannabis Industry Journal.


#CBD #Hemp

AOAC Approves Two New Microbiological Assays


August 17, 2021 7:58 pm

Expert Insights on Milling Cannabis

Expert Insights on Milling Cannabis

If you, your parents, your grandparents, and great grandparents all had the same job, would you consider yourself an expert in the field? While that kind of legacy is tough to find in the cannabis space, Fritsch has a century of experience in industrial milling and they’re bringing that expertise to cannabis.

In the Great Lakes State, family-owned businesses are a major part of the economic landscape.

From Detroit’s J.W. Westcott Company (140 years in operation) to Grand Rapids’ Meijer, Inc. (87 years in operation), Michigan is home to many long-lived family businesses. 

Melissa Fauth is president and CEO of the U.S. division of Fritsch Milling and Sizing Inc., a 4th-generation family-owned German business specializing in industrial milling and sizing solutions.

While not a Michigan native, Fauth’s expertise is helping cannabis companies nationwide scale their operations.

We spoke with Fauth to learn what makes her company unique and what she’s learned from 100 years of industrial milling and sizing.

Cannabis & Tech Today: What challenges is Fritsch solving for the cannabis space?

Photos courtesy of Fritsch.

Melissa Fauth: Processing operations and laboratories working with cannabis and hemp have lacked access to professional milling instrumentation that was engineered with their unique material in mind.

The precision milling systems offered by Fritsch allow clients to prepare their variable starting material with a repeatable outcome, in the most ideal way for their downstream application needs.

The Pulverisette instruments mitigate the occurrence of physical and chemical degradation to maintain the sample integrity and the highest quality yields, for maximized efficiency in production or for analysis.

C&T Today: What makes your solutions unique?

MF: Commitment, experience, and ongoing developmental processes.

Aside from the inherent ROI from material integrity, operational parameter adjustability, controlled and consistent particle size output, temperature mitigation, and ability to follow GLP and GMP principles — the Fritsch Team is unique.

The Pulverisette 19 (P19), for instance, has a long history — decades in fact — of serving food, pharma, and agriculture.

As the emerging cannabis industry blossomed in the Americas, Fritsch business, application, and engineering professionals proactively invested in external collaborations, R&D projects, experienced successes and failures-putting the best suited technology through rigorous trials to engineer a new generation of instruments that were specifically optimized for the attributes of this valuable crop, that is as unique as you and I are. 

C&T Today: How is your experience driving innovation within the sector?

MF: Contributions of the past, present and future converge to provide solutions that come from 100 years of technical history, responding to the needs and challenges of today, and striving for continuous improvement as we anticipate the industry goals of tomorrow.

This unique position as a 4th generation family-owned business provides our clients a wealth of experience, from the multitude of industries we serve, for size reduction and particle characterization from agriculture to aerospace.

C&T Today: What does the future hold for Fritsch Milling & Sizing?

MF: Exciting developments are always on the horizon because it is an ongoing process rather than a singular event.

Process automation and production system integration for material handling, monitoring, and conveyance have just launched — offering stock, semi-custom, and fully custom engineering with our partner organization Sample Automation LLC.

Larger volume systems, new construction technologies for surfaces, materials, power, electronics, and temperature control system configurations are primary focus areas.

The opportunities for optimization and development arise from well founded, established, and innovative principles that are quality made in Germany since 1920.


#CBD #Hemp
https://cannatechtoday.com/fritsch-expert-insights-from-100-years-of-milling-and-sizing-solutions/
August 17, 2021 11:00 am

Quick Hits: What’s Up With Weed?

Quick Hits: What’s Up With Weed?

Studies 

Studies show that cannabis may be beneficial in helping relieve the symptoms associated with HIV/AIDS. 

Unfortunately, HIV/AIDS creates many complications in the body, resulting in detrimental symptoms and side effects.

These symptoms aren’t always easy to combat, Often, medications taken to stall the effects of HIV/AIDS cause additional side effects. Medical marijuana may help. 

Marijuana and HIV intermix because the cannabinoids within the plant work to mediate the disease’s side effects. Nausea, muscle soreness, weight loss, and nerve pain are all common alongside HIV/AIDS, but medical marijuana appears to regulate these symptoms. 

Reefer Madness

Vermont – The State of Vermont’s Department of Health reports consuming cannabis while pregnant can affect the health of an unborn baby.

The government agency warns that in addition to cannabis potentially impairing judgment and coordination, different forms of cannabis can have various levels of THC and can cause severe reactions. 

An article published in Vermont’s Addison Independent does not cite any studies or research, nor does it explain how the Department of Health has drawn its conclusions, such as, if people use cannabis while pregnant, their babies may be born with a lower birth weight and the growth and development of such babies’ brains can be harmed.

Iowa – Marijuana is the third most common substance identified during admission for substance use disorder treatment for adults 18 years old and older, according to the Iowa Dep’t of Public Health’s Bureau of Substance Abuse (2019).

To combat cannabis consumption, Your Life Iowa launched the Weed’s Not Worth It campaign. 

Local Legislation

The Alabama Medical Cannabis Commission named Dr. Steven Stokes, a radiation oncologist from Dothan, as its chair.

According to Al.com, Dr. Stokes said he has been prescribing medical marijuana to cancer patients in Florida for approximately four years. He was initially skeptical about medical cannabis until he saw positive results.

“It provides relief when what we’re doing is not working,” Dr. Stokes said. “People are continuing to lose weight from cancer, dropping weight, dropping weight, and nothing works. But you put them on medical marijuana, they start gaining weight again. That’s a big improvement.

“If they’re taking chemotherapy for their cancer and they vomit non-stop for two days, and you then give them medical marijuana, and they don’t have any nausea, that’s a great relief.”

According to Dr. Stokes, medical marijuana products could be available in Alabama as early as the fall of 2022. However, he said doctors could be certified to participate in the program as soon as January.

The program will be limited to products made in Alabama.

The Legislature passed a bill in May making Alabama the 37th state to legalize medical marijuana. 

No weed allowed in California prisons is no surprise. 

Prison inmates can’t legally possess marijuana under California’s legal adult-use law, the state Supreme Court ruled Thursday.

The ruling overturns a lower court that found prisoners could have the drug as long as they didn’t consume it. (What were they supposed to do instead? Smell it?) Meaning, possession itself isn’t a crime that should garner additional punishment or penalties, including extra time served.

The case stemmed from five inmates who were caught with cannabis.

According to AP, the justices said the 2019 appellate court ruling allowing prisoners to have up to 1 ounce (28.5 grams) of marijuana “went against common sense.”

The high court sided with the state attorney general in finding the state’s marijuana law approved by voters did not apply to incarcerated Californians. 

Product  Launch 

Cannabis ice cream is coming from Marimed and Emack and Bolios. 

Boston’s cult fav mom and pop ice cream shop Emack and Bolio’s debuts weed ice cream

Conferences & Trade Shows 

Champs’ third annual trade show will take place on Tue, Aug 31, 2021 – Thu, Sep 2, 2021, at the Atlantic City Convention Center adjacent to the Boardwalk. According to a spokesperson for Champs, Delta-8 will be featured at the show along with CBD and glass. 

The National Cannabis Industry Association (NCIA’s)  Midwest Cannabis Business Conference is coming to the TCF Center in Detroit, Michigan, September 22 – 23, 2021

The Cannabis World Congress and Business Expo (CWCBE) focusing on hemp and technology will take place on November 4 – 6, 2021, at New York City’s Javits Convention Center.  


#CBD #Hemp
https://cannatechtoday.com/quick-hits-whats-up-with-weed/
August 16, 2021 11:00 am

New Study Indicates CBD is Good for Dogs Battling Cancer

New Study Indicates CBD is Good for Dogs Battling Cancer

Pets are very popular around the world.

 In fact, it is estimated that 57% of all households across the planet own at least one pet.

Anyone that has owned a pet will likely be very quick to tell you that their pet is a part of their family (and probably follow that up with an unprompted showing of pictures of said pet).

When it comes to levels of popularity, one type of pet is the most popular by far and second place isn’t close.

Roughly one-third of pet owners own a dog (33%). The next closest pet when it comes to popularity is cats (23%), followed by fish (12%).

Dog owners, along with other types of pet owners, get understandably sad and depressed when their pet is suffering from a health condition, especially cancer. 

Fortunately, the results of a recent study indicate CBD may help our suffering canine friends.

CBD and Urothelial Carcinoma Cells

The most common form of bladder cancer found in canines is urothelial carcinoma. 

Urothelial cells help the bladder expand when the dog’s bladder is full and contract when the bladder is empty.

Previous studies have found CBD can help humans suffering from bladder urothelial carcinoma and international researchers set out to find out if the same can be said with CBD and canines.

Cannabidiol reduced cell viability and induced apoptosis in canine urothelial cells as determined by crystal violet viability assay and annexin V/propidium iodide flow cytometry,” the researchers stated.

The researchers went on to say, “Furthermore, combinations of cannabidiol with mitoxantrone and vinblastine chemotherapy yielded significantly reduced cell viability and increased apoptosis compared to single agent treatment alone. The drug interactions were deemed synergistic based on combination index calculations.”

“Cannabidiol showed promising results as a single agent or in combination with mitoxantrone and vinblastine for treatment of canine urothelial carcinoma cells,” the researchers concluded.

Be Extra Careful With Animals and Cannabis

Before you rush out and obtain any and all cannabis products that you can find and give them to your dog or other pet, make sure to do your research.

Not all products, even CBD products, are created equal. CBD may be good for dogs, but other additives to CBD products that are designed for humans may not be good for dogs.

Also, dosage sizes can vary widely depending on the type of pet, the size of the pet, etc.

Always make sure to talk to your pet’s veterinarian before giving your pet CBD. Thankfully, more veterinarians are specializing in cannabis therapy for pets than ever before.


#CBD #Hemp
https://cannatechtoday.com/new-study-indicates-cbd-is-good-for-dogs-battling-cancer/
August 13, 2021 11:00 am

4 Trends Propelling the U.S. Cannabis Testing Market: 2021-2027

4 Trends Propelling the U.S. Cannabis Testing Market: 2021-2027

As the legalization of cannabis in the U.S. continues to grow, stringent regulatory requirements around the country are being adopted to ensure that only safe and high-quality cannabis is sold. The U.S. cannabis testing market is estimated to see tremendous growth over the coming years. Further, the FDA has made several resources available for addressing cannabis products like CBD to ensure that consumers and stakeholders are getting safe products.

According to Global Market Insights, Inc., U.S. Cannabis testing market size is projected to surpass USD 4.1 billion at a CAGR of 10.4% through 2027, in light of below mentioned trends:

Strategic initiatives by major industry players

HPLC (high pressure liquid chromatography) instrument.

Prominent players operating in the U.S. cannabis testing market such as CannaSafe, Anresco, Collective Wellness of California, EVIO Inc., Digipath Inc., PSI Labs, SC Labs, Inc., Steep Hill, Inc. etc. are focusing on developing enhanced cannabis testing solutions and accreditation for gaining strong market presence. For example, earlier this year SC Labs developed a comprehensive hemp testing panel that is purported to meet testing standards in every state with a hemp program.

Citing another instance, in 2019, a leading cannabis resource Leafly, introduced the Leafly Certified Labs Program, under which a network of labs is independently assessed by Leafly for quality and accuracy. This program has been designed to address inconsistency in cannabis testing by ensuring that lab data comes from labs that have been confirmed to provide accurate results.

Rising adoption of high-pressure liquid chromatography (HPLC) technique

A lot of cannabis testing procedures are carried out using liquid chromatography. It is estimated to witness higher preference over the coming years. In 2020, the liquid chromatography segment recorded a valuation of USD 662.4 million. Further, liquid chromatography is a valuable alternative to gas chromatography when it comes to analysis of cannabinoids, pesticides and THC which is why this technology is often preferred for potency testing as it offers more precise analysis. Moreover, purification standards are highly controlled in liquid chromatography which helps in obtaining accurate results, which is complementing the segment growth.

Growing popularity of heavy metals testing for cannabis

Cannabis samples are liquified in strong acid in a pressurized microwave prior to evaluation for heavy metal content. Image courtesy of Digipath, Inc.

Heavy metals are known to be one of the major contaminants found in cannabis and its products apart from residual solvents, microbial organisms and pesticides. In addition, heavy metals are highly toxic in nature and on exposure can lead to poisoning and other complications. As a result, heavy metal testing for cannabis and its products is increasingly becoming popular. Several government organizations have made heavy metal testing mandatory for cannabis products. Moreover, increasing legalization of cannabis across several countries for adult use and medical purposes is likely to instigate the demand for heavy metal testing of cannabis products, thereby fostering the growth of heavy metals testing segment over the coming years. For the record, in 2020, the segment had recorded a market revenue of USD 352.5 million.

Increasing support from government bodies in the Mountain West

With increasing legalization for medical and adult use, the cannabis testing market in the Mountain West zone of the U.S. is likely to observe a tremendous growth over time. Moreover, growing support from various government bodies is playing a key role in enhancing the business space. For example, Montana’s Department of Revenue helps labs get licensed along with the state’s environmental laboratory that oversees inspections and licensing. Further, presence of a large number of cultivators of cannabis and manufacturers of cannabis-based products are also positively influencing the regional market growth. Considering the significance of these growth factors, the U.S. cannabis testing market in the Mountain West is estimated to register a substantial CAGR of 9.6% through 2027.

The post 4 Trends Propelling the U.S. Cannabis Testing Market: 2021-2027 appeared first on Cannabis Industry Journal.


#CBD #Hemp

4 Trends Propelling the U.S. Cannabis Testing Market: 2021-2027


August 11, 2021 10:10 pm

4 Trends Propelling the U.S. Cannabis Testing Market: 2021-2027

4 Trends Propelling the U.S. Cannabis Testing Market: 2021-2027

As the legalization of cannabis in the U.S. continues to grow, stringent regulatory requirements around the country are being adopted to ensure that only safe and high-quality cannabis is sold. The U.S. cannabis testing market is estimated to see tremendous growth over the coming years. Further, the FDA has made several resources available for addressing cannabis products like CBD to ensure that consumers and stakeholders are getting safe products.

According to Global Market Insights, Inc., U.S. Cannabis testing market size is projected to surpass USD 4.1 billion at a CAGR of 10.4% through 2027, in light of below mentioned trends:

Strategic initiatives by major industry players

HPLC (high pressure liquid chromatography) instrument.

Prominent players operating in the U.S. cannabis testing market such as CannaSafe, Anresco, Collective Wellness of California, EVIO Inc., Digipath Inc., PSI Labs, SC Labs, Inc., Steep Hill, Inc. etc. are focusing on developing enhanced cannabis testing solutions and accreditation for gaining strong market presence. For example, earlier this year SC Labs developed a comprehensive hemp testing panel that is purported to meet testing standards in every state with a hemp program.

Citing another instance, in 2019, a leading cannabis resource Leafly, introduced the Leafly Certified Labs Program, under which a network of labs is independently assessed by Leafly for quality and accuracy. This program has been designed to address inconsistency in cannabis testing by ensuring that lab data comes from labs that have been confirmed to provide accurate results.

Rising adoption of high-pressure liquid chromatography (HPLC) technique

A lot of cannabis testing procedures are carried out using liquid chromatography. It is estimated to witness higher preference over the coming years. In 2020, the liquid chromatography segment recorded a valuation of USD 662.4 million. Further, liquid chromatography is a valuable alternative to gas chromatography when it comes to analysis of cannabinoids, pesticides and THC which is why this technology is often preferred for potency testing as it offers more precise analysis. Moreover, purification standards are highly controlled in liquid chromatography which helps in obtaining accurate results, which is complementing the segment growth.

Growing popularity of heavy metals testing for cannabis

Cannabis samples are liquified in strong acid in a pressurized microwave prior to evaluation for heavy metal content. Image courtesy of Digipath, Inc.

Heavy metals are known to be one of the major contaminants found in cannabis and its products apart from residual solvents, microbial organisms and pesticides. In addition, heavy metals are highly toxic in nature and on exposure can lead to poisoning and other complications. As a result, heavy metal testing for cannabis and its products is increasingly becoming popular. Several government organizations have made heavy metal testing mandatory for cannabis products. Moreover, increasing legalization of cannabis across several countries for adult use and medical purposes is likely to instigate the demand for heavy metal testing of cannabis products, thereby fostering the growth of heavy metals testing segment over the coming years. For the record, in 2020, the segment had recorded a market revenue of USD 352.5 million.

Increasing support from government bodies in the Mountain West

With increasing legalization for medical and adult use, the cannabis testing market in the Mountain West zone of the U.S. is likely to observe a tremendous growth over time. Moreover, growing support from various government bodies is playing a key role in enhancing the business space. For example, Montana’s Department of Revenue helps labs get licensed along with the state’s environmental laboratory that oversees inspections and licensing. Further, presence of a large number of cultivators of cannabis and manufacturers of cannabis-based products are also positively influencing the regional market growth. Considering the significance of these growth factors, the U.S. cannabis testing market in the Mountain West is estimated to register a substantial CAGR of 9.6% through 2027.

The post 4 Trends Propelling the U.S. Cannabis Testing Market: 2021-2027 appeared first on Cannabis Industry Journal.


#CBD #Hemp

4 Trends Propelling the U.S. Cannabis Testing Market: 2021-2027


August 11, 2021 10:10 pm

Quick Hits: The Latest in Cannabis News

Quick Hits: The Latest in Cannabis News

Legalization: 

Arkansas activist group is gathering signatures to get adult-use cannabis on the ballot. 

Activists in President Bill Clinton’s home state of Arkansas –where prior to being POTUS 42 he infamously admitted that he smoked marijuana but “didn’t inhale,”– are pushing to get an adult-use cannabis amendment on the 2022 ballot. 

Arkansas True Grass started petitioning in May 2020 and has gathered an estimated 10,000 signatures so far. 

The amendment would legalize the sale and possession of any part of a cultivated cannabis plant to people 21 and older. 

Citizens would be able to buy up to four ounces of smokeable or vape carts of cannabis per day. 

There also would be no cap on the number of adult-use dispensaries, which is an issue in Arkansas, since medical dispensaries are limited to 40, according to Emily Scott of National Public Radio KUAF. 

Illinois announces social equity cannabis dispensary license lottery winners.

The Illinois Department of Financial and Professional Regulation announced on Thursday the social equity cannabis dispensary licenses, via lottery, with 55 winners chosen out of 589 applicants to operate as retailers in the Prairie State’s lucrative adult-use cannabis market. 

“The conditional licenses were awarded via the state’s Social Equity Justice Involved Lottery, which lawmakers designed to ensure that members of communities disproportionately impacted by the War on Drugs are represented in the state’s cannabis industry,” according to Forbes

“Social equity and justice are the heart and soul of the Adult-Use Cannabis Program in Illinois,” said Toi Hutchinson, senior cannabis advisor to Gov. J.B. Pritzker. 

 “Today’s results open the door to increasing the diversity of the industry and continue building on our successes in expunging convictions and investing in communities disproportionately harmed by the failed war on drugs.”

Full Story here

With five months until Montana’s adult-use marijuana market opens up, municipalities are figuring out what its communities’ assimilation of legal cannabis will entail. 

Voters legalized adult-use cannabis last November, and the Legislature sorted out additional details during its session this spring. 

It’s now up to municipalities to determine which zoning districts dispensaries will be allowed in and whether legal cannabis will be subject to local option sales taxes. 

Some parts of the state, like Billings, are also considering prohibiting adult-use cannabis altogether.

House Bill 701 calls for a 20% state tax on all non-medical cannabis sold in the state and allows local voters to tack on an extra 3% municipal tax.  

Full story here.

New Mexico names its Cannabis Advisory Committee ahead of schedule.

New Mexico’s newfound Cannabis Control Division has empaneled the Cannabis Regulatory Advisory Committee to advise it on the formation of the state’s adult-use cannabis industry. 

New Mexico legalized cannabis for adults age 21 and older in April, through legislation that laid out a process for building the regulatory framework that will govern and tax the new marketplace.

Certain amounts of cannabis products became legal to possess and consume in private on June 29, but the CCD — a division of the state Regulation and Licensing Department — has until next April to open retail sales through licensed and regulated vendors. Regulators have pledged to make it happen sooner.

Full Story from Las Cruces Sun-News

To discover what has changed following marijuana legalization in New Mexico, click here. 

Prohibition: 

Paterson City, New Jersey Council votes no on adult-use cannabis businesses.

In an effort to buy extra time, the City Council is moving to ban all adult-use cannabis businesses from Paterson, NJ, despite Mayor Andre Sayegh’s support for an initiative he says could produce $1.5 million in annual fees.

In an 8-0 vote late Wednesday night, the council gave preliminary approval to opting out of the state’s adult-use cannabis program. 

Sayegh’s plan would have allowed as many as 36 businesses to cultivate, manufacture, sell and deliver cannabis.

“I think the whole city is going to smell like marijuana,” said Councilman Shahin Khalique, who has opposed the marijuana business plan ever since it was proposed, according to Joe Malinconico via the Paterson Press

Wallingford, Connecticut officials move to prohibit adult-use cannabis businesses.

Despite being one of 35 Connecticut cities and towns granted social equity status for cannabis licenses, local officials are moving to prohibit any cannabis operation in town, according to Mary Ellen Godin, via My Record-Journal

In a July 19 letter addressed to the town’s Planning and Zoning Commission, Mayor William Dickinson Jr. and Health Director Stephen Civitelli called for a text amendment that prohibits cultivation, micro-cultivation and dispensaries in all zones.  

Dickinson and Civitelli cited federal laws prohibiting cannabis use and public health and safety concerns.

“It is not enough that it is prohibited by federal law,” the letter stated. “Health concerns about and objections to marijuana use are now public record preceding the legislature’s enactment of the marijuana legalization public act.”

Full story 

Studies:

The National Library of Medicine published a few studies regarding medical cannabis and pain relief. 

Medical cannabis treatment is associated with sustained relief, and decreased use of analgesics in chronic pain patients. The studies are as follows:

Additional information on the use of cannabis among patients with chronic pain is available from NORML.

Another study published in the NLM in April reveals that Cannabidiol reduces withdrawal symptoms in nicotine-dependent rats

Rats are widely used in medical studies because their genetic, biological, behavioral characteristics closely resemble humans. 

The objective of this study was “to test the preclinical efficacy of a chronic CBD treatment in reducing nicotine dependence using measures of withdrawal symptoms including somatic signs, hyperalgesia, and weight gain during acute and protracted abstinence.” 

Oceanic Boundlessness 

Psychedelic drugs such as psilocybin and LSD can induce an experience known as “oceanic boundlessness,” which is characterized by a sense of awe and a feeling of oneness with the world. 

New research, published in the Journal of Psychopharmacology, provides preliminary evidence that high doses of cannabis can also produce this type of altered state of consciousness.

“Once the psilocybin labs started emphasizing that oceanic boundlessness seemed to be the mechanism underlying the molecule’s antidepressant effects, nearly every cannabis fan couldn’t help but ask, ‘Hey! Doesn’t marijuana have comparable effects?’” said study author Mitch Earleywine, a professor of psychology at the University at Albany. 

Read the full story from PsyPost

Funerals:

A heartbreaking loss to the cannabis community 

Jackson Salemme, a 15-year-old boy with epilepsy who fought to legalize medical marijuana in Pennsylvania, passed away.  

His mother, Cara, found the teen unresponsive in his bedroom when she checked up on him last week in their home. 

“We find peace knowing that Jackson stayed here with us for 10 years to teach us all kindness and compassion and how to be advocates for each other and our children,” Cara said. 

(This author personally hopes he meets another inspiring child advocate, Charlotte Figi, in heaven.)

Jackson’s funeral service is at 11 a.m. on Tuesday, August 10, at Christ United Church of Christ, 32 Baltimore St., Codorus Township, PA. 

Full Story here. 

Upcoming webinars 

Learn something new  with the from the National Cannabis Industry Association (NCIA): 

August 24: Advanced Risk Mitigation for Cannabis: Best Practices and Policies.

September 1:  1 PM: Conscious Cultivation through Integrated Pest Management.   3 PM: CAOA or Chaos? – Unpacking the Cannabis Administration & Opportunity Act

September 15: Five Growth Hacks Cannabis Retailers Can Learn from Mainstream Retailers


#CBD #Hemp
https://cannatechtoday.com/quick-hits-the-latest-in-cannabis-news/
August 11, 2021 11:00 am

Seeking Surety in Michigan’s Cannabis Industry

Seeking Surety in Michigan’s Cannabis Industry

State governments are worried about cannabis companies. 

Will they follow regulations? 

Are they abiding state laws — and if not, how can the state regain losses from fees or fines caused by the company’s failures? 

This is where surety bonds come in. 

Most states require cannabis companies to carry a surety bond to secure their operating license. 

It acts as a contract between three parties: the business owner, the bond provider, and the state. 

What is a Surety Bond?

 A surety bond agreement is a financial guarantee that the company will follow regulations. 

If the company makes a mistake that costs the state money, the state can make a claim to the bond provider. 

Once the money is paid, the business owner must repay the bond provider. 

This all seems straightforward, except this is cannabis — where nothing is as easy as it seems. 

Cannabis is federally illegal. 

So, despite the state’s requirement to carry a bond, most financial services don’t work with cannabis operators for fear of federal penalties. 

Find a Carrier Surety One President and Chief Underwriter Constantin Poindexter explains, “There has been enough controversy surrounding legal cannabis that offering insurance vehicles has been severely limited. One of the first surety companies to enter the space was hit with a lawsuit alleging, among other things, that the surety conspired with other parties to violate a federal statute.” 

This lawsuit set a negative precedent for the rest of the industry

“One of the world’s largest reinsurance facilities immediately announced its complete withdrawal from anything cannabis — which pretty much nixed quick growth of insurance programs,” noted Poindexter. 

Rise Above the Risks 

Despite these early hurdles, some operators are able to see cannabis for the opportunity it is. 

Surety One is one of a handful of companies that have found a way to work with these forward-looking carriers to provide bonds to the industry.

 But, even if a surety is willing to work with cannabis companies, they’re often not willing to work with “risky” clients. 

“Start-ups without an operating history, parties with damaged credit, and other challenges are able to receive a fair review from Surety One, Inc.’s underwriters, where they are simply turned away by others.” 

He feels in order to be successful in the insurance business, you have to go where there’s risk.

 “Anyone can [underwrite] all of the easy, low risk stuff, but that doesn’t help the little guy that may not fit neatly into a carrier’s standard underwriting box.” 

Ask the Experts 

In the state of Michigan, some municipalities have instituted surety bond requirements that are costly or cumbersome to the extent that few surety companies will work with them.

 In these instances, the cannabis company may choose to offer collateral as an added incentive to bond providers. 

Navigating the rules and regulations of the hemp and cannabis industries isn’t easy. 

Working with certified professionals is often the best recourse. 

As Poindexter noted, “My team takes whatever time is necessary to help clients understand what they need, how to apply for it, and ensure delivery of the appropriate surety bond. We turn our backs to no one.”


#CBD #Hemp
https://cannatechtoday.com/seeking-surety-in-michigans-cannabis-industry/
August 10, 2021 11:00 am

Will Mexico Become the Top Legal Cannabis Producer in 2021?

Will Mexico Become the Top Legal Cannabis Producer in 2021?

Mexico and the cannabis plant have a complicated history. For several centuries, the cannabis plant was consumed in Mexico for medical and recreational purposes, and hemp was used to make various finished goods.

Mexico’s cannabis scene changed dramatically with the onset of prohibition.

After cannabis was prohibited around the globe, Mexico became a top international source for illegal cannabis.

Unregulated cannabis from Mexico dominated illegal sales beyond Mexico’s borders for many years, especially in the United States. It is no secret that gangs and cartels largely benefited financially from those sales.

Demand for illegal cannabis has waned in recent years in the United States with the rise of the legal cannabis industry, and that evolution is ramping up elsewhere as nations reform their cannabis laws.

That has had a huge impact on Mexico’s cannabis trade, which is still largely based on illegal cannabis exports.

That is likely to change in 2021.

Mexico’s Supreme Court ruled in 2018 that cannabis prohibition was illegal, and lawmakers in Mexico have worked ever since to craft a measure to implement the Court’s decision.

After a series of delays and deadline extensions granted by Mexico’s Supreme Court, on June 28, 2021, the Court decriminalized the recreational use of cannabis.

It’s unclear at this time exactly what cannabis legalization looks like in Mexico, but it’s safe to assume legal exports will eventually be part of the equation.

If or when legal exports start to take shape, Mexico will instantly become a legal international cultivation powerhouse.

Compared to Canada, cannabis is much cheaper to cultivate in Mexico, giving it a distinct advantage.

The cannabis plant grows naturally in Mexico, which is not the case in Canada’s much colder climate, and labor is considerably cheaper in Mexico which is another advantage from the perspective of producing quality cannabis at a lower price.

Uruguay is different from Canada, in that its climate and cost of labor is closer to that of Mexico.

But whereas Uruguay limits its domestic industry to residents, Mexico will presumably allow sales to tourists, which is going to be big for helping build Mexico’s legal cannabis industry.

Domestic sales will help companies scale up in Mexico, which in turn will help them build the necessary foundation for driving sales abroad.

Adult-use legalization in Mexico is going to have a massive butterfly effect on the international cannabis industry, as well as in the region.

With Mexico legalizing cannabis for adult-use, it creates a situation in which the United States is sandwiched between two legalized countries.

That will increase the pressure on the U.S. to do the same, and once the U.S. gets on the right side of history it will be the biggest cannabis policy domino to fall, likely opening up the floodgates to legalization across the planet.


#CBD #Hemp
https://cannatechtoday.com/will-mexico-become-the-top-legal-cannabis-producer-in-2021/
August 9, 2021 11:00 am

Will Mexico Become the Top Legal Cannabis Producer in 2021?

Will Mexico Become the Top Legal Cannabis Producer in 2021?

Mexico and the cannabis plant have a complicated history. For several centuries, the cannabis plant was consumed in Mexico for medical and recreational purposes, and hemp was used to make various finished goods.

Mexico’s cannabis scene changed dramatically with the onset of prohibition.

After cannabis was prohibited around the globe, Mexico became a top international source for illegal cannabis.

Unregulated cannabis from Mexico dominated illegal sales beyond Mexico’s borders for many years, especially in the United States. It is no secret that gangs and cartels largely benefited financially from those sales.

Demand for illegal cannabis has waned in recent years in the United States with the rise of the legal cannabis industry, and that evolution is ramping up elsewhere as nations reform their cannabis laws.

That has had a huge impact on Mexico’s cannabis trade, which is still largely based on illegal cannabis exports.

That is likely to change in 2021.

Mexico’s Supreme Court ruled in 2018 that cannabis prohibition was illegal, and lawmakers in Mexico have worked ever since to craft a measure to implement the Court’s decision.

After a series of delays and deadline extensions granted by Mexico’s Supreme Court, on June 28, 2021, the Court decriminalized the recreational use of cannabis.

It’s unclear at this time exactly what cannabis legalization looks like in Mexico, but it’s safe to assume legal exports will eventually be part of the equation.

If or when legal exports start to take shape, Mexico will instantly become a legal international cultivation powerhouse.

Compared to Canada, cannabis is much cheaper to cultivate in Mexico, giving it a distinct advantage.

The cannabis plant grows naturally in Mexico, which is not the case in Canada’s much colder climate, and labor is considerably cheaper in Mexico which is another advantage from the perspective of producing quality cannabis at a lower price.

Uruguay is different from Canada, in that its climate and cost of labor is closer to that of Mexico.

But whereas Uruguay limits its domestic industry to residents, Mexico will presumably allow sales to tourists, which is going to be big for helping build Mexico’s legal cannabis industry.

Domestic sales will help companies scale up in Mexico, which in turn will help them build the necessary foundation for driving sales abroad.

Adult-use legalization in Mexico is going to have a massive butterfly effect on the international cannabis industry, as well as in the region.

With Mexico legalizing cannabis for adult-use, it creates a situation in which the United States is sandwiched between two legalized countries.

That will increase the pressure on the U.S. to do the same, and once the U.S. gets on the right side of history it will be the biggest cannabis policy domino to fall, likely opening up the floodgates to legalization across the planet.


#CBD #Hemp
https://cannatechtoday.com/will-mexico-become-the-top-legal-cannabis-producer-in-2021/
August 9, 2021 11:00 am

Finding a Better Way: Sustainable Leadership Awards

Finding a Better Way: Sustainable Leadership Awards

What does sustainability mean to you?

For Cannabis & Tech Today, it means fostering an industry that will thrive while preserving the natural resources necessary for continued growth.

For 2020’s Sustainable Leadership Awards, we chose three applicants setting the standard for sustainable energy consumption, packaging, and stewardship.

Graham Farrar, president and chief cannabis officer for Glass House Group, discusses why environmental stewardship is central to his company’s mission.

Brain Domann, sales and marketing director for Humidi shares solutions to the industry’s packaging problem.

And Derek Gould, director of marketing and communications for Solar Therapeutics invites you to join him in creating a more eco-friendly future.

In this special feature, we’ll shine a spotlight on how they’re leading the charge, what’s most important to them, and how all companies, big or small, can work toward more sustainable operations.

Glass House Group President and Chief Cannabis Officer: Graham Farrar

Cannabis & Tech Today: What is Glass House Group’s approach to sustainability?

Graham Farrar. Photo courtesy of Glass House Group.

Graham Farrar: We try to really advocate for this low-touch agricultural approach we practice.

Cannabis in agriculture is a bit of an outlier, in that it’s a highly-regulated business with a lot of friction, a lot of costs, but you’re not in the single-digit margin percentage like a lot of ag is — where they’re really struggling to stay alive — which allows us to do things like invest in using beneficial insects instead of pesticides.

There’s a positive circle that starts with that, which is, if we spend twenty grand a month with the beneficial insect’s guys, and then some other companies do, and then the [insect company] can scale up.

As they get bigger, the price comes down, and then maybe now it’s available to the tomato guys because they can afford it now — and then the tomato [industry] is 1000 times bigger than cannabis.

So if that industry can take even just a little bit, the size of it makes it that much bigger, and then the insect’s price comes down and then more people can get access to it.

So you can start this virtuous cycle. I think cannabis can help blaze that path for the rest of agriculture, which will end up making a lot more difference than we do.

Humidi Sales and Marketing Director: Brian Domann

Brian Domann. Photo courtesy of Humidi.

C&T Today: How is Humidi helping tackle some of the industry’s environmental issues?

Brian Domann: What we really sought for and our ultimate goal has always been, how can we have a net positive impact on the environment?

And while we initially wanted to incorporate hemp into our packaging, we also really needed to have a strong product that would be durable and have the shelf life of a traditional product and provide that same protection, integrity for the cannabis, or any of the products that are stored in our packaging.

And that’s why, ultimately, we went with canola-based bio plant materials.

It is the only product on the market that can be fully compostable in a home compost heap.

There are no microplastics leftover and the product will act as a food source for bacteria that are naturally occurring in the soil.

C&T Today: How do you envision the future of cannabis packaging?

BD: I’d love to envision the future being a net-zero impact on environmental production, which it’s always hard to get there.

But I think if the cannabis market can lead the charge against plastic pollution and show what’s possible and what can be done for some of these mass packaging markets or consumer packaged goods in general.

There are sustainable products out there that are not truly as sustainable as folks think.

And the one biggest thing that we’re really trying to articulate, from an education standpoint to an end consumer or a distributor, is that this is the first product that has 0% plastic.

There’s not a trace of plastic in these products.

Solar Therapeutics Director of Marketing and Communications Derek Gould 

C&T Today: How does Solar Therapeutics incorporate sustainable practices into its ethos?

Solar Therapeutics CEO Edward Dow. Photo courtesy of Solar Therapeutics.

Derek Gould: The way we’ve incorporated and implemented green infrastructure into our entire facility and its operations is huge.

We’re a full-blown power plant. We’re generating about 5.4 megawatts. One megawatt can power about a thousand small homes.

Our vision and mission is to replicate what we have here in Massachusetts and demonstrate that in other States.

It’s a very arduous process to source these sustainability components, especially when you’re talking about the size of the facility that we’re working in.

But, I think being a responsible corporate citizen is crucial.

When you are looking at the statistics, indoor cannabis cultivation is trending towards being the second most unsustainable industry in the country — and that’s behind data storage centers.

I think, to take a conscious approach, to make changes even though it costs more upfront, to start implementing those things and demonstrate how to be a leader in the space — and it’s not too late, it’s actually very early and we can make this happen — is major for us.

We really want to plant our flag and be the first multi-state operator that’s touting these carbon emissions percentages that are above and beyond.

If we could be at 90% emissions-free, that would be huge; 50 to 60% is where we’re operating right now.

I think it’s key, if this industry is to continue to operate and be responsible, you really have to start pivoting and implementing these sustainable approaches.

C&T Today: What advice would you offer operators looking to become more sustainable?

DG: You don’t have to go all-in on sustainability right off the bat.

There’re a lot of low-hanging fruit and very easily implemented, inexpensive ways, and procedures that can make your facility at least start to be a little bit more sustainable.

It’s imperative we start really considering this approach to cultivating cannabis.

We’re going to start seeing more states crack down on thresholds for sustainable practices for indoor cultivators because, again, it’s such an energy hog.

So, I think to have that foresight and understanding, that this is where we’re headed in this industry and for us to be a stalwart of this movement, is paramount for us.


#CBD #Hemp
https://cannatechtoday.com/finding-a-better-way-sustainable-leadership-awards/
August 2, 2021 11:00 am

Medical marijuana money in NC

Medical marijuana money in NC

Speaking to the North Carolina Senate Finance Committee on medical marijuana money, 19’26” mark on video:https://www.wral.com/nc-medical-marijuana-bill-approved-by-another-senate-panel/19782886/

And here’s a verbatim transcript, all too accurate, I’m afraid, in reporting my stream-of-consciousness delivery:

“I’m Pat Oglesby with the Center for New Revenue. I think you’re leaving a lot of money on the table here. $50,000 [for an intial license]. These folks would if you had an auction, I hesitate to think how many people, how much money people would pay for these licenses . . .  in Maryland last earlier this month, a medical marijuana license [sold] for $8 million dollars … there’s another way and Canada has done it. They have the provinces have, there have a monopoly on medical marijuana, That’s how it started delivery only. Online only. No glamour, no glitz. The patients just get the patients the medicine and the government gets the money.  In Louisiana. The government gets the money that the state of Louisiana has a monopoly on medical marijuana growing and it uses the L. S. U. And Southern University which correspond to our N. C. State and A. N. T. And they get that money. Now people say, well then the patient is not going to buy it from the government. They don’t trust the government and that may be true, but I trust the government and that’s why I’m here today and I really hope you all take a good look, getting some more revenue out of this thing. Thank you very much.”


#CBD #Hemp
Medical marijuana money in NC
August 1, 2021 9:13 pm

EXCLUSIVE: Cannabis Trade Show Raided by the Feds

EXCLUSIVE: Cannabis Trade Show Raided by the Feds

July 28, 2021, LAS VEGAS, NEVADA – Cannabis culture and accessories trade show, Champs, was allegedly raided because a vendor participating in the event unwittingly gave the Las Vegas district attorney an unauthorized product sample. 

The following day, social media reports of the feds raiding the venue started cropping up. Various vendors began posting that the officers ordered the attendees to wait outside while they inspected the scene.

The Champs trade show is highly regarded as a decent show to attend if one is looking for “glass,” pipes, bongs, and other smoking accessories. Think of it like a conference center containing an enormous head shop with networking, advocacy, and education thrown in.

Trade Show Raided for Delta-8 THC

As a result of yesterday’s occurrence, plainclothes police officers (“undercovers”)  are walking the show floor today while its vendor booths are currently being searched for any Delta-8 THC and similarly prohibited products.

According to TheBlackListxyz’s Instagram page, the scenario unfolded when a vendor gave a prohibited, clandestine sample to the State’s Attorney General unknowingly. Providing samples to the show’s attendees is against the rules.  As a result, some vendors were asked to vacate the premises. 

Big Mike, the founder of popular nutrient products for cannabis cultivators, Advanced Nutrients, posted the following on his Instagram:

New Laws Prohibit Delta-7,-8, and -10

Facebook user Dalton Gambino posted a screenshot regarding Nevada’s recent prohibition of Delta -7, -8, and -10 via bill SB49. 

The SB49 bill amends previous cannabis legislation with an update stating:

(1) any commodity or product made using hemp which exceeds the maximum THC concentration established by the State Department of Agriculture; and (2) a product or commodity made from hemp and manufactured or sold by a cannabis establishment that exceeds the maximum THC concentration established by the Cannabis Compliance Board. Existing law defines THC as (1) delta-9-tetrahydrocannibinol; (2) delta-8-tetrahydrocannibinol; and (3) the optical isomers of such substances. (NRS 453.139) Section 3.5 of this bill revises the definition of THC as (1) delta-9-tetrahydrocannabinol and any structural, optical, or geometric isomer thereof; (2) delta-8-tetrahydrocannibinol; (3) delta-7-tetrahydrocannibinol; and (4) delta-10-tetrahydrocannibinol. – is prohibited. 

Cannabis community member Ben Owens posted videos of an organizer advising everyone at the event to ditch or hide their illicit stash of Delta-8 on Twitter. Additionally, no advertising or promotion of the cannabinoid is allowed on banners or booths.

Despite the interruption, the trade show at the Las Vegas Convention Center was allowed to continue. The event is scheduled to wrap up on July 30, 2021.

The Nevada district attorney could not be reached for comment. 


#CBD #Hemp
https://cannatechtoday.com/exclusive-cannabis-trade-show-raided-by-the-feds/
July 29, 2021 1:13 am

Prepared remarks for NC Senate Finance Committee, July 22, 2021, on medical marijuana

Prepared remarks for NC Senate Finance Committee, July 22, 2021, on medical marijuana

Mr. Chairman and Members of the Committee:

Thank you for having me.  I’m Pat Oglesby.  I live in Senator Foushee’s district now, but I’m originally from the home of the Shad Festival, Grifton.  I’ve practiced tax law, been a staff lawyer for the Joint Congressional Committee on Taxation and the U.S. Senate Finance Committee, taught classes at the Kenan-Flagler Business School, and been a member of angel investment groups.  I’ve founded the Center for New Revenue, a non-profit that looks at marijuana revenue, and advised state governments on marijuana, pro bono and for pay.  

I’m an analyst, not an advocate.  There’s a lot of money on the table.  A billion dollars’ worth of medical marijuana was soldin the first 40 months of medical-only legalization in Maryland.  This month, a single medical marijuana license there sold for $8 million.

There’s another way.  In Canada, provinces started out having a government retail medical marijuana monopoly – online only, delivery only, no glitz.  In Louisiana, the 2 land grant universities, LSU and Southern, have had a monopoly on growing medical marijuana for years.  Federally illegal!  Yes, but the federal government knows that, and is winking – and not lifting a finger.

There are pros and cons.  The for-profit model is likely to be more efficient and patient-friendly.  Government can be bureaucratic.  Buying from the government is like chowing down at the school cafeteria; buying from entrepreneurs is like dining on Restaurant Row. Government sales cost more to start up, though they bring in more revenue in the long run. Government sellers can set fair prices and prevent diversion.  They won’t try to boost demand, and won’t say advertising restrictions are unconstitutional. 

Maybe people don’t trust government.  But in a 2013 poll, North Carolina voters preferred government marijuana sales over private sales by a 3 to 1 margin.  The poll is available at www.newrevenue.org.  

Patients need medicine.  Someday, somehow, we’ll stop making them break the law.  There’s no single right way to do it – but a lot to think about.  I wish you well.

+++

Speakers were given only 2 minutes instead of the 3 I hoped for, so I ad libbed. More to come.


#CBD #Hemp
Prepared remarks for NC Senate Finance Committee, July 22, 2021, on medical marijuana
July 28, 2021 8:05 pm

Pesticide Remediation by CPC

Pesticide Remediation by CPC

Like any other natural product, the biomass of legal cannabis can be contaminated by several toxic agents such as heavy metals, organic solvents, microbes and pesticides, which significantly influence the safety of the end products.

Let’s just consider the toxicological effects. Since cannabis products are not only administered in edible forms but also smoked and inhaled, unlike most agricultural products, pesticide residue poses an unpredictable risk to consumers. One example is the potential role of myclobutanil in the vape crisis.

Unfortunately, federal and state laws are still conflicted on cannabis-related pesticides. Currently, only ten pesticide products have been registered specifically for hemp by the U.S. Environmental Protection Agency. So, the question arises what has to be done with all pf the high-value, but also contaminated cannabis, keeping in mind that during the extraction processes, not only the phytocannabinoids get concentrated but the pesticides as well, reaching concentrations up to tens or hundreds of parts per million!

Currently, there are three different sets of rules in place in the regulatory areas of Oregon, California and Canada. These regulations detail which pesticides need to be monitored and remediated if a certain limit for each is reached. Because the most extensive and strict regulations are found in Canada, RotaChrom used its regulations as reference in their case study.

Centrifugal Partition Chromatographic (CPC) system

To illustrate that reality sometimes goes beyond our imagination, we evaluated the testing results of a THC distillate sample of one of our clients. This sample contained 9 (!) pesticides, of which six levels exceeded the corresponding action limits. The most frightening, however, regarding this sample, is that it contained a huge amount of carbofuran, a category I substance. It is better not to think of the potential toxicological hazard of this material…

The CPC-based purification of CBD is a well-known and straightforward methodology. As the elution profile on the CPC chromatogram of a distillate shows, major and minor cannabinoids can be easily separated from CBD. At RotaChrom, this method has been implemented at industrial-scale in a cost effective and high throughput fashion. In any case, the question arises: where are the pesticides on this chromatogram? To answer this, we set ourselves the goal to fully characterize the pesticide removing capability of our methodologies.

Our results on this topic received an award at the prestigious PREP Conference in 2019. The ease of pesticides removal depends on the desired Compound of Interest.

Here is a quick recap on key functionalities of the partition chromatography.

  • Separation occurs between two immiscible liquid phases.
  • The stationary phase is immobilized inside the rotor by a strong centrifugal force.
  • The mobile phase containing the sample to be purified is fed under pressure into the rotor and pumped through the stationary phase in the form of tiny droplets (percolation).
  • The chromatographic column in CPC is the rotor: cells interconnected in a series of ducts attached to a large rotor
  • Simple mechanism: difference in partition

Let’s get into the chemistry a bit:

The partition coefficient is the ratio of concentrations of a compound in a mixture of two immiscible solvents at equilibrium. This ratio is therefore a comparison of the solubilities of the solute in these two liquid phases.

The CPC chromatogram demonstrates the separation of Compounds of Interest based on their unique partition coefficients achieved through a centrifugal partition chromatography system.

CPC can be effectively used for pesticide removal. About 78% of the pesticides around CBD are very easy to remove, which you can see here:

In this illustration, pesticides are in ascending order of Kd from left to right. CBD, marked with blue, elutes in the middle of the chromatogram. The chart illustrates that most polar and most apolar pesticides were easily removed beside CBD. However, some compounds were in coelution with CBD (denoted as “problematic”), and some compounds showed irregular Kd-retention behavior (denoted as “outliers”).

If pesticides need to be removed as part of THC purification, then the pesticides that were problematic around CBD would be easier to remove and some of the easy ones would become problematic.

To simulate real-world production scenarios, an overloading study with CBD was performed, which you can see in the graph:

It is easy to see on the chromatogram that due to the increased concentration injected onto the rotor, the peak of CBD became fronting and the apparent retention shifted to the right. This means that pesticides with higher retention than CBD are more prone to coelution if extreme loading is applied.

To be able to eliminate problematic pesticides without changing the components of the solvent system, which is a typical industrial scenario, the so-called “sweet spot approach” was tested. The general rule of thumb for this approach is that the highest resolution of a given CPC system can be exploited if the Kd value of the target compounds fall in the range of 0.5-2.0. In our case, to get appropriate Kd values for problematic pesticides, the volume ratio of methanol and water was fine-tuned. Ascending mode was used instead of descending mode. For the polar subset of problematic pesticides, this simple modification resulted in an elution profile with significantly improved resolution, however, some coelution still remained.

In the case of apolar pesticides, the less polar solvent system with decreased water content in ascending mode provided satisfactory separation.

Moreover, if we focus on this subset in the three relevant regulatory areas, the outcome is even more favorable. For example, myclobutanil and bifenazate, dominant in all of the three regulatory regions, are fully removable in only one run of the CPC platform.

Based on these results, a generic strategy was created. The workflow starts with a reliable and precise pesticide contamination profile of the cannabis sample, then, if it does not appear to indicate problematic impurity, the material can be purified by the baseline method. However, if coeluting pesticides are present in the input sample, there are two options. First, adjusting the fraction collection of the critical pesticide can be eliminated, however the yield will be compromised in this case. Alternatively, by fine-tuning the solvent system, a second or even a third run of the CPC can solve the problem ultimately. Let me add here, that a third approach, i.e., switching to another solvent system to gain selectivity for problematic pesticides is also feasible in some cases.

In review, RotaChrom has conducted extensive research to analyze the list of pesticides according to the most stringent Canadian requirements. We have found that pesticides can be separated from CBD by utilizing our CPC platform. Most of these pesticides are relatively easy to remove, but RotaChrom has an efficient solution for the problematic pesticides. The methods used at RotaChrom can be easily extended to other input materials and target compounds (e.g., THC, CBG).

The post Pesticide Remediation by CPC appeared first on Cannabis Industry Journal.


#CBD #Hemp

Pesticide Remediation by CPC


July 28, 2021 2:16 pm

Innovation and Ingenuity Surprise Judges at Cannabis Pitch Contest

Innovation and Ingenuity Surprise Judges at Cannabis Pitch Contest

Four businesses attended the Winter Emerge 2020 Virtual Cannabis Conference & Expo to compete in the Investor Pitch Contest hosted by Leafwire and Regennabis.

In order to qualify and win, the companies had to show a comprehensive plan that included a focus on sustainability in the cannabis industry.

Each was given the opportunity to make a 4-minute pitch, followed by a 4-minute question and answer period with potential investors.

Geoff Trotter, co-founder of Regennabis, and Peter Vogel, CEO and co-founder of Leafwire, moderated the event.

Out of the four presentations came four very distinct and unique ideas.

Just BioFiber Pitches a Perfect Plan

Just BioFiber was the event’s clear winner with a project that has global implications environmentally and financially.

Dave Ladouceur. Photo courtesy of Just BioFiber.

Dave Ladouceur, CEO of Just BioFiber, explained that the company produces a truly sustainable building solution.

The company produces custom building blocks comprised of hemp fiber combined with a proprietary lime slurry mix to create one of the most sustainable building materials on the market. 

Hemp agriculture can produce 250% more fiber than cotton and 600% more fiber than flax on the same amount of land.

Hemp processing uses one-tenth of the energy that it takes over years and years to fully develop a forest for timber construction.

Ladouceur said the company desperately needs to expand its factory to increase production. He added the company is losing out on millions in business right now because it simply can not keep up with demand.

“We’ve had to stop taking orders,” he said. “There’s a backlog because the company is too small to keep up with demand. A 3-5 million annual block production facility could net a substantial profit.”

An investment would allow Just BioFiber to stabilize the company, work off the sales backlog and stop turning away orders, become cash flow positive in Q3 2021, and allow them to upgrade their plant to handle 20,000 bricks per month.

“It’s an environmental gem that will be a great solution for the people, the planet, and prosperity,” Ladouceur said. Another benefit to the fiber blocks is that construction time is cut drastically. The time needed to frame a 2,000 sq. ft. home is about half the time of traditional wood-frame construction.

The blocks also offer a substantial increase in safety. They have a two-hour fire rating at 1,800 degrees. “These things will not catch fire,” Ladouceur said. “We’ve tried with torches directly heating them and nothing. No smoke. No fire.”

One judge pointed out that could make the blocks very desirable for places like California where wildfires are a way of life. 

They can also withstand up to 250 mile-per-hour winds.

The pandemic hit Just BioFiber particularly hard, which is why they entered the contest. A $30 million investment to take the company global was called off in March 2020 as the pandemic sent life to a screeching halt. 

“The company licked its wounds and pushed forward,” he said. After naming Just BioFiber as the winner, Trotter said the next steps in the process would follow close behind.

“I will be working with each of the investors as a follow-up with Peter [Vogel] to see what opportunity there may be to reach out with each of you for an even longer conversation,” Trotter said. “One that gets into the guts of your businesses and to give you really a fair crack at an investment.”  

Gladbrook Holdings Customizes Your Prescription

Warren Blesofsky. Photo courtesy of Gladbrook Holdings.

Coming in second place was Gladbrook Holdings of Long Beach, CA. Warren Blesofsky, president and co-founder, made the presentation.

Gladbrook holds a variety of assets in the cannabis space, including both real estate and retail sales.

The project for which the company is seeking investors is its Dial It In subscription service. Dial It In is a medical marijuana subscription service that will deliver your specific, regular order directly to your door. 

“When the big money came into California, it rushed for recreational marijuana,” Blesofsky said. “It left the medical market mostly neglected.” That space is where he feels Dial It In could provide a valuable service. He said the company will use all-electric automobiles and is developing truly sustainable packaging.

In addition to plant-based biodegradable plastic, the company is developing a child-proof cardboard packaging system.

While not complete, Blesofsky said he believes the next iteration of the cardboard package will be the final product. 

The company is seeking approximately $9 million in funding this year and believes the majority of that will come from private investors.

Gladbrook also plans to operate a recreational marijuana leg of Dial It In, known as Discreet St. Between the two businesses, Blesofsky believes the company will set the industry standard in sustainable packaging for years to come.

Feel State Inc. Offers Turn-Key Solutions

David Melnick. Photo courtesy of Feel State Inc.

In third place was St. Louis, MO-based Feel State Inc. CEO David Melnick made the company’s pitch.

Feel State is offering a franchise option for cannabis dispensaries.

The Feel State licensing system is designed to offer a turnkey solution for business owners looking to delve into the cannabis space. 

“We’re giving people new to the industry a way to take the guesswork out of opening a dispensary,” Melnick said. “We’ll provide our partners with the tools needed to succeed.”

Feel State will open its first dispensary in St. Louis this spring.

The company is finalizing additional deals in Missouri, Oklahoma, and Colorado.

Judges for the competition were Codie Sanchez, managing director and partner of Entourage Effect Capital; Emily Paxhia, co-founder and managing partner for Poseidon Asset Management; Kellie Seringer, portfolio manager at Symmetry Capital Management, LLC; and Lindsay Blackett, CEO of PeakTerra Ventures Inc.

The next Investor Pitch Contest will take place during Spring 2021 Emerge on March 30-April 1, 2021. Visit emergecanna.com for tickets and for more information on the contest.


#CBD #Hemp
https://cannatechtoday.com/innovation-and-ingenuity-surprise-judges-at-cannabis-pitch-contest/
July 27, 2021 11:00 am

Quick Hits: Proposed Bill Brings Justice to War on Drugs Victims

Quick Hits: Proposed Bill Brings Justice to War on Drugs Victims

Legislation

The highly-anticipated proposed Senate bill that would federally legalize marijuana was publicly announced on  July 14, 2021.

The Cannabis Administration and Opportunity Act is a proposed bill in the United States Congress to recognize legalization of cannabis by the states. 

The authors are Senate Majority Leader Chuck Schumer (D-New York), Senator Cory Booker (D-New Jersey), and Senator Ron Wyden (D-Oregon). 

Referred to as the Cannabis Administration and Opportunity Act, it removes marijuana from the Controlled Substances Act (CSA) Schedule 1 designation, and allows states autonomy to determine their own cannabis laws, similar to the way alcohol is federally regulated. 

Revenue generated by federal taxes would support restorative justice to victims of the war on drugs, and public health and safety research, according to National Law Review.

Kim Rivers, CEO of retail cannabis chain Trulieve (CSE: TRUL, OTC: TCNNF) supports the measure. 

“Trulieve is supportive of the work being done and put forth in the Cannabis Administration and Opportunity Act draft. This is a comprehensive and balanced proposal that will address the social issues that have plagued communities disproportionately affected by the War on Drugs as well as provide the platform to remove the hindrances and uncertainties holding back the industry and allow it to thrive.

“Once the stigma is removed, we will see an acceleration of job creation and states will have the economic engine needed to capitalize and participate in the industry’s growth. Americans have been vocal, and it’s time for smart, broad federal changes to reflect the voice of the people,” said Rivers.

Product Launches 

Hash Gummies 
PLUS Hash Gummies. Photo courtesy of PLUS.

Back by popular demand, Plus, a cannabis and hemp CPG company in the U.S., announced yesterday the release of the second batch of its limited-edition PLUS Hash Gummies, made in collaboration with hash co., Biscotti Brands.

The Company’s orange blossom-flavored PLUS Hash Gummies are infused with cold water hash extracted from MAC (aka Miracle Alien Cookies) flower, a hybrid strain known for its relaxing and uplifting effects. 

Each gummy contains 10mg of THC and is flavored with all-natural essence from Seville and Valencia oranges and orange blossom to complement MAC’s smooth citrus and floral accents.

Pre-Rolls
4Front Ventures Terp Stix. Photo courtesy of 4Front Ventures.

4Front Ventures Corp. this week announced the launch of Terp Stix distillate-infused pre-rolls. 

The joints are now available in one gram singles at 4Front’s Mission Dispensaries in South Chicago and Calumet City, Illinois for $25.00, in addition to WA and MA. 

The 4Front will continue to roll out its Terp Stix singles to partner dispensaries across the state. 

Media

Bravely launched at the beginning of the pandemic, Spanish cannabis culture site El Planteo is keeping its head above (bong) water.

“We launched El Planteo with the objective of bridging the gap in knowledge around plant medicine in the Spanish-speaking world through simple, easy-to-consume content. We aim to normalize cannabis, hemp, and psychedelics, and educate people on their many uses and benefits through constructive journalism. We also strive to provide financial literacy to people in Latin America, seeking to incentivize local entrepreneurship and investing,” says El Planteo CEO Javier Hesse. 

If “hierba” is the only Spanish word you know, perhaps it’s time to expand your horizons, by discovering and learning to read El Planteo.


#CBD #Hemp
https://cannatechtoday.com/quick-hits-proposed-bill-brings-justice-to-war-on-drugs-victims/
July 23, 2021 6:30 pm

5 Pivotal Trends Propelling Growth For the Medical Cannabis Market: 2021-2027

5 Pivotal Trends Propelling Growth For the Medical Cannabis Market: 2021-2027

Growing awareness and public support for medical cannabis around the world has pushed regulatory authorities to consider the legalization of medical cannabis, which remains the major factor driving growth for the medical market. Cannabis-based medication has conventionally been used and studied to be an effective therapeutic solution for various disorders. Increasing R&D activities for the development of novel solutions and applications has led to various formulations being approved by The United States Food & Drug Administration (FDA). For instance, in 2020, the FDA had approved application of Epidiolex for treating seizures related to tuberous sclerosis complex in patients aged one year and above. On account of shifting interest towards the benefits of medical cannabis and significant technological advancements, application of medical cannabis is increasing rapidly, which is positively impacting the overall business space.

According to Global Market Insights, Inc., the medical cannabis market size was valued at USD 22.4 billion in 2020 and will record exceptional growth numbers in the coming years, considering the emergence of the following trends:

Development of new products by key market players

Prominent players operating in the medical cannabis industry such as Canopy Growth Corporation, Aurora Cannabis Inc., Aphria Inc., GW Pharmaceuticals, ABcann Medicinals Inc., The Supreme Cannabis Company, etc. are focusing on strategies pertaining to product development and acquisitions in order to gain a strong market presence. Citing an instance in 2018, GW pharmaceuticals, announced that it had received an FDA clearance for its first plant-based pharmaceutical cannabidiol for treating rare pediatric epilepsies. Apparently, the approval helped the company expand its portfolio while giving it the innovator’s advantage in cannabis-based treatments.FDAlogo

Rising demand for treating nausea conditions

Medical cannabis is finding extensive usage in the treatment of nausea conditions especially for the patients undergoing chemotherapy, as a part of cancer treatment. Numerous tetrahydrocannabinol- and cannabidiol-based medications have been approved for treating the symptoms of nausea. The rising incidences of cancer and nausea segments across medical cannabis markets is anticipated to register a substantial CAGR of 18.4% through 2027.

Increasing preference for topical route of administration

Topical administration of medical cannabis is gaining prominence as topical solutions such as lotions and creams can be directly applied to the skin for the treatment of an injury. They are also replacing opioids for injury-related pain management as these have shown several side effects. Topical products also allow for self-administration that’s minimally invasive, while exhibiting limited side effects. With increasing adoption of topical route of administration, the segment is estimated to register an appreciable valuation of $5 billion by 2027.

Higher sales through dispensaries

Dispensaries have become a prime distribution channel globally. Considering the stringent regulatory scenario around medical cannabis, its consumption and sales are highly monitored by authorities in order to avoid any abuse or instances that lead to addiction. It is relatively easy for both suppliers and consumers to engage in a conventional brick and mortar store model under a regional medical cannabis program. Given that, dispensaries are anticipated to retain dominance in the market over the coming years. In 2020, the segment had held a sizeable market share of 58.4%.

Rising consumption of medical cannabis in Latin America

South American countries like Argentina and Chile are the major consumers of medical cannabis in the region. While Argentina has legalized the domestic cultivation of cannabis, Chile is known to have a history of medical cannabis with various clinical trials being performed since 2014. The country is one of the leaders in the LATAM medical cannabis industry wherein the regulatory authorities keep on simplifying the laws time and again. With favorable regulatory scenarios, the regional market is projected to expand significantly by recording a CAGR of 20.9% through 2027.

The post 5 Pivotal Trends Propelling Growth For the Medical Cannabis Market: 2021-2027 appeared first on Cannabis Industry Journal.


#CBD #Hemp

5 Pivotal Trends Propelling Growth For the Medical Cannabis Market: 2021-2027


July 21, 2021 4:44 pm

New Study Suggests Domesticated Cannabis Originated in China

New Study Suggests Domesticated Cannabis Originated in China

The relationship between the cannabis plant and humankind goes back many, many years. But where did it originate? Could genomic research determine its origins?

You will be hard-pressed to find a plant that is as dynamic as the cannabis plant, which is why it’s been so popular among humans for so long.

Humans all over the world have used the cannabis plant to make clothing and other textiles for centuries, as well as using cannabis for medical purposes.

By comparison, cannabis use for recreational purposes is a relatively new phenomena. However, it has also occurred for many, many years.

Historically, researchers thought that cannabis was first domesticated in Central Asia. A new study suggests that may not be accurate.

Is China the Birthplace of Domesticated Cannabis?

A team of international researchers recently sequenced and analyzed over 100 cannabis genomes in an attempt to try to pinpoint the start of humans domesticating cannabis.

After looking over the compiled information, the researchers concluded that the cannabis plant was likely not domesticated in Central Asia, but rather in East Asia (China).

The analysis applies to both hemp-grade cannabis as well as cannabis with higher THC levels, and researchers believe that domestication started roughly 12,000 years ago.

As part of the study, researchers compared samples of feral cannabis from Switzerland, China, India, Pakistan, and Peru as well as samples from “commercial” sources.

The compiling of samples and related study took place over the course of four years.

China’s Long History With the Cannabis Plant

To anyone that is familiar with China’s long history with the cannabis plant, the results of this study are likely not too surprising.

After all, Chinese pottery dating back to 10,000 BC included imprints of hemp fiber and hemp cloth is thought to have originated in China during the Chou Dynasty.

China is also believed to be the first place that cannabis was used for medical purposes, with cannabis being listed among the “50 Fundamental Herbs of Traditional Chinese Medicine.”

The sad irony is that China currently prohibits cannabis, with the exception of hemp, and people caught possessing, selling, and/or cultivating cannabis face stiff penalties.


#CBD #Hemp
https://cannatechtoday.com/new-study-suggests-domesticated-cannabis-originated-in-china/
July 21, 2021 11:00 am

Marijuana sales in North Carolina, public or private? 2013 poll

Marijuana sales in North Carolina, public or private? 2013 poll

Full results with more cross-tabs are at https://newtax.files.wordpress.com/2013/03/nc-marijuana-polling-march-2013.pdf. I hope to refer to this poll at a meeting of the North Carolina Senate Finance Committee the afternoon of July 21, 2021.


#CBD #Hemp
Marijuana sales in North Carolina, public or private? 2013 poll
July 21, 2021 6:32 am

Senate Marijuana Bill’s Taxes Are Old-Fashioned.

Senate Marijuana Bill’s Taxes Are Old-Fashioned.

The new Schumer-Wyden-Booker marijuana legalization bill is available.

It’s disappointing that the sticks precisely to the early 2017 design of the Blumenauer-Wyden bill, with ad valorem taxes for five years before switching to “specific” (non-ad valorem) taxes, only at that late date taxing flower by weight and concentrates by THC.  See http://thehill.com/blogs/pundits-blog/economy-budget/327694-marijuana-legalization-grows-closer-with-senate-tax. 2017 is a long time ago for a drug that was first legalized in 2012; we’ve come a long way in what we know since then.

That five-year delay may have had some possible justification in 2017, but not now.  But even then, ad valorem taxes were outdated.  Sure, no one was taxing anything by THC content – but several states had already worked out taxing raw plant matter by weight, the state of the art tax system in 2017.  In the intervening four years, Canada, legalizing in 2018, moved straight into taxing flower by weight immediately, and concentrates by THC content almost immediately.  No five-year delay!  The system up north seems to be humming.  Lots of states tax by weight already, and Canada has the gold standard using both bases, weight and THC.  I don’t know why we don’t just go ahead and copy it — now.



#CBD #Hemp
Senate Marijuana Bill’s Taxes Are Old-Fashioned.
July 15, 2021 6:41 pm

Too Many Cannabis Firms Put Sustainability in Last Place

Too Many Cannabis Firms Put Sustainability in Last Place

Cannabis has long been considered a green industry by the masses.

As a standalone item, the cannabis plant is very environmentally friendly. This is particularly true when it comes to hemp, a variety of the cannabis plant with a huge range of environmental benefits. An extremely versatile and robust crop, hemp uses far less land and water than other common crops and even captures carbon dioxide and regenerates soil. Approximately 20,000 products can be made from its seed, fiber and flower, from biodegradable plastics to food supplements, meaning all in all – it is an environmentally and economically sustainable crop

Yet as with most things, when cultivated in mass, the cannabis plant isn’t quite so green anymore. With its high demand for water, land and artificial lighting, cannabis cultivation can actually leave a large environmental footprint (this does however, pale in comparison to the food industry).

What’s more, many firms do not properly understand how to correctly treat and apply chemical fertilizers and pesticides, and use a machine gun approach to growing their crops. This can result in unnecessary bleed waste, which in turn can kill micro-organisms and contaminate soil, water and other vegetation. Packaging has also been cited as particularly environmentally unfriendly in the cannabis industry, with several organizations using single use plastic for their products, due to the strict guidelines attached to packaging products of a medical or pharmaceutical nature.

A field of hemp plants, (Cannabis sativa L.)

So as the CBD, medical and even adult use cannabis industries become increasingly commercialized across the globe, there is risk cannabis might start moving in the wrong direction when it comes to sustainability.

Still relatively new, the cannabis sector is nascent and exciting, with the global cannabis market size valued at $10.60 billion in 2018 and projected to reach $97.35 billion by the end of 2026. Yet as the industry grows, so too will its footprint.

I’ve seen it first-hand. The industry being hugely competitive, so for companies vying for precious investment and fighting for a spot on the stock market, often, sustainability is the last thing on their minds. In my opinion, this is wrong. Not only morally – we all play a part in looking after our planet – but it’s also a poorly calculated business decision.

It’s no secret sustainability and ESG have become a hot topic when it comes to investing. Just yesterday, Credit Suisse told CNBC that the pandemic has accelerated the trend towards sustainable investments. The bank has even introduced an exclusion strategy whereby those investing can actively exclude controversial sectors.

So with the environment firmly on investors’ minds, cannabis firms need to realize that actually, if they want to secure the support of forward-thinking shareholders, they need to consider more than just the bottom line and truly take the sustainability of their operations into account.

photo of outdoor grow operation
Outdoor growing can require less energy inputs

Luckily, there are practices which cannabis cultivators can take on board to reduce their environmental footprint. To start with – growing outdoors. This enables cannabis farmers to harness the sun’s natural power, saving them money on electricity bills and increasing energy efficiency. With cannabis being a rather thirsty plant, water use is also a major concern – although this is nothing compared to the amount of water used by cotton plants. However, it is in fact possible to design indoor operations which recycle close to 100% of the water use, including capturing the perspiration from plants – at AltoVerde this is something we are looking to implement in our upcoming Macedonian sites.

Firms keen to improve on sustainability should also cultivate in a way in which soil is fully replenished and repaired after use – this is called regenerative farming, and it’s extremely effective for maintaining and improving soil quality, biodiversity and crop yields. Another interesting concept is the use of hemp. Some farmers have started using hempcrete – a concrete-like material made from harvested cannabis plants. As if the recycling aspect wasn’t good enough, hempcrete is actually carbon negative, meaning the production of hemp for hempcrete removes more carbon from the atmosphere than it produces.

It’s been incredibly exciting to be a part of the cannabis industry and I am excited to watch its growth in the years to come. It’s taken hard work for the sector to improve its traditionally poor image and to be accepted across the globe, so now, cultivators must lead by example and stop industry from being branded as one which pollutes. By transitioning to more environmentally sustainable practices, firms will be doing their bit for the planet, attracting the investors of tomorrow and ensuring their own success for years to come.

The post Too Many Cannabis Firms Put Sustainability in Last Place appeared first on Cannabis Industry Journal.


#CBD #Hemp

Too Many Cannabis Firms Put Sustainability in Last Place


July 14, 2021 3:29 pm

What No One Tells You About Hemp Bioplastics

What No One Tells You About Hemp Bioplastics

One of the most significant dangers to our wildlife, environment, and global climate is something nearly every person on Earth uses every single day: plastic (single-use plastic in particular).

It is devastating oceans and waterways, covering land and beaches, and filling landfills at a staggering rate.

This is not a problem we will be able to outrun.

Thankfully, there are cannabis companies across the globe dedicated to developing hemp-based solutions to our plastic problem.

Scientists are using hemp to create biodegradable plastics, called bioplastics, that are harmless to the environment and degrade in just a fraction of the time of standard single-use plastic.

The Plastic Plague

Almost every household item is made of- and packaged in- plastic.

Distribution has items covered in layers upon layers when they ship to stores.

Shipping items to your home is no different.

In 2018, the EPA estimates 27 million tons of plastic were dumped into American landfills alone.

As of 2020, National Geographic reported an estimated 5 trillion tons of plastic and micro-plastic in our oceans.

This problem becomes even more serious when you consider it takes approximately 1,000 years for a single piece of plastic to decompose. 

A More Sustainable Future 

Compared to plastic’s thousand-year decomposition rate, hemp bioplastic takes only 6 months to fully break down.

Additionally, the production of hemp bioplastic drastically reduces the amount of greenhouse gas and fossil fuel emissions compared to standard plastics.

The Hemp Plastic Company is one business working to alleviate the plastic problem.

They’ve created a hemp-based polymer resin that can be used to create a multitude of things that would normally be made of hard plastic: pens, drinkware, dinnerware, food containers, household items, assembly items, and more.

CEO of The Hemp Plastic Company Glen Kayll says we have to think outside the box when we think of plastic solutions.

“We all should consider that there are hundreds of millions of pounds of plastic consumed in rigid durable goods in the automotive, appliance, consumer products, packaging, construction, industrial, and other industries –– global change needs to include, but also go beyond, grocery bags and drink bottles.”

When asked if he ever saw a future that completely replaced plastic with hemp bioplastics, Kayll remarked, “While I don’t know if that’s entirely realistic, since plastic is an exceptional material used in thousands of applications, I can definitely see a future where millions of pounds of fossil fuel plastics are replaced with mother nature’s easy to grow, carbon sequestering, hemp. Why wouldn’t we?”

Editor’s Note: An Affordable Reality?

Hemp bioplastics are amazing, but there are barriers to implementation. 

According to Hemp Magazine, petroleum-based polypropylene pellets fluctuated between $1.00-$1.15 per pound in 2018.

If hemp plastics were to compete with petroleum plastics, the price per pound would need to be no more than $1.27 per pound.

Market prices for hemp plastic that year were $2.35 per pound.

In North America, most hemp fiber used in manufacturing is imported from Europe.

New Frontier Data reported more than 100 million pounds have crossed the Atlantic since 2015.

Until domestic cultivation can match demand, the cost of shipping will continue to drive up prices. 

The hemp industry must create an infrastructure to support large-scale processing, build relationships with established manufacturers, and expand its agricultural footprint before bioplastics can become an affordable reality.


#CBD #Hemp
https://cannatechtoday.com/what-no-one-tells-you-about-hemp-bioplastics/
July 6, 2021 4:15 pm

The Not-So-Definitive Guide to Delta-8-THC

The Not-So-Definitive Guide to Delta-8-THC

The Science of Delta-8-THC

Delta8, also known as Δ8-THC, is not new to the scientific community. It is simply another of the 150+ identified cannabinoids produced by this amazing plant.

Δ8-THC and its more well-known “sibling” Δ9-THC (as well as other isomers like Δ10-THC) have the exact same chemical makeup: C₂₁H₃₀O₂. What makes Δ8-THC and Δ9-THC different is the location of a single double bond on an aromatic carbon ring.

The structure of Δ8-THC.

In Δ9-THC, it’s between carbon 9 and 10. For Δ8-THC, it’s between carbon 8 and 9. While this kind of change may seem small and inconsequential, this slight change in chemical bonding can drastically change the overall shape of the molecule enough that it is no longer recognized by the same receptors in the body, or possibly change how much of the molecule can be absorbed.

Such a change could also have the potential to block the receptors of other molecules or even change the shape of other receptors to make them able to bind more to other molecules. It’s these types of interactions that are one theory to what is happening during the “entourage effect” of full spectrum vs isolate cannabinoids and ultimately what could be causing Δ8-THC to produce a different effect than Δ9-THC.

Another potential difference that could be caused by this change in double bond location is the inherent stability of the chemical composition. Some studies have suggested that Δ8-THC is more stable than Δ9-THC and doesn’t oxidize into CBN as easily, but this is based on small scale, chemical analyses from stringently isolated, pure components all performed in scientific research labs.

Most Δ8-THC currently on the market has been created by utilizing an acid such as acetic acid or formic acid that converts CBD into an intermediary compound, which can commonly be Δ9-THC. This intermediary chemical reaction is then neutralized with an alkaline solution containing chemicals like pentane.

The structure of Δ9-THC

Occasionally the reaction will require a catalyst such as boron trifluoride or magnesium silicate and finally the mixture will then be neutralized with compounds like sodium bicarbonate before the Δ8-THC can be collected from the final solution.

Other methods exist but are usually proprietary intellectual property and competition has prevented many of these methods from being published and scrutinized.

Even so, there are some dangerous chemicals used in this process and even if you end up with 95% pure Δ8-THC isolate, the question remains as to what the other 5% of the composition is.

In that state, and using these methods for synthesis, is this form of Δ8-THC still as stable as previous small-scale, pure crystallization methods?

What kind of degradation occurs and at what synthesis and storage conditions? What trace solvents remain? What is the purity of the chemicals being used by the manufacturer?

It’s these kinds of questions that show a need for continuing research, testing, transparency, and verifiable data to build a clear picture if it is intended to be used or ingested by consumers.

Chromatogram on Δ8-THC

This lack of transparency and uncertainty is causing problems with more than just the consumer advocacy side of Δ8-THC.

Testing labs across the country are having issues with Δ8-THC samples that are purported to be “isolate” or “pure Δ8”, but have drastically elevated levels, above current legal limits, of Δ9-THC.

Current theories to the cause of this disconnect include factors such as the stability and accuracy of manufacturing processes, proper treatment and preparation of samples, the accuracy of testing methods, the proper testing equipment to use, the stability of Δ8-THC with current manufacturing processes and storage conditions, as well as the ever-present problem of the hemp and cannabis industry; unscrupulous, unethical, or unknowledgeable businesses.

The Industry Today

Initial studies from the 70s have suggested Δ8-THC has the capacity to reduce tumor size in mice and in the 80s, it was determined to be a slightly less effective bronchodilator than the more “infamous” cannabinoid and closely related isomer, Δ9-THC. While cannabinoid research in the US has never been copious, starting in the late 80’s US research on cannabinoids all but halted.

This led to most research to be performed in other countries, particularly Israel. In the 90s, Israeli researchers found evidence that Δ8-THC helped decrease the symptoms of nausea in pediatric cancer patients.

By the 2000s, other studies linked it to possible increases in appetite as well as having an effect on key neurotransmitters. Outside of these few limited studies, that were never broadly disseminated and mostly only focused on mouse models, no one really cared about such a minor cannabinoid.

Any research that was performed focused on the much more well-known Δ9-THC/THCA. Any mention of Δ8-THC was relegated to obscure passages on internet forums such as Erowid or rumors that passed like oral traditions in the secret tribes of stoners.

Even after medical marijuana policies and laws were passed by California, later joined by Colorado, Washington, Oregon, and others, this minor cannabinoid remained in obscurity.

Things changed with the passing of the 2018 Farm Bill, and with it, hemp production in the U.S. country exploded. This increase in cannabis cultivation across the country began a new renaissance into the exploration of the effects of the lesser-known cannabinoids as growers, processors, and consumers all began “chasing cannabinoids” in the hopes of finding the “next CBD”.

As the market became flooded with CBD products of all kinds and prices began to drop due to the oversupply some people began to convert their excess CBD into Δ8-THC which still mostly unknown and selling at 10 or more times what CBD could be sold for. Since Δ8-THC is not technically mentioned in the controlled substances act but has been historically included in it by the DEA, these entrepreneurs were counting on a technical reading of the 2018 Farm Bill.

As this Δ8-THC was derived from now legal hemp, it was seen as a way to get a euphoric high without violating Federal law. But is it in fact legal? The DEA has held a particular position on this, which was most recently clarified in the publication of their Interim Final Rules for Hemp where it states that “synthetic cannabinoids” are also considered to be marijuana and are controlled substances.

This means that according to the DEA and US law enforcement, Δ8-THC is still a Schedule 1 Controlled Substance, and as such, is not legal in any way in the United States.

This is where all the confusion started. Who has ruling or legislative authority over this? Does the 2018 Farm Bill supersede the Controlled Substances Act?

What constitutes “derived” vs “synthesized” as a legal definition? Attorneys, CEOs, journalists, analysts, “Average Joes” and “Karens” from Facebook have all weighed in with their opinion, but to date no one has brought any of these “theories” before the court and until then current precedent would most likely stand with the DEA’s ruling. As of late spring 2021, many states have begun banning Δ8-THC entirely rather than deal with the confusion.

Others have simply absorbed it into their current medical or recreational cannabis infrastructure by relegating it to licensed cannabis facilities under medicinal or adult-use laws. The inability or unwillingness of the government to address the issue at the federal level has the same effect as current cannabis regulations be it hemp or marijuana.

Regulation varies drastically from state to state and creates an uneven playing field ripe for confusion, shady practices, illicit markets and potentially unsafe or at best mislabeled products.

For example, in Florida, you can go buy Δ8-THC products at most any roadside gas station, and since it’s being produced under the current patchwork of hemp cultivation laws, the only safety compliance or quality control testing requirements are that it contains less than 0.3% Δ9-THC.

This is compared to the state of Kentucky, which has completely banned Δ8-THC in all forms.

So, is this the beginning of the end for Δ8-THC? That’s not very likely. Any number of factors would lead to the conclusion that Δ8-THC and other isomers are likely here to stay but will probably be regulated.

Deschedulization of THC seems like more and more of a fast-approaching reality, rather than the distant pipe dream it has been for decades. The DEA is currently in the process of expanding access to marijuana for more research.

As more cannabinoids are researched and more clinical data is available, more isomers like Δ8-THC will likely be utilized. Considering that more states are enacting regulations that require safety testing for hemp and CBD products, it is far more likely that Δ8-THC will see similar regulation and continue to be produced and sold, even though it is recognized as a psychoactive compound.

That being said, the current flood of Δ8-THC products on the market very well could be a fad that has been fed by the recent price collapse of the CBD market that has thousands of growers, processors, and manufacturers of CBD trying to use up their back inventory of CBD and try to get a better price for it as Δ8-THC.


#CBD #Hemp
https://cannatechtoday.com/guide-to-delta8-thc/
June 30, 2021 11:00 am

Can Cannabis Buyers Make the Industry More Equitable and Sustainable?

Can Cannabis Buyers Make the Industry More Equitable and Sustainable?

Although cannabis consumers are highly focused on safe, high-quality products that are effective, how often are consumers thinking about the ethos with which cannabis companies operate?

As the cannabis community continues to evolve, many are realizing that buying responsibly from companies who care can make a real difference in the industry and in the world.

After all, the process of buying cannabis is different from buying other products in so many ways.

Legalization creates layers of complexity for the buyer’s journey depending on the geography of that journey.

But to really understand just how different buying cannabis is, when compared to buying most other products, it’s important to look in two other directions: equity and sustainability. 

Equity in the Consumer Journey

First, it’s important to take a look back in history — specifically at the American media, where false information has been propagated for decades. 

Nearly a century ago, in fact, the Federal Bureau of Narcotics, now called the DEA, renamed cannabis “marijuana.” 

In the 1930s, according to Robyn Lawrence, author of Pot in Pans: A History of Eating Cannabis, the U.S. government rolled out a rebranding campaign depicting cannabis as “a frightening ‘new’ drug used primarily by Mexicans and African Americans that could turn upstanding, middle class (white) kids into helpless victims and raging monsters.”

Then in 1994, Harper’s magazine interviewed former domestic policy chief John Ehrlichman, who admitted in that interview that the government intentionally criminalized hippies and black people in order to “disrupt those communities.” 

Ehrlichman is quoted as saying, “We could arrest their leaders, raid their homes, break up their meetings, and vilify them night after night on the evening news. Did we know we were lying about the drugs? Of course we did.”

And from there, the rest is history. 

Today, research conducted by the ACLU shows that there is racial profiling and bias in marijuana enforcement.

Black people are 3.6 times more likely than white people to be arrested for marijuana possession, despite similar usage rates. 

Contrary to what many might believe, this disparity has not improved during the last decade.

In fact, the trends have become more alarming in most states.

But there is hope.

Cannabis buyers who are committed to restoring equity can take small steps in order to begin creating a brighter future. 

What You Can Do

Buying ‘ethical weed’ is one solution.

• Buyers can support organizations committed to ensuring some of the revenue generated is rerouted to rebuilding communities and preventing unjust and inequitable incarceration.

• Ask your dispensary about their ethical practices and if they can’t provide any, find one who can. Or, if you buy online, do just a little research. 

Using your voice, your vote, and your wallet is another solution. 

• Contact your senators and representatives to rail against bias in marijuana enforcement. 

• Support organizations like The Drug Policy Alliance, which works to fund prisoner reentry programs, or invest in communities that have been heavily affected by biased mass incarcerations.

Sustainability in the Consumer Journey

Sustainability initiatives are making their way onto corporate radar across a variety of industries.

And the cannabis sector is no different. 

Some find it ironic, considering the cannabis plant, on its own, is quite sustainable.

Cannabis grows quickly in a wide array of atmospheric conditions after all. 

Cannabis can also be called eco-friendly.

Farmers in Italy have been known to cultivate cannabis in order to decontaminate polluted soil.

And the hemp varietal actually absorbs and reduces global atmospheric carbon dioxide.

But despite the product’s environmental friendliness, the cannabis sector of the economy is not so environmentally friendly.

The legal cannabis sector struggles to live up to the carbon-negative hype of the plant itself.

Sustainability in the cannabis industry is hampered by lighting, irrigating, and packaging problems. 

• Indoor growing practices to generate just 1 kilogram of cannabis can produce as much carbon dioxide as three million cars, according to a study by the Global Footprint Network. 

• One single plant can consume as much as 150-250 gallons of water to reach the flowering state. 

• Because of hefty federal requirements, many companies resort to plastic packaging for its affordability. And that plastic can be up to 30 times the weight of the product it contains.

What You Can Do

How often do consumers give thought to where the product is coming from and where the packaging ultimately goes? 

According to one Nielsen report, 73% of Millennials are willing to pay more for sustainable goods, and this includes packaging.  

When more consumers become mindful about where the product is coming from and where the packaging ultimately goes, this percentage can surely increase.

Look for responsible dispensaries and packaging take-back programs like one started in early 2020 in Colorado.

Unrecyclable vape cartridges and other plastics that go out the door with customers are taken back in an effort to avoid clogging up the recycling system.

Equity & Sustainability — One Business Doing Both

Many cannabis businesses tout their innovative ideas for remaining profitable and keeping an eye on ethical practices and sustainability.

But there is one company that lets those practices lead and is seemingly keeping that one eye on profitability.

The company clearly states on their website, “We will never put profits over a clean and beautiful earth.”

Pure Beauty is a Los Angeles company with a brand that combines cannabis with ultra-hip streetwear vibes.

The company, who prioritizes a high-quality flower, also has a serious moral compass.

The female and minority-owned company views the history of injustice within the industry as a call to action to promote equity and fairness.

Pure Beauty donates a portion of their proceeds to fund programming for current and post incarcerated populations. 

That’s not all.

At Pure Beauty, all of the water used in their cultivation is collected from the air.

Not one drop comes from the California tap. 

The cultivation practices have zero runoff because even “eco-friendly” fertilizers and nutrients can contaminate surrounding water supplies, making life inhabitable for indigenous species.

Pure Beauty also creates soil “food webs” for insects and then donates by-product soil to public parks. 

And while they are legally bound to properly package their products, Pure Beauty makes every effort to use as little packaging as possible.

Most of the packing material is paper and they’ve been perfecting a child-resistant mylar bag made from plant starch.

Just when it seems Pure Beauty sounds too good to be true, they top it off with modesty and say: “We’re not perfect, but we’re trying.”

All photos courtesy of Pure Beauty.


#CBD #Hemp
https://cannatechtoday.com/can-cannabis-buyers-make-the-industry-more-equitable-and-sustainable/
June 28, 2021 11:00 am

Blockchain, Sustainability, and Redman at Day 3 of Emerge

Blockchain, Sustainability, and Redman at Day 3 of Emerge

“There are no heroes in politics. Each of us has a responsibility to do good by each other and move this industry forward,” said Sephida Artis, National Cannabis Party (NCP) co-founder and national director.

Conferences and the connections made during these events can be a powerful tool for moving the industry forward. That was especially evident during day three of the Emerge Virtual Cannabis Conference & Expo.

Innovators from every vertical came together to share their expertise. 

Putting Politics on the Blockchain

The day kicked off with the NCP calling on all cannabis enthusiasts to unite for political change. The NCP is using emerging technologies to drive their movement.

“Emerging tech will allow us to inject policy into the marketplace,” said NCP Emerging Technologies Board of Directors Representative Kamea LaFontaine.

NCP Emerging Technologies Board of Directors Representative Kamea LaFontaine

The party plans to use blockchain to support and empower its members. Its transparency and security provide an ideal platform for ensuring transactions (ie: votes) are counted and protected.

“The NCP is dead set on making sure politicians are held accountable for what they’re promising and that there’s transparency so people can get involved and drive that change for the industry,” said Artis.

Their passion for the cannabis community was a powerful start to the day.

Legislation and Compliance Focus for Day 3

If your business was impacted by the vape shipping ban, the Cannabis Vape Products vs Congress session offered some insight. Speakers Tami Wahl, government affairs and public policy advisor, and Chris Day, founder of the Global Cannabis Network Collective, led the discussion.

“This is a backdoor measure to get at the cannabis and hemp industries,” said Wahl. The “Preventing Online Sales of E-Cigarettes to Children Act” prevents the USPS from shipping vaping products. The ban has been delayed but is impacting thousands of cannabis companies in its scope. 

Wahl is working to help the postal service navigate this issue. She hopes to develop a solution that could bridge consumer safety and the needs of entrepreneurs. 

Sustainability and Safety

Solutions to the packaging problem are in high demand. How can the industry move away from petroleum-based plastic toward renewable options like hemp?

Dama Distributing CEO and Founder Cole Gibbs specializes in hemp plastics and with more investment could establish a high-volume production facility that would have implications far beyond the cannabis space. 

Cole Gibbs, founder and CEO of Dama Distributing.

Any single-use plastic can be made with hemp plastic, from toothbrushes to hair combs to soda bottles.

He said while his hemp plastic costs a few cents more, it’s a small price to pay.

“It’s more expensive than the traditional model. Even recycled plastics are more expensive than virgin plastics. The beauty is that our products aren’t dollars more than traditional plastics and we’ve found consumers are willing to pay for it,” said Gibbs.

Part of building a sustainable industry is using safe business practices. All it takes is a few bad actors using low-quality manufacturing practices to create bad press for the entire sector.

The Vaping and Federal Legalization session touched on this, noting heavy metals and glues used in low-quality vaporizers. These poor quality products could cause lung damage and create a bad name for the vape industry as a whole. CEO of Orchid Ventures Corey Mangold, who led the session, advised all vaping companies to use emission tests.

This form of testing collects the vapor from the device and analyzes its contents, offering companies true insight into their product quality.

Another often neglected area of manufacturing is the grinding process. Poor quality grinders can damage trichomes, alter moisture content, and degrade flower quality.

STM Canna Technical Support Associate Christopher Mendoza and Chief Revenue Officer Jessica Ferranti led a discussion around proper grinding techniques, noting that most grinder tech was adapted from other industries.

STM developed the Revolution Grinder to address this gap in the market and offer a more gentle and efficient solution for high-volume processing.

3 Days of Serving the Community

Another theme of the Emerge conference seemed to arise organically rather than being a set focal point, and that was a desire to serve the community.

Mahala Herron discussed her sustainable CBD lifestyle brand, Hala Hemp, noting it’s her passion for people and the planet that really drive her ambition. “I want to make sustainability not only accessible, not only cool, but normal,” said Herron.

Jon Goldman, SVP of Mortgage Lending at Guaranteed Rate Affinity also has a passion for helping people.

He realized there were many in the cannabis space who felt they couldn’t qualify for a home loan because of the federal prohibition of cannabis and cannabis-related banking transactions.

Jon Goldman, SVP of Mortgage Lending at Guaranteed Rate Affinity

“A lot of people in the cannabis industry think they can’t get loans … that is simply not true,” said Goldman.

He warmly welcomed audience questions and even offered his personal cell number to attendees should they have any mortgage-related concerns to discuss with him.

The day ended with an hour long conversation with MC and record producer Redman. The multi-talented musician is known for his films and music advocating for the plant.

His newest venture with the NCP could pave a real path to federal legalization by uniting millions of pro-cannabis voters across the country.

NCP Co-Founder and MC Redman

“I’m fascinated by how far we’ve come with this plant,” said Redman. He discussed his many current projects, from co-founding the NCP to his radio show Muddy Waters on SiriusXM, as well as his upcoming album release of the same name Muddy Waters 2.

“I feel like there’s not anything I can’t do. Throw me in the fire and I’ll do it,” said Redman. 


#CBD #Hemp
https://cannatechtoday.com/blockchain-sustainability-and-redman-at-day-3-of-emerge/
June 25, 2021 7:06 pm

Quick Hits: More States Legalize Cannabis

Quick Hits: More States Legalize Cannabis

Connecticut Legalizes Cannabis

Members of the state House and Senate approved S.B. 1201 on Thursday, legalizing the adult-use marijuana market.

Next, they submitted the measure to Democratic Gov. Ned Lamont, who is expected to sign the bill into law.

The Nutmeg State will be the fifth after New York, New Mexico, Virginia, and technically New Jersey that approved legalization this year. 

Rhode Island Senate Approves Adult-Use Cannabis 

The Senate Judiciary Committee approved a bill on Monday that would legalize, tax, and regulate marijuana for adult use, marking the first time such a bill has moved to the floor of either chamber of the General Assembly in Rhode Island.

The bill would create an independent cannabis control commission to oversee the program and issue licenses for cannabis retailers passed 6 to 2.

It’s expected to go to the full Senate next Tuesday.

Legalization in Virginia

Cannabis becomes legal in Virginia on July 1.

According to Virginia’s chapter of NORML, the legalization law allows for possession by adults 21+ of up to one ounce and personal, home cultivation of up to 4 plants per household by adults 21+ at their primary residence, if the plants have labels, are out of public view, and kept away from children. 

Additionally, adult-sharing of up to one ounce in private without remuneration; and continued participation in the medical cannabis program, which allows buying marijuana. It delivers at Virginia dispensaries. 

However, the selling of marijuana seeds will still be illegal, and so will transporting seeds across state lines. 

Full story here. 

Product Launches

Photo courtesy of Gem + Jane.

CannaCraft launched its new brand Gem + Jane: A sparkling botanical beverage that blends simple ingredients with microdoses of cannabinoids, including THCV, Delta-8 THC, and CBD.

The drink will be available exclusively at Sweet Flower dispensary locations throughout greater Los Angeles beginning June 17th. 

The original, pioneering edibles editor for High Times magazine and author of cannabis cookbook Bong Appetit, Chef Elise McDonough, serves as Brand Manager for Gem + Jane.  

Emphasizing the natural tastes and aroma of citrus, berries, herbs, and flowers (Think Petal with cannabis added), the Gem + Jane beverage line blends complex layers of playful flavors on the palate.

It delivers a light, manageable dose of cannabis for most consumers.

It comes in four sophisticated flavors, as well as an unflavored, pure Simply Seltzer for mixing up mocktails or enjoying on its own.

The Elderflower Pear, Lemon Blueberry Lavender, and Strawberry Hibiscus varieties contain a blend of 4mg Delta-8 THC and 2mg CBD for more mellow moments like relaxing with friends. 

The Simply Seltzer and Yuzu Rose Raspberry flavor each contain 4mg THCV and <2mg THC. 

Drop 2.0

Drop Delivery, an all-in-one delivery technology suite for cannabis retail businesses, announced Wednesday the launch of a new white-labeled consumer e-commerce web-based app, Drop 2.0.

The app includes a more customizable homepage, improved product search capabilities, highly detailed product filtering, and a more engaging way for consumers to take advantage of retailers’ deals.

Drop Delivery CEO and Co-founder Vanessa Gabriel cite wanting to emulate and elevate the best mainstream e-commerce experiences with the development of Drop 2.0. 

Expanding upon ordering ahead, Drop 2.0 offers retailers an app-based e-commerce shopping experience akin to Sephora or Instacart.

The new app provides more freedom to customize the web-based app based on their specific hyperlocal preferences and provides customers with fresh, powerful shopping tools. 

“While cannabis e-commerce is relatively new, e-commerce is not, and consumers expect certain features to be a part of that shopping experience,” said Gabriel. “That includes being able to search for products based on current and past searches, highly categorized product filters, and being able to take advantage of discounts and deals all in the same place. 

Mendi CBD

Because the world needs yet another celebrity-endorsed CBD brand, Mendi Founder and CEO Rachael Rapinoe, sister to 2x World Cup Champion Olympic gold medalist Megan Rapinoe, and co-founder Brett Schwager have created Mendi.

The Portland, Oregon-based brand is “championing their cause to level the playing field by innovating natural alternatives to sports medicine.”

Their “proprietary blends of all-natural hemp CBD products target pain relief, inflammation, and mood to improve sleep and recovery.” 

Like Carli Lloyd using CBD Medic before it, Mendi aims to soothe the shin splints for the athlete or gym rat in all of us. 


#CBD #Hemp
https://cannatechtoday.com/quick-hits-more-states-legalize-cannabis/
June 18, 2021 6:22 pm

SC Labs Develops Comprehensive Hemp Testing Panel

SC Labs Develops Comprehensive Hemp Testing Panel

SC Labs, a cannabis testing company with roots in Santa Cruz, California, announced this week that they have developed a comprehensive hemp testing panel that covers a number of contaminants on a national regulatory level. In the press release, the company says they aim to fill the void of national hemp testing requirements.

The hemp testing panel they have developed purportedly meets testing standards in states that require contaminant levels below a certain action limit. The SC Labs hemp testing panel could theoretically be used for regulatory compliance testing across the country, reaching action limits and analyte levels that meet the strictest state requirements.

The panel tests for pesticides, heavy metals, microbiology, mycotoxins, residual solvents and water activity. In the press release, the company says they have received ISO accreditation for the panel, although it’s not immediately clear to what standard it has been accredited.

Still, the test panel is one sign of progress in the long road to nationally harmonized testing standards. “As an industry, we’ve been advocating for national, standardized, and transparent testing regulations for years now,” says Jeff Gray, CEO of SC Labs. “The government has been slow to respond so we decided it was time to act. As an industry, we’ve been advocating for national, standardized, and transparent testing regulations for years now. The government has been slow to respond so we decided it was time to act.”

SC Labs is headquartered in Santa Cruz, but has licenses in California, Oregon, Texas and Colorado (pending). Their California and Oregon locations are both ISO 17025-accredited and conducting THC-containing cannabis testing, as well as hemp testing.

The post SC Labs Develops Comprehensive Hemp Testing Panel appeared first on Cannabis Industry Journal.


#CBD #Hemp

SC Labs Develops Comprehensive Hemp Testing Panel


June 16, 2021 6:55 pm

Five Cannabis Leaders Forecast Industry Changes

Five Cannabis Leaders Forecast Industry Changes

There’s no question that the cannabis industry is booming and changing daily. MJBizDaily recently released a publication that expects marijuana sales to boost the economy by $92 billion in 2021 alone. That statistic is up 30% from last year, and the same analysis predicts it will reach upwards of $160 billion by 2025.

With all of this incredible growth, significant changes are on the horizon. So, we decided to ask five top leaders in the cannabis and CBD industries about the changes they anticipate happening in the next five years. 

Here’s what they shared. 

1 . Products Will Become More Accessible to the Consumer

“[The majority of CBD products] are trying to be luxury brands and premium brands. And that just isn’t a sustainable marketplace, nor what serves most consumer needs,” explains Sequoia Prince-Lazarus, Founder and CEO of Lazarus Naturals.

He founded his company to fill a void in the marketplace, and his mission was to make farm-to-bottle CBD products that were both effective and affordable. He believes we’ll see more accessible products like his in the future, and in the next five years the industry will normalize, and prices will fall. 

“I think [brands] are trying to effectively milk it for all it’s worth before the prices come down,” he shared. And the high prices are coming at the expense of consumers.

Because luxury brands are nearly ten times the cost of typical supplements, it’s difficult for the average consumer to include CBD as part of their health routine. 

As more and more brands enter the marketplace, Price-Lazarus predicts that we’ll see a lot more commoditization and more affordable brands. “Eventually, the prices will be no more than twice the price of normal supplements, and they may even be more affordable than over-the-counter drugs or at least similar prices,” he shared. 

2. Tailored Delivery Methods to Fit Each Use Case

As more and more scientists research cannabinoids from a medical perspective, Price-Lazarus also predicts that we’ll see delivery methods tailored to each use case. “Right now, we’re operating off of anecdotal evidence for the most part—and also a few research papers,” he shared. 

But as medical research expands, he predicts scientists will know which delivery methods are most effective for treating each ailment. “You’ll have to understand market trends and consumer preference and pair that in.

But I think it will be more important to know what type of cannabinoids, at what exact levels, and determining the right and proper serving,” he explained.

As the industry better understands the answers to these questions, more brands will take a scientific approach to how CBD should be delivered. Delivery methods that fit the use case of those substances will reign supreme, meaning more effective products for consumers. 

3. Brands Will Understand the Power of Cannabinoid Combos

Because there’s not very much research done on isolated cannabinoids that aren’t THC, Marcus Quinn, CEO of Your CBD Store, says there’s tons of opportunity to study the combination of cannabinoids. “[Medical research] hasn’t even begun to look at how [certain cannabinoids] work together,” he explained.

Quinn and his wife, Rachael Quinn, founded their company after using CBD products to treat Rachael’s Crohn’s disease. After finding much-sought-after relief from the hemp products, the duo realized they could help heal others with the supplement.

And they even began creating their own products, which are tested and certified by ISO-accredited labs.

“[The industry] looks totally different than it did five years ago. And I think five years from now, it’s going to look totally different, too,” Quinn explained. “We know CBD somewhat blocks THC, but we don’t know if that affects the efficacy of the THC. And now, we know about even more cannabinoids, like CBG and CBN.”

Quinn believes that as interest peaks and regulations change, more researchers will start asking the right questions. “Like, what [cannabinoid combos] are the best? Does it vary from person to person? Or are there different ratios that give you better [results]?”

If brands want to survive in the next five years, their offerings can’t remain stagnant. Because more innovative brands will force the industry to stay on the cutting edge.

Brands that thrive will identify the cannabinoid combination trends. They’ll work with the research and listen to the science.  And they’ll adapt their products accordingly to provide the best in the market. 

4. Brands Will Focus More on Developing People

According to Nichole LaMay, Head of HR and Culture at Mammoth Distribution, cannabis brands have left employee development on the table for far too long. “There’s an opportunity for growing and developing people in this industry,” she explained. “So being able to have solid learning, development and succession plans that continue to evolve and grow employees will be important.”

She says brands will need to take an innovative and unique approach to these programs if they want to reach and resonate with their audience. They’ll also need to invest in performance-proven c-suite leaders who align with their culture. 

“Having people who are passionate about what they do helps you drive everything you’re doing,” she explained. “When you have a healthy, robust culture where people want to come to work and want to collaborate for the greatest good, you see the greatest results.”

5. More Small Businesses to Help Local Communities and Support The Global Good

Thomas Rimbach, Co-Founder, and CEO at Baked Bros, says predicting the next five years is challenging. “Because where I want to see it and where we might end up —with a bunch of money and corporate backing —are two different directions.” 

He hopes that small businesses in America will be able to keep and maintain the footing they’ve helped build thus far. “I’d like to see small businesses helping local communities and supporting globally, but I don’t know how it’s going to work out once it’s federally legal and big money opens up.”

Rimbach told us there’s one thing he knows for sure: Small businesses (like his) will drive the industry forward with more sustainable business practices and put consumers first. “We want to prevent [the cannabis industry] from going to this corporate setting—where people are forgotten and treated as a ticket,” he shared.

Predicting what’s next in cannabis is a tall order. With rules that vary from state to state, constant regulation changes, and a chance to become federally legal, this industry is constantly changing. Whatever happens next will make or break the brands that built the industry—and only the most innovative will survive. 


#CBD #Hemp
https://cannatechtoday.com/five-cannabis-leaders-forecast-industry-changes/
June 14, 2021 4:06 pm

Quick Hits: Criminal and Social Justice Reform in Cannabis Industry

Quick Hits: Criminal and Social Justice Reform in Cannabis Industry

The NFL and NFLPA will award $1M in up to five grants as the league seeks to know more about the efficacy of cannabis and CBD for pain management.

The National Football League and its Players Association are providing $1 million in funding for research into pain management and cannabinoids through its joint pain management committee, the NFL announced on Tuesday.

The league and union launched the committee last year and said cannabis is included in its research into alternative therapies for pain management.

According to Gangapreneur, “Up to five grants are expected to be awarded by Thanksgiving as the league seeks to learn more about the efficacy of cannabis and CBD and their potential as alternatives to opioids.”

Full story here. 

Zelira Therapeutics has licensed its ZTL-106 proprietary cannabinoid formulation to Levin Health for a chronic pain treatment clinical trial on retired athletes.

Zelira Therapeutics Ltd (ASX: ZLD, OTCQB: ZLDAF), a company that focuses on the development of clinically validated cannabinoid-based medicines, announces that it has licensed a proprietary cannabinoid formulation to Levin Health Limited (Levin Health) to undertake a clinical trial to test the efficacy of the formulation in treating sports-related chronic pain experienced by retired professional and amateur athletes.

Studies show that retired athletes are more likely to suffer chronic pain and associated conditions such as depression and anxiety due to injuries and physical exertion over long periods.

While clinical data is currently limited, medicinal cannabis may provide a safe and effective targeted treatment option for this large cohort.

The clinical trial to be conducted by Levin Health will address this.

In addition to licensing the proprietary formulation to Levin Health, Zelira and Levin Health have entered into a Project Management Agreement, whereby Levin Health will pay for the trial and engage Zelira to project manage the clinical trial to be undertaken at La Trobe University’s Sport and Exercise Medicine Research Centre in Victoria, Australia.

Morocco’s House of Councilors finally passes their cannabis legalization bill.

After several amendments, Morocco’s House of Councilors has finally approved the intensely debated measure on the limited legalization of cannabis.

Morocco’s Parliament put Bill No. 13.21, concerning the commercialization and legal uses of cannabis, up for a vote during today’s governmental plenary session.

It passed by a majority vote, with 41 advisers voting in favor and 11 voting against. 

The bill aims to improve Moroccan farmers’ income and give rise to “promising and sustainable” job opportunities in the country’s rural regions. 

Full story here.   

Connecticut: Senate Lawmakers Advance Adult Use Marijuana Legalization Bill

(Via NORML) Members of the Connecticut state Senate have approved legislation, Senate Bill 1118, to legalize the adult use of marijuana, regulate its commercial retail sales, and tax the potency of THC. 

SB 1118 allows adults 21 and older to legally purchase and possess up to 1.5 ounces of marijuana in public and up to five ounces of marijuana in their private residence. 

Beginning October 2021, state-registered medical cannabis patients will be permitted to cultivate up to three mature and three immature marijuana plants.

Non-patients must wait until 2023 until they are legally allowed to home-cultivate marijuana for personal use.

Those with past criminal records for activities involving up to four ounces of cannabis will automatically expunge their convictions.

Those with convictions for more serious offenses can petition the courts to take action.  

The proposed measure also limits the discriminatory actions that employers, hospitals, and others may take against those who test positive for past cannabis exposure.

The bill also provides protections for parents and tenants who use cannabis in compliance with the law.

It mandates that the odor of marijuana alone cannot be used as a basis for police to search an individual.

It prohibits jail time as a penalty for those under 21 years of age who are caught in possession of marijuana.

Under the legislation, marijuana flowers available at retail facilities will be capped at 30 percent THC, while concentrated products (except vape cartridges) will be capped at 60 percent THC.

Senate lawmakers approved the bill with a 19 to 17 vote.

House lawmakers are expected to consider the proposal shortly.

Lawmakers face a tight deadline of Wednesday, June 9, 2021, at midnight to move SB 1118 through the House and to the Governor’s desk before the legislative session adjourns for the year.

The Hawthorne Social Justice Fund within The Scotts Miracle-Gro Foundation Announce New Grants

Today, the Hawthorne Gardening Company (Hawthorne) announced the first grantees of The Hawthorne Social Justice Fund within The Scotts Miracle-Gro Foundation.

These organizations are contributing to criminal and social justice reform for the cannabis industry. 

The $2.5 million fund is dedicated to non-profit organizations working toward social justice reform within state-regulated cannabis industries.

The recipients include Minorities for Medical Marijuana and United Returning Citizens.

In addition, Hawthorne is funding the NuLeaf Project, an organization that provides direct support for minority cannabis entrepreneurs through a corporate donation. 

As North America’s household name in indoor and hydroponic growing supplies, Hawthorne has committed to using its influence and resources to help drive criminal justice reform related to cannabis prohibition and contribute to shaping a more equitable post-prohibition cannabis industry. 

“Our commitment to being a good company is what drove us to create The Hawthorne Social Justice Fund within The Scotts Miracle-Gro Foundation. As we announced earlier this year, establishing the fund with an initial investment of $2.5 million to support non-profit organizations with cannabis social justice missions,” said Chris Hagedorn, Executive Vice President and Division President of Hawthorne. “This fund deepens Hawthorne’s commitment to sparking change as policy reform advances across the country and states address the legacy of racial inequity tied to cannabis prohibition. We promise to support programming that helps communities and individuals who have been negatively affected by the long-standing and systemic inequality related to cannabis prohibition in the United States.”

The Hawthorne Social Justice Fund grantees were chosen because of the powerful work they’re doing to address the negative impacts caused by the disproportionate number of cannabis-related arrests and incarcerations involving persons of color to support minority entrepreneurs and increase investments in minority communities. 

The work of the Fund’s grantees includes:

 

  • Minorities for Medical Marijuana provides advocacy, outreach, research, and training related to business, social reform, public policy, and health/wellness in the cannabis industry. Its Project Clean Slate program offers expungement clinics and wraparound services nationwide for those affected by past marijuana possession charges. At the same time, Project Safe Access NV assists members of the Latino community in accessing medical marijuana. 

 

  • NuLeaf Project is working to build intergenerational wealth via the legal cannabis industry for the communities disproportionately harmed by cannabis criminalization–including Black and Brown communities. Hawthorne is a corporate sponsor for the Nu School Accelerator Program, which offers financial support and technical expertise on cannabis startup financing and operating an ancillary business.

 

  • United Returning Citizens provides job search and training, life and financial literacy skills, and transitional and stable housing for citizens reentering society from correctional facilities. This partnership focuses on workforce development, helping people with cannabis convictions in a high-unemployment area (Youngstown, Ohio) find employment and start hemp and indoor cultivation businesses.

 

Product Launches:

Homie: Helping Homeless Youth One Hoodie At A Time

Homie was born in 2015 from a shared passion between three friends eager to break down the stigma associated with homelessness and help young people who found themselves living on the streets.

Homie continues to draw awareness to the faces and stories of everyday youth affected by homelessness and allows them to share their narrative in a dignified way – ultimately destigmatizing and humanizing the issue.

With its recent expansion in the U.S., Homie seeks to continue empowering young people and raising awareness across the globe from Melbourne to Los Angeles.

 Homie has designed trendy and comfortable all-season pieces, collaborating with Champion, a household name in hoodies,  to create a new line. 100% of profits go towards achieving their mission of supporting young people affected by homelessness or hardship and help them become their champions. 

House of Saka announces the release of Saka Spark Mimosa. 

Photo courtesy of House of Saka.

House of Saka, Inc., Napa Valley producers of the award-winning cannabis beverages Saka PINK and Saka WHITE, announced Tuesday the launch of much-anticipated single-serve offering, Saka Spark ‘Mimosa.’

House of Saka Spark ‘Mimosa’ is the first and only cannabis-infused beverage to blend alcohol-removed, premium, California sparkling Chardonnay with the natural essence of orange blossom, nectarine, and a Mimosa-strain specific live resin to bolster its organic cannabis emulsion. 

Available in single-serve, 187ml (6 ounces) champagne bottles with a micro-dose of 5mgs of full-spectrum THC per bottle, Saka Spark Mimosa delivers all the flavor and celebration of a traditional Mimosa, without the adverse health effects and excessive calories of alcohol. 

“Saka Spark Mimosa marks the next evolution in cannabis beverages,” explains Tracey Mason, Co-founder & CEO. “Offering enhanced bioavailability, a unique, strain-specific full spectrum experience, and unparalleled flavor, House of Saka continues to set the standard for quality and true innovation in the infused beverage sector.”

Just in time for summer imbibing, Mimosa is available wherever House of Saka Vinfusions™ are sold. 

Plus Pride Limited Edition Pride Rainbow Sherbet

Photo courtesy of PLUS.

PLUS announces the release of a celebratory rainbow-marbled gummy from California’s cannabis cube connoisseurs, featuring a rainbow sherbet flavor and an uplifting Sativa strain. 

Ten percent of the proceeds of Plus Pride sales will be donated to the San Francisco-based, Black trans-women led Transgender, Gender-Variant & Intersex Justice Project (TGIJP) to further their mission of ending the human rights abuses committed against Black and Brown TGI people inside of California prisons, jails, detention centers and beyond.

TGIJP provides advocacy, legal and re-entry services, direct life-saving services like temporary housing, employment, and transportation.

The gummies are $18 and contain 5mg THC. Pride and more varieties are available throughout California.


#CBD #Hemp
https://cannatechtoday.com/quick-hits-criminal-and-social-justice-reform-in-cannabis-industry/
June 11, 2021 10:47 pm

Trade Secrets: Innovators Share Their Strategies for Industry Domination

Trade Secrets: Innovators Share Their Strategies for Industry Domination

Each quarter, Cannabis & Tech Today speaks with innovative brands from around the country to discover who is leading the call for a more resilient, thoughtful, transparent cannabis industry.

This issue, we’re highlighting three brands receiving national attention for their commitment to excellence within the cannabis community. 

Clear Cannabis Inc.

Rich Batenburg Jr., has decades of experience developing scalable business models in various industries.

As president and chairman of Clear Cannabis, Inc., Batenburg is using his expertise to develop an infrastructure for the company capable of scaling to a national level.

Rich Batenburg Jr.: What was going to happen with cannabis in my mind was exactly what happened with cable.

Richard M Batenburg. Photo courtesy of Clear Cannabis, Inc.

A bunch of mom-and-pop operators who were very passionate about the product, very customer-centric, but did not have the skills and the foresight and capitalization to build heavy weight infrastructure that could scale to handle millions of customers as opposed to thousands of customers.

So I thought “Hey, this is my opportunity to fix all this stuff that’s been broken in cable before it happens in cannabis.”

Once we have ubiquitous legalization, big food, big pharma, big tobacco, and big agriculture will likely be taking over this industry.

It takes money to scale up.

There are thousands of inventive, creative, sincere, gentle geniuses in the business that have come up with products.

What you don’t see is the massive distribution and commercialization of those products.

That’s really our focus.

What I liked about Clear Cannabis is it has a trade secret component to it, it has a formula.

It’s not based on things you can’t own.

Nobody can own a strain name.

It’s not a capitalistic thing, but a brand needs to have its own identity and its own interpersonal and emotional connection to the customer and it needs to have a brand promise that can be replicated. 

GrowRay Technologies

Ash Ganley. Photo courtesy of GrowRay Technologies

The cannabis space, in many ways, is about collaboration.

The industry relies on different sectors coming together to create solutions.

Ash Ganley, CEO of GrowRay Technologies understands the fractured nature of the industry and is working to unite growers with technology and science to create a more efficient cultivation ecosystem. 

Ash Ganley: “We realized quickly that the market is not always going to be so high margin that you could hide bad business practices and hide a lack of efficiency in your operation and production.

And now that’s happening across the country.

As prices are coming down and regulations are increasing in terms of how much electricity you use per square foot, etc., a lot of growers who used pre-legal, scaled-up practices are losing their businesses because they’re not taking those low-margin, high-efficiency lessons from traditional agronomy.

That’s what we’re doing, is really learning cannabis from a whole systems technical point of view, knowing all the while that we have to get better.

Photo courtesy of GrowRay Technologies

We’re never going to be good enough.

You always have to keep learning.

But we’re pushing the envelope, and we know that.

So, we have to be curious.

We have to be hungry.

We have to learn together.

The whole issue of legality in cannabis has forced a lot of businesses to operate in a silo or in a vacuum.

So it’s a very fractured industry and that has hamstrung innovation in a big way.

We’re just trying to approach it from that point of view.

Aspen Green

Colorado-based Aspen Green is one of only seven USDA Organic certified full-spectrum hemp and CBD brands in the country.

Their products are free from toxins, formaldehyde, phthalates, parabens, and sulfates.

They’re one of five brands recognized by Realm of Caring for their commitment to transparency, quality, and integrity.

To learn more about the company’s commitment to serving the industry, we spoke with Aspen Green President and CEO Brandon Lewis.

Brandon Lewis. Photo courtesy of Aspen Green.

Brandon Lewis: We are filling the need for education around the hemp plant, it’s properties, and where to find the actual science that’s been conducted for decades — which can start with a simple search at the National Institute of Health. 

We are passionate about assisting people in what to look for in high-quality hemp & CBD products even if not from Aspen Green. 

We believe cannabis will be federally legal within 5 years and consumers will be educated on the value of the whole hemp plant and all of its properties. 

We also believe laws will become uniform versus how fragmented they are currently at the state level. 

We also see the industry maturing to focusing on various regions where the plant is grown, much like wine. 

In our opinion, what Napa is to wine — the Colorado Rockies are to hemp.


#CBD #Hemp
https://cannatechtoday.com/trade-secrets/
June 11, 2021 11:00 am

How Effective is Your Internal Auditing Program?

How Effective is Your Internal Auditing Program?

The word “audit” evokes various emotions depending on your role in an organization and the context of the audit. While most are familiar with and loathe the IRS’s potential for a tax audit, the audits we are going to discuss today are (or should be) welcomed – proactive internal quality audits. A softer term that is also acceptable is “self-assessment.” These are independent assessments conducted to determine how effective an organization’s risk management, processes and general governance is. 

“How do you know where you’re going if you don’t know where you’ve been” – Maya Angelou

Internal quality audits are critical to ensuring the safety of products, workers, consumers and the environment. When planned and performed periodically, these audits provide credible, consistent and objective evidence to inform the organization of its risks, weaknesses and opportunities for improvement. Ask yourself the question: do your clients/vendors rely on you to produce reliable, consistent and safe products? Assuming the answer is yes, what confidence do you have, and where is the documented evidence to support it?

Compliance units within cannabis businesses are typically responsible for ensuring a business stays legally compliant with state and federal regulations. This level of minimum compliance is critical to prevent fines and ensure licenses are not revoked. However, compliance audits rarely include fundamental components that leave cannabis operators exposed to many unnecessary risks.

Internal quality audits are critical to ensuring the safety of products, workers, consumers and the environment.

As a producer of medical and adult-use products that are ingested, inhaled or consumed in other forms by our friends, family and neighbors, how can you be sure that these products are produced safely and consistently? Are you confident that the legal requirements mandated by your state cannabis control board are sufficient? Judging by the number of recalls and frustrations voiced by the industry regarding the myriad of regulations, I would bet the answer is no.

What questions do internal audits address? Some examples include:

  • Are you operating as management intends?
  • How effective is your system in meeting specified objectives? These objectives could include quality metrics of your products, on-time delivery rates and other client/customer satisfaction metrics.
  • Are there opportunities to improve?
  • Are you doing what you say you do (in your SOPs), and do you have the recorded evidence (records) to prove it?
  • Are you meeting the requirements of all applicable government regulations?

There are potential drawbacks to internal audits. For one, as impartiality is essential in internal audits, it may be challenging to identify an impartial internal auditor in a small operation. If your team always feels like it is in firefighting mode, it may feel like a luxury to take the time to pull members out of their day-to-day duties and disrupt ongoing operations for an audit. Some fear that as internal assessments are meant to be more thorough than external assessments, a laundry list of to-do items may be uncovered due to the audit. But, these self-assessments often uncover issues that have resulted in operational efficiencies in the first place. This resulting “laundry list” then affords a proactive tool to implement corrective actions in an organized manner that can prevent the recurrence of major issues, as well as prevent new issues. The benefits of internal audits outweigh the drawbacks; not to mention, conducting internal audits is required by nearly every globally-recognized program, both voluntary (e.g. ISO 9001 or ASTM Internationals’s Cannabis Certification Program) and government required programs such as 21 CFR 211 for Pharmaceuticals.

Internal Auditing is a catalyst for improving an organization’s effectiveness and efficiency by providing insight and recommendations based on analyses and assessments of data and business processes. Additional benefits of internal audits include giving your organization the means to:

  • Ensure compliance to the requirements of internal, international and industry standards as well as regulations and customer requirements
  • Determine the effectiveness of the implemented system in meeting specified objectives (quality, environmental, financial)
  • Explore opportunities for improvement
  • Meet statutory and regulatory requirements
  • Provide feedback to Top Management
  • Lower the cost of poor quality

Findings from all audits must be addressed. This is typically done in accordance with a CAPA (Corrective Action Preventive Action) program. To many unfamiliar with Quality Management Systems, this may be a new term. As of Jan 1, 2021, this is now a requirement for all cannabis licensed operators in Colorado. Many other states require a CAPA program or similar. Continuing education units (CEUs) are available through ASTM International’s CAPA training program, which was developed specifically for the cannabis industry.

Examples of common audit findings that require CAPAs include:

  • Calibration – Production and test equipment must be calibrated to ensure they provide accurate and repeatable results.
  • Document and record control – Documents and records need to be readily accessible but protected from unintended use.
  • Supplier management – Most standards have various requirements for supplier management that may include auditing suppliers, monitoring supplier performance, only using suppliers certified to specific standards, etc.
  • Internal audits – Believe it or not, since internal audits are required by many programs, it’s not uncommon to have a finding related to internal audits! Findings from an internal audit can include not conducting audits on schedule, not addressing audit findings or not having a properly qualified internal auditor. Are you looking for more guidance? Last year, members of ASTM International’s D37 Committee on Cannabis approved a Standard Guide for Cannabis and Hemp Operation Compliance Audits, ASTM D8308-21.

If you are still on the fence about the value of an internal audit, given the option of an inspector uncovering a non-conformance or your own team discovering and then correcting it, which would you prefer? With fines easily exceeding $100,000 by many cannabis enforcement units, the answer should be clear. Internal audits are a valuable tool that should not be feared.

The post How Effective is Your Internal Auditing Program? appeared first on Cannabis Industry Journal.


#CBD #Hemp

How Effective is Your Internal Auditing Program?


June 9, 2021 3:58 pm

5 Laws Every Vape Company Owner in the U.S. Should Know

5 Laws Every Vape Company Owner in the U.S. Should Know

It’s always an advantage to know the vaping laws governing the marketing, sales, and use of vape products, especially if you’re a company in the e-cigarette industry. In the U.S, the sales and use of vape pens, liquid nicotine, e-cigarettes, e-liquids, or bulk import of such products aren’t without a list of requirements and regulatory guidelines.

You need to ensure compliance for your company and employees. This calls for an in-depth understanding of the rules and regulations surrounding customer age verifications, product placements and displays, sampling, internet and mail orders, restricted store sections, and many more.

Like most laws in the U.S, there are state and federal regulations for nicotine devices. Certain states in the U.S consider vaping companies to be manufacturers and retailers. What this implies is that you’ll have to deal with additional rules and laws. Ensuring that you’re compliant will save you a lot of delays, fees, and fines.

This article covers five essential laws you should understand as a vape company in the U.S. But before diving into it, let’s look at a general overview of vape regulations.

A Quick Overview

In the latter part of December 2020, a budget package saw the light of day after its passing by Congress.

The package included the likes of the coronavirus relief bill, but what would interest most vape companies was a 5000-page document also located inside the package.

This document was the law called the Preventing Online Sales of E-Cigarettes to Children Act.

It regulated several vape products, like the dual battery vape mods and the more sophisticated vape setups like the Tesla Punk Vape MOD. But this was just a piece of the iceberg, and laws such as these can easily go unnoticed if you’re not paying attention. So let’s take a closer look at five of them.

1.   Preventing Online Sales of E-Cigarettes to Children Act

President Trump signed this Act into law in 2020. In the vaping industry, this act is commonly called the “vape mail ban.”

However, vape companies will feel the effects of the Preventing Online Sales of E-Cigarettes to Children Act reaching past the postal delivery. Despite its popularity since December 2020, this law isn’t new.

It had previously passed the House back in 2019 and, in July 2020, made its way to the Senate in somewhat different forms. However, the Senate received a call-to-action from CASAA concerning the bill before its passing in the summer.

Overall, few vape businesses and vapers are alarmed by the possible impacts of its passage, not knowing its full impacts.

2.   Preventing All Cigarette Trafficking (PACT)

All vendors of vapor products and businesses that deal in devices that deliver flavor, the nicotine from an aerosolized solution, or other substances that enable users to inhale will have to comply with Prevent All Cigarette Trafficking (PACT) from late March 2021. This law also goes by the name Jenkins Act.

It regulates regular vapor products that deliver nicotine and non-nicotine vapor products, which the government might regard as containing hemp oil.

Failure to abide by the rules and regulations stipulated by the Jenkins/PACT Act exposes vape companies to the possibility of heavy fines in the sums of $5,000 to $10,000 for each violation.

3.   FDA Regulation of ENDS

Electronic nicotine delivery systems, otherwise termed ENDS, are devices such as vape pens, electronic cigarettes, vaporizers, and e-pipes, among many others. All these devices are non-combustible tobacco products.

The FDA in 2016 concluded a ruling that extended CTP’s regulatory domain to cover tobacco products, including ENDS that fall under the category of tobacco products.

Hence, the FDA controls the import, advertising, sale, packaging, distribution, labeling, and manufacture of all such products. Its regulations also cover the parts and components of ENDS. However, it excludes all accessories. Some examples of such components include:

  • Battery
  • Atomizer
  • Cartomizer
  • Cartridge
  • Clearomizer
  • Tank System
  • Drip Tip
  • Programmable software

4.   FDA Tobacco Regulations

Businesses that produce, modify fabricate, mix, fix, assemble, repack, label, import, or relabel ENDS must also abide by the requirements for manufactures, in addition to the first three laws.

If your company falls into this category, the FDA considers you a tobacco product “manufacture.” Even companies that import finished tobacco products must comply just like tobacco products distributors or manufacturers.

Therefore, you’ll have to register your company and submit the list of products, advertisements, and labeling. Per the regulations, other details you’ll need to submit include an ingredient listing and data.

5.   Protecting American Lungs And Reversing the Youth Tobacco Epidemic Act

In February 2020, the U.S House of Representatives approved a bill to tackle the youth tobacco crisis. The name of this bill was the Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020.

It bans most flavored tobacco and vaping products such as mint and menthol flavor. Plus, it imposes taxes on nicotine e-cigarettes and affects vape companies.

Conclusion

One vital fact to always keep in mind, law and regulations are always subject to modification via the passing of new legislation, federal decisions, ballot initiatives, high court rulings, or other approved methods. Therefore, It’s always necessary to follow the latest developments and know current information.

Often, understanding the complex rules and how they affect your business can be challenging. Therefore, you may need an attorney in addition to your legal research to clear all your doubts.


#CBD #Hemp
https://cannatechtoday.com/laws-vape-company-u-s/
June 4, 2021 11:00 am

Mark Your Calendars: The Cannabis Extraction Virtual Conference

Mark Your Calendars: The Cannabis Extraction Virtual Conference

On June 29, 2021, Cannabis Industry Journal is hosting the Cannabis Extraction Virtual Conference. From Noon to 5 pm EST, you’ll get access to five veterans of the extraction market discussing a variety of topics related to the ins and outs of extracting cannabis and hemp.

Hear from subject matter experts who will share their perspectives on cannabis and hemp extraction, supercritical CO2 extraction, post-processing, risk management, hazards and controls, optimization, closed loop hydrocarbon extraction, machine learning algorithms and more.

Alex Hearding, Chief Risk Management Officer at the National Cannabis Risk Management Association (NCRMA) will kick things off with a session exploring the Hazards and Controls of Extraction with Liquified Petroleum Gases. Dr. Markus Roggen, Founder & CEO of Complex Biotech Discovery Ventures, will follow that up with a discussion surrounding the kinetics and thermodynamics of cannabis extraction.

Other talks from the Cannabis Extraction Virtual Conference include:

  • The Quest to Discover the Limnits of CO2 Extraction
    • Jeremy Deihl, co-founder & CTO of Green Mill Supercritical
  • The Future of Cannabis Concentrates: Developments in Hydrocarbon Extraction and Manufacturing
    • Michelle Sprawls, Laboratory Director at CULTA
  • Process Scale Up in the Cannabis/Hemp Industry
    • Darwin Millard, Committee ViceChair on ASTM International’s D37.04 on Processing & Handling of Cannabis

You can check out the agenda in its entirety and register here. Attendees will have the opportunity to ask speakers questions during the live Q&A session that follows each session. Registration is complimentary. For sponsorship opportunities, contact RJ Palermo at [email protected]

The post Mark Your Calendars: The Cannabis Extraction Virtual Conference appeared first on Cannabis Industry Journal.


#CBD #Hemp

Mark Your Calendars: The Cannabis Extraction Virtual Conference


June 2, 2021 5:11 pm

CU Boulder, Charlotte’s Web Begin Sleep & Anxiety Studies

CU Boulder, Charlotte’s Web Begin Sleep & Anxiety Studies

Charlotte’s Web Holdings announced a new collaboration with the University of Colorado-Boulder and their Research and Education Addressing Cannabis and Health (REACH) Center. The University’s REACH Center will conduct a preclinical study on how hemp oil can influence sleep quality and anxiety.

Charlotte’s Web and University of Colorado-Boulder Collaborative Study to Assess CBD and CBN’s Potential to Support Improved Sleep (CNW Group/Charlotte’s Web Holdings, Inc.)

The study will use Charlotte’s Web hemp products, including their full spectrum hemp formulations containing CBN, CBD and less than 0.3% THC. Monika Fleshner, PhD, Professor of Integrative Physiology and member of the Center for Neuroscience at the University of Colorado, will be the project lead and will conduct the study in her Stress Physiology Laboratory. “There is a great need for properly controlled experimental studies that are designed to test the potential neural and physiological impacts of hemp derived phytocannabinoids,” says Dr. Fleshner. “With support from CU REACH and Charlotte’s Web, our research will explore both the efficacy and mechanisms of how these substances can affect complex brain-mediated behavior, such as disturbed sleep.”

Tim Orr, senior vice president of Charlotte’s Web and president of its CW Labs division, is currently working on more than twelve scientific research studies with the company. “Charlotte’s Web is committed to advancing science on the benefits and safety of CBD and other hemp phytocannabinoids through rigorous scientific investigations such as this sleep and anxiety study,” says Orr. “We’re honored to team up with CU’s REACH Center to explore the potential impacts of full-spectrum hemp extract with CBD and CBN on anxiety and sleep quality.”

Long term, Charlotte’s Web expects this study will help build the foundation for future clinical studies to “better understand how specific ratios of cannabinoids and different delivery formats are effective at supporting improved sleep quality and instilling healthier sleep architecture in humans,” reads the press release.

The post CU Boulder, Charlotte’s Web Begin Sleep & Anxiety Studies appeared first on Cannabis Industry Journal.


#CBD #Hemp

CU Boulder, Charlotte’s Web Begin Sleep & Anxiety Studies


June 2, 2021 4:39 pm

Different Ways Hemp Can be Utilized as House-Building Materials

Different Ways Hemp Can be Utilized as House-Building Materials

Hemp is a miracle material. When most people think of it, one or two uses might come to mind. But, when you really do your research on everything hemp is used for, you quickly start to see how valuable it is.

Right now, it’s important to shine a light on the fact that hemp can be used for home construction in a variety of ways. Lately, the cost of lumber has skyrocketed due to a shortage. There are also concerns about the sustainability of traditional building materials and how they might be impacting the planet.

Could hemp be the solution for those problems? Yes.

Using hemp as a building material is more than just a “pipe dream” (no pun intended). Instead, it’s a viable option that could cut costs and benefit the environment.

Not sure how it can be used and whether it truly is the right solution? Let’s look at the benefits and a few ways hemp can be implemented into construction materials.

The Benefits of Hemp for Building

If you think hemp can’t hold a candle to lumber or other building materials, think again. Nowadays, hemp is used to manufacture:

  • Rope
  • Textiles
  • Bioplastics
  • Insulation

There’s are several reasons why it’s being used to make so many things. First, it’s both fire and mold-resistant. That’s important if you live in a damp environment. Plus, it allows builders to rely less on using chemical fire retardants, which can cost money and be harmful to the environment.

Hemp can also be used to upgrade your home with new additions. It’s a much safer construction product than materials used in the past. For example, hemp can be used to replace old insulation that might contain asbestos.

If your home was built before the 1970s, you may have insulation or other building materials containing asbestos, which can cause damage to your respiratory system and may even cause cancer or mesothelioma. Hemp is a natural, safe, and healthy replacement.

If you’re building from the ground up, using materials like hempcrete can also be beneficial for the environment.

Sustainability is important, especially in the construction industry. But, so is cost. With lumber prices on the rise, can you save money by using hemp instead?

Sustainable Savings

Part of the reason why hemp is more cost-effective than other materials is that it’s sustainable. It’s a renewable resource that makes it easier to stay on a realistic budget with your home construction. A hemp-made house costs roughly the same as a normally-built house. Now, with rising material costs, it may be even cheaper than traditional options.

Materials like hempcrete are more commonly used for smaller projects, making them a big draw for tiny homes. If you’re on a strict budget or you have bad credit, using hemp to build your home can help you to avoid overspending. You might also be able to build or buy even if you have bad credit because you’ll be able to put down a larger downpayment.

It’s also important to note that the hemp tech industry is rapidly growing. In the future, that could mean even more hemp-based building materials for housing. Currently, hemp wood companies are becoming more prominent, creating everything from flooring to cabinets.

Hemp is also being used to replace certain plastic materials, which will also impact the building industry and how materials are used. If you’re not ready to build a home or upgrade right now, keep your eyes open for how hemp is going to grow (again, literally) in the future.

Hemp and Your Home Can Go Hand-in-Hand

Hemp is sustainable. It’s cost-effective. It’s growing in popularity, and it’s even got its own tech industry. Needless to say, it’s a trendy topic right now in the construction world. But, on a more personal level, hemp can be a fantastic addition to your home – inside or outside.

For example, because hemp wood is becoming more popular, you can use it to decorate your home’s interior. It can give you a more “rustic” and natural look that fits perfectly into a sustainability mindset. Natural wood accents are perfect for shabby chic homes, and they can make your space feel warmer and more inviting.

Because hemp is also used to create textiles, you can decorate with it. Some of the most common hemp fabrics include:

  • Linen
  • Terrycloth
  • Twill
  • Cotton muslin

From your sheets to your curtains, you could end up having a hemp home top to bottom and feel good about the environmentally sound choices you’re making.

If you’ve never considered hemp for building, now is a perfect time to do your research. If you’re already interested in the hemp industry, constructing a home using hemp building materials could be the next step in utilizing it. The more popular it becomes, the more we’re likely to see it as a strong competitor to traditional costly materials.


#CBD #Hemp
https://cannatechtoday.com/hemp-house-building-materials/
May 31, 2021 11:00 am

Challenges with Process Scale Up in Cannabis/Hemp Extraction

Challenges with Process Scale Up in Cannabis/Hemp Extraction

What makes scaling up your process so difficult?

There are many factors that can lead to the challenges people face when scaling up their processes. These challenges are not unique to the cannabis/hemp industry, but they are exacerbated by the consequences generated from decades of Reefer Madness. In my time operating in the cannabis/hemp space, 15+ years, I have seen established equipment vendors and sellers of laboratory supplies, like Sigma-Aldrich (now Millipore-Sigma), Fisher-Scientific, Cerilliant, Agilent, and others, go from reporting individuals inquiring about certified reference materials to setting up entire divisions of their companies to service the needs of the industry. Progress. But we are still a fledgling marketplace facing many challenges. Let’s look at a few specific to process scale up.

Darwin Millard will deliver a presentation on this topic during the Cannabis Extraction Virtual Conference on June 29. Click here to learn more.Equipment Availability: Lack of available equipment at larger and larger process scales can severely impact project timelines. Making not only equipment acquisition difficult, but also limiting the number of reputable equipment manufacturers you can work with.

Non-Linear Expansion: NEVER assume your process scales linearly. Perhaps one of the most avoidable mistakes during process scale up. You will quickly find that for many processes you cannot just put in a larger unit and expect a proportional increase in output. This is because as process equipment increases so to must utilities and other supporting infrastructure, but not only that, process vessel geometry, proportions, and design are contributing factors to process efficiency as your scale of operations increases.

Hazardous Material Quantities: Just as important to the process as the equipment are the solvents and reagents used. As your scale of operations increases so does your demand and production of hazardous materials; solvents including carbon dioxide (CO2), ethanol, and liquid petroleum gases (LPG) like Butane and Propane are obvious hazards, but so too are the refrigerants used in the chillers, fuels used to power generators, steam created to heat critical systems, and effluents and wastewater discharged from the process and supporting systems. Not every municipality wants thousands of gallons of flammable substances and hazardous waste being generated in their backyard…

Contractor/Vendor Misrepresentation: Finding out in the middle of you project that your contractor or equipment vendor has never set up a system at this scale before is never a good feeling. Unfortunately, contractor and vendor misrepresentation of qualifications is a common occurrence in the cannabis/hemp space.

If all this was not bad enough, all too often the consequences of improper planning and execution are not felt until your project is delayed or jeopardized due to misallocation of funds or undercapitalization. This is especially true when scaling up your production capacity. Now let’s look at some ways to avoid these mistakes.

The Rule of 10

Construction drawings for a piece of process equipment.

When scaling up your process, NEVER assume that a simple linear expansion of your process train will be sufficient. It is often the case that process scale up is non-linear. Using the Rule of 10 is one way of scaling up your process through a stepwise iterative approach. The Rule of 10 is best explained through an example: Say you are performing a bench-top extraction of a few grams and want to scale that up to a few thousand kilograms. Before jumping all the way to your final process scale, start by taking a smaller jump and only increase your bench-top process by a factor of 10 at a time. So, if you were happy and confident with your results at the tens of grams scale, perform the same process at the hundreds of grams scale, then the thousands of grams scale, tens of kilograms scale, and so forth until you have validated your process at the scale of operations you want to achieve. By using the Rule of 10 you can be assured that your process will achieve the same yields/results at larger and larger scales of operation.

Scaling up your process through an iterative approach allows you to identify process issues that otherwise would not have been identified. These can include (but by no means should be considered an exhaustive list) improper heat transfer as process vessels increase in size, the inability to maintain process parameters due to inadequately sized utilities and/or supporting infrastructure, and lower yields than expected even though previous iterations were successful. However, this type of approach can be expensive, especially when considering custom process equipment, and not every processor in the cannabis/hemp space is going to be in the position to use tools like the Rule of 10 and instead must rely on claims made by the equipment vendor or manufacture when scaling up their process.

The Cannabis/Hemp Specific Process Equipment Trap

How many times have you heard this one before: “We have a piece of process equipment tailor-made to perform X,Y,Z task.”? If you have been around as long as I have in the cannabis/hemp space, probably quite a few times. A huge red flag when considering equipment for your expansion project!

Unless the equipment manufacturer is directly working with cannabis/hemp raw materials, or with partners who process these items, during product development, there is no way they could have verified the equipment will work for its purported use.

GMP compliant phytocannabinoid processing facility underconstruction.

A good example of this are ethanol evaporation systems. Most manufacturers of evaporators do not work with the volumes of ethanol they claim their systems can recover. So how did they come up with the evaporation rate? Short answer – Thermodynamics, Heat Transfer, and Fluid Mechanics. They modeled it. This much surface area, plus this much heat/energy, with this much pressure (or lack thereof), using this type of fluid, moving through this type of material, at this rate of speed, gets you a 1000-gal/hr evaporator or some other theoretical value. But what is the real rate once an ethanol and cannabis/hemp solution is running through the system?

For a straight ethanol system, the theoretical models and experimental models are pretty similar – namely because humans like alcohol – extensive real-world data for ethanol systems exist for reference in designing ethanol evaporators (more accurately described as distillation systems, i.e. stills). The same cannot be said for ethanol and cannabis/hemp extract systems. While it is true that many botanical and ethanol systems have been modeled, both theoretically and experimentally, due to prohibition, data for cannabis/hemp and ethanol systems are lacking and the data that do exist are primarily limited to bench-top and laboratory scale scenarios.

So, will that 1000-gal/hr evaporator hit 1000-gal/hr once it is running under load? That’s the real question and why utilizing equipment with established performance qualifications is critical to a successful process scale up when having to rely on the claims of a vendor or equipment manufacturer. Except this is yet another “catch 22”, since the installation, operational, and performance qualification process is an expensive endeavor only a few equipment manufacturers servicing the cannabis/hemp market have done. I am not saying there aren’t any reputable equipment vendors out there; there are, but always ask for data validating their claims and perform a vendor qualification before you drop seven figures on a piece of process equipment on the word of a salesperson.

Important Takeaways

Improper design and insufficient data regarding process efficiencies on larger and larger scales of manufacturing can lead to costly mistakes which can prevent projects from ever getting off the ground.

Each aspect of the manufacturing process must be considered individually when scaling your process train because each element will contribute to the system’s output, either in a limiting or expansive capacity.

I go further into this topic in my presentation: Challenges with Process Scale Up in the Cannabis/Hemp Industry, later this month during Cannabis Industry Journal’s Extraction Virtual Conference on June 29th, 2021. Here I will provide real-world examples of the consequences of improper process scale up and the significance of equipment specifications, certifications, and inspections, and the importance of vendor qualifications and the true cost of improper design specifications. I hope to see you all there.

Until then. Live long and process.

The post Challenges with Process Scale Up in Cannabis/Hemp Extraction appeared first on Cannabis Industry Journal.


#CBD #Hemp

Challenges with Process Scale Up in Cannabis/Hemp Extraction


May 27, 2021 4:24 pm

Eteros Technologies Launches the New Mobius M9 Sorter in Las Vegas

Eteros Technologies Launches the New Mobius M9 Sorter in Las Vegas

What happens in Vegas, stays in Vegas.

This won’t be the case, however, for the new Mobius M9 Sorter, which was displayed at Eteros Technologies’ “Demo in the Desert” exhibition on May 13 in Las Vegas.

In fact, this innovative cannabis processing equipment will make cultivator’s jobs a whole lot easier, and will not just be limited to those who reside in Nevada.  

“We hope our ‘Demo in the Desert’ event showed what is possible for the industry going forward,” said Eteros Founder and CEO Aaron McKellar. “There are solutions out there for our growers to be even better, faster, and more efficient than ever before.”

Eteros Technology, which is the parent company of Mobius, plans to hire a dozen full-time employees for its Las Vegas facility, and more job opportunities will arise with future plans to branch out.

“The M9 Sorter is assembled right here in Las Vegas for our U.S. customers,” said Dana Mosman, director of marketing and sales for Eteros. “This automated technology is essential for the hemp and cannabis industry in a burgeoning and competitive marketplace.”

The Mobius M9 Sorter will be a game-changer for cannabis and hemp cultivators and process, as its many functions allow for the machine to handle more product in less time while increasing accuracy in sizing.

M9’s features include:

  • An industry-leading 9 sorting belts
  • An industry-leading 78” sorting zone for high-speed and precise sizing of product
  • A longer sorting table that leads to more accurate results
  • Every grading slot is longer, creating more opportunity for an accurate sort, and each grading partition is fully adjustable
  • All stainless steel construction
  • Sanitary construction for GMP workflows
  • Adjustable infeed hopper: tool-free adjustment and removal for feeding or conveyor infeed
  • Reversible table for operation in either left or right outfeed configuration
  • Easy access for cleaning with safety interlocked end panels and rear door
  • 7” HMI color controller
  • Accurately grades up to 200KG/HR
  • Quick and tool-free removal of all belts and rollers for easy and safe cleaning.

You know the cannabis industry must be booming when products like the M9 Sorter are created with cultivators in mind.

With more growers able to efficiently produce more and more cannabis and hemp to meet consumer demand, this means a more sustainable, healthy future.

For being a so-called desert, Nevada is starting to look pretty green.


#CBD #Hemp
https://cannatechtoday.com/eteros-technologies-launches-the-new-mobius-m9-sorter-in-las-vegas/
May 27, 2021 11:01 am

Increasing Global Lumber Prices May Help Hemp Industry

Increasing Global Lumber Prices May Help Hemp Industry

Lumber has been one of the most common building materials in construction for a very long time.

It is not the most popular building material on earth, as that distinction goes to concrete. However, wood is still very popular and has been for centuries.

Houses, wagons, bridges, and a number of other things have been made out of wood in many different countries throughout the world both historically and currently.

Unfortunately, prices for lumber have increased exponentially this year, which may ultimately prove to be a blessing to the global hemp industry.

Exploding Prices for Lumber

Lumber is a commodity that is traded around the world. Virtually every country on earth uses lumber for various purposes.

Using the NASDAQ as a measure, the cost of lumber has nearly tripled in just the last year.

If you have visited a home improvement store or lumberyard in the last year to make a purchase, then the sticker shock you experienced really hammered things home (no pun intended).

Fortunately for builders across the planet, there is a building material alternative that is much better for the environment.

Hemp As A Building Material

When many folks think about hemp, they tend to think of hemp products like rope, paper, and clothing.

In recent years, demand for hemp has skyrocketed thanks to the increased popularity of CBD products. Many CBD products are derived from hemp.

However, there’s another use for hemp that is likely to gain in popularity thanks in part to increased lumber prices: hemp as a building material.

The inner woody fibers from hemp plants can be used to make boards similar to wood boards, often referred to as ‘hemp board.’

Another use for hemp in building materials is for making hempcrete, which is similar to concrete yet is much more earth-friendly.

Hemp grows much faster than trees, and in many cases is more pest and fire-resistant. Historically, prices for hemp building materials are more than lumber, but the gap is closing more and more with every passing month.


#CBD #Hemp
https://cannatechtoday.com/lumber-prices-help-hemp-industry/
May 19, 2021 11:00 am

The New Delta 8 THC Market: A Q&A with the Founders of DeltaVera

The New Delta 8 THC Market: A Q&A with the Founders of DeltaVera

Delta 8 THC (delta-8-tetrahydrocannabinol) sprung onto the scene late last year in a big way. While similar to the much more widely-known delta-9-tetrahydrocannabinol that produces a lot of the psychoactive effects associated with ingesting cannabis, delta 8 THC can be derived from hemp with less than 0.3% delta 9 THC. Given the legality of hemp-derived products following the 2018 Farm Bill, delta 8 THC can be produced in some states where delta 9 THC still remains illegal.

While delta 8 is considerably different in its psychoactive effects from its cousin, it does overlap in some ways. It can still produce some more manageable, less “heady” versions of delta 9’s effects like euphoria and relief found in the many medical applications of cannabis. DeltaVera, a company that launched less than six months ago, aims to share that more manageable THC experience with the masses.

The sharp rise of the delta 8 market means that DeltaVera is poised for growth. With distribution contracts inked, exciting partnerships in the works and a large surge in consumer demand, the founders of DeltaVera are at the ready to capitalize on this lesser-known molecule and bring it to the forefront of the nascent hemp industry. Starting out as a small family business, Sam and Craig Andrus launched DeltaVera with their third founder, PK Isacs.

We sat down with Sam Andrus and PK Isacs, two of the founders of DeltaVera, an award-winning brand, to ask them about their plans for expanding, how they became entrepreneurs and why they think delta 8 is the next big thing in cannabis.

Cannabis Industry Journal: Tell me about your company. How did you get started in the cannabis space?

Sam Andrus, cofounder of DeltaVera

Sam Andrus: I had an early start in the Delta 8 THC industry on the sales side. We knew we wanted to get into the market, but observed a number of aspects in the space that needed to be addressed: the most important being quality control, transparency and brand trust. With this as a backdrop we launched DeltaVera. Highly curated, approachable, transparent and value-oriented with a strong focus on reliability and trust. The DeltaVera family is made up of three operating managers and the sales team. We are three founders with complementary skill sets: Craig, who has domain expertise in finance, governance and startups, PK who has experience in business and marketing and my sales experience round out the management team.

We have yet to solicit outside capital and have funded ourselves internally as we create our brand and refine our product offering. That said, we are seeing numerous opportunities in strategic partnerships and expansion, which will require additional capital. And we are excited to start this expansion process.

CIJ: What makes the Delta 8 space so remarkable? Why are your SKUs primarily formulated with Delta 8?

Sam Andrus & PK Isacs: Delta 8 THC is an alternative/complement to delta 9 THC, CBD and other cannabinoids. Its status as non-federally scheduled and its less potent psychoactive effects make it appealing in its own right. Delta 8 THC can help with healthier sleep patterns and with pain management in a way that CBD can’t, without a strong “head high” that many of our customers like to avoid. Additionally, it’s shorter lived and doesn’t give you any negative residual effects, which makes it beneficial for people on tighter schedules. These factors make it easier for us to approach markets that are inaccessible to both delta 9 THC and CBD, such as older demographics. In a world where delta 9 is legal, there will still be a place for delta 8.

PK Isacs, cofounder of DeltaVera

While we are very proud of our suite of smokable products, we are currently focusing our efforts on edibles: our Delta Discs are our mainstay, though we are expanding our product line to include nano-emulsion products such as liquid shots and nano gummies. They strongly appeal to our target demographics; additionally, the edible market is growing very quickly in states that allow the sale of hemp-derived consumables.

CIJ: Continuing on the delta 8 front – right now it is considered a cannabinoid legal for interstate commerce, much like CBD, correct? Do you think that will change? 

Sam & PK: That is currently the case. Delta 8 THC is newer, and as such, it has even more ambiguity in regards to its legal future. But what’s most exciting (and our most challenging task right now), is informing consumers about the benefits of delta 8. We are one of a few companies solely focused on the consumption of delta 8, because of its similar benefits to delta 9 and CBD – our products are the perfect happy medium: a high with less psychoactive effects and all the health benefits of both, making it a desirable alternative to all consumers.

In addition, we are looking at some combinations of delta 8/CBDA, delta 8/CBN, delta 8/THCV and are very excited to begin test marketing these combinations. These proprietary blends of minor/major cannabinoids can cater to a niche target demographic as they can be curated to have very specific and unique effects when combined in the right quantities with the right delivery system. They will also be able to serve a larger customer base as these cannabinoids can all be derived from hemp.

CIJ: How do you think the FDA would regulate your product? Do you welcome federal oversight?

DeltaVera gummy products

Sam & PK: Regardless of whether or not we are regulated we are committed to a high level of transparency and trust. As noted in unregulated markets, like the supplement market, you don’t always know what you are getting in terms of purity and potency. We are changing that paradigm by adding unique QR codes to our sustainable containers which reference COAs [certificates of analyses] specific to the contents of the case. A lot of the space is naturally trying to avoid that kind of regulatory interference, but we are currently doing our best to self-regulate and make sure that our consumers are fully informed about what they’re receiving.

We will be the first to say that there aren’t as many laws governing delta 8 THC as there could be, and that’s why we’ve spent so much time and money on self-regulation. All of our products have very clear nutritional information in addition to test results down to one hundredth of one percent. As for what category these products should fall under: we have a wide range of products, and each one has its place under a different umbrella of regulation. We hope that the federal government will take advantage of the vast array of studies that have been conducted on delta 8 THC since it was first extracted in 1942 to step up to this product that is, in our experience, helping so many people.

CIJ: Tell me about how your business has grown so far.

Sam & PK: When we sell to a retailer, we try to provide them with as much material as possible on what delta 8 THC is and what differentiates DeltaVera’s products. Still, we’ve had some difficulty in places with limited delta 8 THC exposure. That being said, when someone tries our product, there is a high likelihood that they become a repeat customer (and they tell their friends). Given our newness to the market (Our brand launched in January 2021) initial indications are – we have a good rate of repeat orders, and we’ve heard the same from our brick-and-mortar partners.

The DeltaVera Delta Discs

Our distribution network has grown tremendously; we’ve taken a three-pronged approach to distribution: partnerships with like-minded companies in compatible spaces, an e-commerce market on our website, and a commission-based sales structure to reach brick-and-mortar establishments. To date, most of our distribution takes place in the latter two spaces, due to the added time and commitment involved in forming partnerships. As a company we are taking a more creative approach on how we present our product and alternative ways to consume it. We have some exciting collaborations in the works; follow us on social media to stay up to date with everything on the horizon. We are very enthusiastic about our partnerships however, with our first collaboration with WaxNax, a Denver-based company revolutionizing the cannabis dabbing experience, hitting the shelves this week.

CIJ: What is your marketing plan?

Sam & PK: We are working on building a social media presence. Natalie, who is leading the charge on social media, recommended we take an organic approach to build our base. We want to avoid falling into the “paid ad”, “spam” vibe as long as we can. We are currently focused on building a community through delta 8. Our mission is making DeltaVera a brand for all lifestyles, athletes, creatives, travelers or business professionals. We’re confident in our product, and have faith that it can speak for itself.

CIJ: How do you ensure quality in your products?

Sam & PK: Our products are of guaranteed quality with our licensed growers and manufacturers. We provide COAs, informing the retailer & consumer about each product, displaying full panel tests on cannabinoids and heavy metals. These preliminary and secondary lab tests ensure our product is below 0.3% delta 9 THC in all our products. Through third-party labs, we run full panel tests which pick up a variety of cannabinoids; for most of our products we focus on the level/purity of delta 8. Our products are screened for both contaminants and heavy metals.

All this information is housed conveniently on our website that can be reached through our QR codes.

CIJ: What are your plans to grow the business in the future? 

Sam & PK: We feel very confident in our three methods of distribution: partnerships, e-commerce and a commission-based sales structure. We’ve made tremendous ground on partnerships, and are very excited about numerous partnerships we have in the pipeline. We’ve reached out to some incredible groups in the CBD space, the THC space and a few groups that you wouldn’t normally associate with cannabinoids, but with whom we’ve workshopped some really creative ideas that we’re really looking forward to bringing to market.

Readers can use promo code “CIJ” to get 15% off their first order here

[youtube https://www.youtube.com/watch?v=0ClGOVrYRlc?feature=oembed&wmode=opaque&w=790&h=444]

The post The New Delta 8 THC Market: A Q&A with the Founders of DeltaVera appeared first on Cannabis Industry Journal.


#CBD #Hemp

The New Delta 8 THC Market: A Q&A with the Founders of DeltaVera


May 17, 2021 11:14 pm

Defining Hemp: Classifications, Policies & Markets, Part 2

Defining Hemp: Classifications, Policies & Markets, Part 2

In Part 1 of this series we answered the question: What is “hemp”; and addressed some of the consequences of defining “hemp” as a thing. In Part 2, I will explore this topic in more detail and provide some commonsense definitions for several traditional hemp products based on a classification approach rather than separating “cannabis” from “hemp”.

Classifications, Specifications, and Test Methods – Establishing Market Protections for Hemp Products Through Standardization

Does making a distinction between “hemp” and “cannabis” make it easier to protect the interests of the seed and fiber markets?

On the face of it, this question seems obvious. Yes, it does.

Up to this point in history, the bifurcation of the cannabis plant into resin types and non-resin types has served to provide protections for the seed and fiber markets by making it easier for producers to operate, since the resins (the scary cannabinoids, namely d9-THC) were not involved. Today, however, the line in the sand, has been washed away, and “hemp” no longer only refers to non-resin producing varieties of the cannabis plant.

The structure of cannabidiol (CBD), one of 400 active compounds found in cannabis.

As more and more hemp marketplaces come online with varying limits for d9-THC the need for standardization becomes even more pressing. Without standardization, each marketplace will have its own requirements, forcing businesses looking to sell their products in multiple jurisdictions to comply with each region’s mandates and adds a significant level of burden to their operations.

Providing an internationally harmonized definition for hemp is an important first step but allowing the d9-THC limit to vary from jurisdiction to jurisdiction has some unintended (or intended) consequences (#NewReeferMadness). These discrepancies between legal marketplaces will inevitably lead to the establishment of global trade regions; where, if your product cannot meet the definition of “hemp” in that region, then you could effectively be barred from participating in it.

A process which has already started. Harmonizing around 0.3% is great for the US, Canada, and European Union, but what about other stakeholders outside of these markets?

And, at what point does the conflict of hemp from one region with a d9-THC content of 0.3% and hemp from another region with a d9-THC content of 1% being sold into the same market become a problem?

Perhaps a better long-term solution for protecting the market interests of “hemp product” stakeholders would be to establish specifications, such as identity metrics, total cannabinoid content, especially d9-THC, and other quality attributes which have to be verified using test methods for a product to be classified as “hemp”. This system of standards (classifications, specifications, and test methods) would allow for more innovation and make it significantly easier for cannabis raw materials that meet these specifications to find a use rather than being sent to the landfill. Bolstering advancements and opening the door for more market acceptance of the cannabis plant, its parts, and products.

An Alternative Approach to Defining Hemp

Below are some proposed definitions related to common terminology used in the hemp marketplace based on the concept that there are no hemp plants, there are only cannabis plants that can be classified as hemp, and hemp products are simply cannabis products that meet certain specifications to allow them to be classified and represented as hemp.

  • Hemp, n—commercial name given to a cannabis plant, its parts, and products derived therefrom with a total d9-THC content no more than the maximum allowable limit for the item in question. (Maybe not the best definition, but it makes it clear that not only does the limit for d9-THC vary from jurisdiction to jurisdiction it varies from product type to product type as well.)
  • Hemp flower, n—commercial name for the inflorescence of a cannabis plant that can be classified as hemp.
  • Hemp seed, n—commercial name for the seeds of a cannabis plant which are intended to be used to grow another cannabis plant that can be classified as hemp.
  • Hempseed, n—commercial name for the seeds of a cannabis plant which are intended to be used as food or as an ingredient in food.
  • Hemp seed oil, n—commercial name for the oils expressed from the seeds of a cannabis plant.
  • Hemp seed cake, n—commercial name for the solid material byproduct generated during the expression of the oil from the seeds of a cannabis plant.
  • Hemp flour/meal/dietary-fiber, n—commercial name for the powdered seed cake of a cannabis plant intended to be used as a food or as an ingredient in food with a protein content no more than 35% by weight.
  • Hemp protein powder, n—commercial name for the powdered seed cake of a cannabis plant intended to be used as a food or as an ingredient in food with a protein content between 35% and 80% by weight.
  • Hemp protein isolate, n—commercial name for the powdered seed cake of a cannabis plant intended to be used as a food or as an ingredient in food with a protein content above 80% by weight.
  • Hemp fiber, n—commercial name for the cellulosic-based natural fibers of a cannabis plant.
  • Hemp shives, n—commercial name for the hurd of a cannabis plant which have been processed to defined specifications.
  • Hempcrete, n—commercial name for a solid amalgamation of various aggregates and binders, typically comprised of the hurd (shives) of a cannabis plant and lime.

The d9-THC limits for each product were purposefully omitted because these specifications still need to be defined for each product type. Leaving the d9-THC limit up to each authority having jurisdiction, however, is not the answer. It is fine if you comply with a lower d9-THC limit and want to sell into a market with a higher d9-THC limit, but what do you do if you are above the limit for the market you want to sell into? For now, you lose out on potential revenue.

Hemp-derived CBD extract

I am not advocating that everyone starts selling “hemp” as “cannabis,” or vice versa, far from it. I am advocating for a more commonsense and inclusive approach to the marketplace though. One that would allow for the commercialization of materials that would normally be going to waste.

To me it is simply logical. There are no hemp plants, there are only cannabis plants that can be classified as hemp. There are no hemp products, there are only cannabis products that can be classified as hemp. In order for a cannabis product to be marketed, labeled, and sold as a hemp product, i.e. to be classified as a hemp, it would need to meet a set of specifications and be verified using a set of test methods first. But fundamentally the product would be a cannabis product being certified as “hemp”. And that is the shift in thinking that I am trying to get across.

Exclusionary Actions – Disenfranchising Stakeholders

The cannabis plant is an amazing plant and to fully capitalize on the potential of this crop we have to start allowing for the commercialization of cannabis raw materials that are not controlled by the UN Single Conventions, i.e. the seeds, stalks, roots, and leaves when not accompanied by the fruiting tops or the resin glands. Not to do so disenfranchises a significant number of stakeholders from participating in established legal avenues of trade for these goods. A concept proposed and endorsed the ASTM D37 in the published standard D8245-19: Guide for Disposal of Resin-Containing Cannabis Raw Materials and Downstream Products.

If you are stakeholder in the hemp marketplace, you may feel threatened by the idea of the market getting flooded with material, but how are the demands of the so called “green economy” going to be met without access to more supply? Organic hemp seed for food production is scarce but there is plenty of conventional hemp seed for the current demand, but what happens when hempmilk is positioned to displace soymilk in every major grocery store? To feed the growth of the human population and allow for a transition to a truly “green economy,” we need to ensure that the policies that we are putting in place are not excluding those looking to participate in the industry and disenfranchising stakeholders from burgeoning marketplaces, nor alienating a segment of the marketplace simply because their plant cannot be classified as “hemp”.

Until next time…

Live long and process.

The post Defining Hemp: Classifications, Policies & Markets, Part 2 appeared first on Cannabis Industry Journal.


#CBD #Hemp

Defining Hemp: Classifications, Policies & Markets, Part 2


May 13, 2021 2:35 pm

Canopy Didn't Mean To Mislead Investors, Judge Says

Canopy Didn't Mean To Mislead Investors, Judge Says A New Jersey federal judge has granted major pot company Canopy Growth’s bid to escape an investor class action accusing it of misleading them about the strength of the Canadian cannabis market, ruling the investors didn’t show that the company intentionally deceived them. #CBD #Hemp https://www.law360.com/cannabis/articles/1383075?utm_source=rss&utm_medium=rss&utm_campaign=section May 10, 2021 7:59 pm

CBD Co. Agrees To Pay $500K Over Health Claims

CBD Co. Agrees To Pay $500K Over Health Claims Cannabis company Cannacraft agreed to pay more than $500,000 in penalties to settle charges brought by a California consumer protection task force accusing it of improperly marketing CBD products as treatments for cancer, Alzheimer’s disease and more. #CBD #Hemp https://www.law360.com/cannabis/articles/1383109?utm_source=rss&utm_medium=rss&utm_campaign=section May 10, 2021 4:11 pm

4 Firms Guide Trulieve's $2.1B Deal For Pot Industry Peer

4 Firms Guide Trulieve's $2.1B Deal For Pot Industry Peer Trulieve Cannabis Corp. will absorb Harvest Health & Recreation Inc. for roughly $2.1 billion to create a premier player in the U.S. pot industry, the companies said Monday, in a transaction put together with help from four law firms. #CBD #Hemp https://www.law360.com/cannabis/articles/1382968?utm_source=rss&utm_medium=rss&utm_campaign=section May 10, 2021 11:04 am

Virginia Marijuana Retailer License

Virginia Marijuana Retailer License

Virginia Marijuana Retailer License

Virginia marijuana retailer license

Virginia Marijuana Retailer License

Recently -on April 7- HB 2312 and SB 1406 were voted to be approved after Gov. Ralph Northam requested amendments from the legislature. 

This bill will replace cannabis prohibition with a system to legalize, tax, and regulate cannabis for adults 21 and older. 

Many — but not all — of the law’s provisions require a second legislative vote in 2022, or “re-enactment.” The provisions to legalize cannabis possession and cultivation on July 1, 2021 do not require re-enactment, nor do penalties for minors possessing cannabis and provisions to allow the regulatory work to start. The provisions to begin the regulatory structure and to legalize sales on January 1, 2024 also do not require re-enactment. Most new penalties — such as for bringing any cannabis into Virginia — do require re-enactment.

What is a Virginia marijuana retailer license?

A Retail marijuana store license, authorizes the licensee to purchase or take possession of retail marijuana, retail marijuana products, immature marijuana plants, or marijuana seeds from a marijuana wholesaler and to sell retail marijuana, retail marijuana products, immature marijuana plants, or marijuana seeds to consumers on premises approved by the Board.

RELATED POST: VIRGINIA MARIJUANA CULTIVATION LICENSE

RELATED POST: MINNESOTA CANNABIS LICENSES

Do you need guidance?

How to apply for a Virginia marijuana retailer license

According to the newest legislation on the matter, here is the information regarding the application for a marijuana retailer license:

  • Every person intending to apply for any license authorized by the newest legislation has to file with the Board an application on forms provided by the Board and a statement in writing by the applicant swearing and affirming that all of the information contained therein is true.
  • Applicants for licenses for establishments that are otherwise required to obtain an inspection by the Department of Agriculture and Consumer Services shall provide proof of inspection or proof of a pending request for such inspection.
    • If the applicant provides proof of inspection or proof of a pending request for an inspection, a license may be issued to the applicant. If a license is issued on the basis of a pending application or inspection, such license shall authorize the licensee to purchase retail marijuana, retail marijuana products, immature marijuana plants, or marijuana seeds; however, the licensee shall not sell retail marijuana, retail marijuana products, immature marijuana plants, or marijuana seeds until an inspection is completed.
  • Each applicant for a license has to post a notice of his application with the Board on the front door of the building, place, or room where he proposes to engage in such business for no more than 30 days and not less than 10 days. 
    • Such notice shall be of a size and contain such information as required by the Board, including a statement that any objections shall be submitted to the Board not more than 30 days following initial posting of the notice required pursuant to this subsection.
    • The applicant shall also cause notice to be published at least once a week for two consecutive weeks in a newspaper published in or having a general circulation in the county, city, or town wherein such applicant proposes to engage in such business. 
    • Such notice shall contain such information as required by the Board, including a statement that any objections to the issuance of the license be submitted to the Board not later than 30 days from the date of the initial newspaper publication.
  • The Board shall conduct a background investigation, to include a criminal history records search, which may include a fingerprint-based national criminal history records search, on each applicant for a license. 
    • The Board may waive, for good cause shown, the requirement for a criminal history records search and completed personal data form for officers, directors, nonmanaging members, or limited partners of any applicant corporation, limited liability company, or limited partnership. 
    • In considering criminal history record information, the Board shall not disqualify an applicant because of a past conviction for a marijuana-related offense.
    • The Board shall notify the local governing body of each license application through the town manager, city manager, county administrator, or other designee of the locality. 
    • Local governing bodies shall submit objections to the granting of a license within 30 days of the filing of the application.
  • Each applicant shall pay the required application fee at the time the application is filed, except that such fee shall be waived or discounted for qualified social equity applicants pursuant to regulations promulgated by the Board. 
    • The license application fee shall be determined by the Board and shall be in addition to the actual cost charged to the Department of State Police by the Federal Bureau of Investigation or the Central Criminal Records Exchange for processing any fingerprints through the Federal Bureau of Investigation or the Central Criminal Records Exchange for each criminal history records search required by the Board. Application fees shall be in addition to the state license fee and will not be refunded.
  • All licensees shall file and maintain with the Board a current, accurate record of the information required by the Board and notify the Board of any changes to such information in accordance with Board regulations.
  • Every application for a permit granted shall be on a form provided by the Board. Such permits shall confer upon their holders no authority to make solicitations in the Commonwealth.
  • The fee for a temporary permit shall be one-twelfth of the combined fees required by this section for applicable licenses to sell retail marijuana or retail marijuana products computed to the nearest cent and multiplied by the number of months for which the permit is granted.

The Board has the authority to increase state license fees. The Board shall set the amount of such increases on the basis of the consumer price index and shall not increase fees more than once every three years. Prior to implementing any state license fee increase, the Board shall provide notice to all licensees and the general public of (i) the Board’s intent to impose a fee increase and (ii) the new fee that would be required for any license affected by the Board’s proposed fee increases. Such notice shall be provided on or before November 1 in any year in which the Board has decided to increase state license fees, and such increases shall become effective July 1 of the following year.

State regulation 

A new Cannabis Control Authority would be created in July 2021 to regulate the adult-use cannabis market. A Board of Directors would issue regulations; grant, suspend, or revoke licenses. 

The Board would establish the number of licensees, which could not exceed 400 retailers, 25 wholesalers, 450 cultivators, and 60 product manufacturers. This would be without counting existing medical cannabis businesses and hemp processors. It would also approve labs. 

It creates two types of cultivation licenses: Class A licenses, which are capped at a certain number of square feet or plants. Class B would be limited to 1% THC. 

It will also establish criteria to evaluate new licensees based on the density of retail stores in the community and to consider any negative public health outcomes in the community. 

  • Vertical integration (owning multiple types of cannabis businesses) would not be allowed except in the case of: 
    • Microbusinesses 
    • Existing medical cannabis businesses, all of which are vertically integrated, and hemp processors may be vertically integrated if they: 1) pay a $1 million fee to the Virginia Cannabis Equity Loan Fund and the Virginia Cannabis Equity Reinvestment Fund; and 2) the business submits a diversity, equity, and inclusion plan to the Cannabis Business Equity and Diversity Support Team and implements it or provides job training services to persons recently incarcerated. 
  • Stores must be geographically dispersed. Their dispersion must be reassessed after every 100 licenses are issued. 
  • Promotes inclusion in licensing by prioritizing social equity applicants. 
    • The bill denes “social equity applicants” as having 66% or more owners who: have a prior cannabis conviction, have a close relative with a cannabis conviction, live either in an area with disproportionate cannabis arrests or that is economically distressed, or graduated from a Virginia HBCU. 
    • Social equity applicants will be given preference from July 1, 2023 until January 1, 2024. Regulators will waive a percent of fees. 
  • Creates a Cannabis Business Equity and Diversity Support Team to identify barriers to inclusion, oer technical assistance, conduct outreach, and develop requirements for diversity, equity, and inclusion plans. 
  • A new 21-member Cannabis Public Health Advisory Council would assess and monitor public health impacts and make recommendations, including about warnings cannabis products’ safety and product composition and public health awareness. 
  • The bill includes requirements for seed-to-sale tracking, packaging, and labeling —including for potency and mandating warning labels — and requires state-created information on risks to be available at the point-of-sale. Delivery, internet-based sales, 
  • Rules would govern outdoor cultivation, sanitation, testing, and advertising. 
  • Regulators would also establish public health and safety guidelines for personal home cultivation, including to protect children and prevent  nuisances, including odor. 

Timeframe of the bill

  • Most of the bill — including legal possession — will take effect on July 1, 2021. (The current penalty for possession of up to an ounce is a civil fine of up to $25.) 
  • Sales would begin no earlier than January 1, 2024. 

Taxes established on the bill

  • A state tax of 21% at the point of retail sale would be levied, in addition to standard 6% sales taxes. The tax does not apply to medical cannabis sales from medical dispensaries. 
  • Localities could impose a tax of up to 3% on sales to consumers in the municipality.
  • Fees would be determined by the Board and can be increased based on ination. 
  • After covering regulatory costs, the revenue would be allocated to: pre-K education for at-risk children (40%); a Cannabis Equity Reinvestment Fund (30%); substance abuse treatment and prevention (25%); and public health programs (5%). 
  • The Cannabis Equity Reinvestment Fund, administered by a 20-member Cannabis Equity Reinvestment Board, would direct funds to: 

Scholarship programs for historically marginalized populations, including those who were in foster care and who have been impacted by substance use; 

  • Grants to support jobs training and placement, workplace development, youth mentoring, and reentry services; 
  • Contributing to the state’s Indigent Defense Fund; and 
  • No -and low- interest loans for social equity applicants.

If you want more information regarding what could you do in order to enter the cannabis industry in Connecticut, don’t hesitate to contact us.

If you want to be updated on the current state of Cannabis legalization, you should check out our map of marijuana legality by state.

RELATED POST: OHIO MARIJUANA DISPENSARY LICENSE APPLICATION

RELATED POST: KENTUCKY BAN OF DELTA-8 THC

Do you need guidance?

Thomas Howard

Thomas Howard

Cannabis Lawyer

Thomas Howard has been in business for years and can help yours navigate towards more profitable waters.

Kentucky Ban of Delta-8 THC

Kentucky Ban of Delta-8 THC

Kentucky Delta-8 THC Hemp Ban Delta-8 THC is illegal according to Kentucky’s interpretation of federal law – at least according to the general counsel of the Department of Agriculture – who really has no authority to make conclusions of federal law. Delta-8 THC has…

Need A Cannabis Attorney For Your Business?

Our cannabis business attorneys are also business owners.  We can help you structure your business or help protect it from overly burdensome regulations.

The post Virginia Marijuana Retailer License appeared first on Cannabis Industry Lawyer – Tom Howard.


#CBD #Hemp

Virginia Marijuana Retailer License


May 8, 2021 1:12 am

Cannabis Bill Roundup: Medical Pot Advances In The South

Cannabis Bill Roundup: Medical Pot Advances In The South Lawmakers in a host of southern states this week advanced or approved bills to reform or create a medical cannabis program, while in states where marijuana is already fully legal, legislators are moving ahead with policies allowing for home grow and union participation in the space. Here are the major legislative developments in cannabis from the last week. #CBD #Hemp https://www.law360.com/cannabis/articles/1382639?utm_source=rss&utm_medium=rss&utm_campaign=section May 7, 2021 8:55 pm

Medical Pot Co. Says IT Biz Faked Signature In $10M Contract

Medical Pot Co. Says IT Biz Faked Signature In $10M Contract A cannabis sales software company has asked a Pennsylvania federal judge to dismiss a subcontractor’s suit over its termination from a $10 million state contract it said was secured based on its status as a Black-owned IT company, saying the subcontractor forged a signature for an unaccepted counteroffer. #CBD #Hemp https://www.law360.com/cannabis/articles/1382529?utm_source=rss&utm_medium=rss&utm_campaign=section May 7, 2021 7:12 pm

UCANN Says It Doesn't Owe Atty Fees After Patent Suit

UCANN Says It Doesn't Owe Atty Fees After Patent Suit United Cannabis Corp. is fighting CBD company Pure Hemp Collective’s bid for $300,000 in attorney fees after United Cannabis dropped a patent infringement suit against the company, arguing it has no liability because Pure Hemp willingly dropped its claims as well. #CBD #Hemp https://www.law360.com/cannabis/articles/1382169?utm_source=rss&utm_medium=rss&utm_campaign=section May 6, 2021 5:31 pm

Pot Co. Can't Sell Nerds Knockoff, Calif. Judge Says

Pot Co. Can't Sell Nerds Knockoff, Calif. Judge Says A California cannabis delivery company can’t sell “Medicated Nerds Rope” after the maker of Nerds brand candy filed a trademark infringement suit against the delivery company, a federal judge in Los Angeles has determined. #CBD #Hemp https://www.law360.com/cannabis/articles/1381886?utm_source=rss&utm_medium=rss&utm_campaign=section May 6, 2021 5:16 pm

Ex-Mayor's Fraud, Bribery Case Nears End As Defense Rests

Ex-Mayor's Fraud, Bribery Case Nears End As Defense Rests A Massachusetts federal jury could begin deliberations as soon as Monday in the fraud and corruption trial of the former mayor of Fall River, after the ex-politician presented a brief defense against claims he drained investor cash from his startup and extracted bribes from cannabis entrepreneurs looking to open in the city. #CBD #Hemp https://www.law360.com/cannabis/articles/1382135?utm_source=rss&utm_medium=rss&utm_campaign=section May 6, 2021 4:28 pm

Ex-Mass. Pot Regulator Joins Vicente Sederberg

Ex-Mass. Pot Regulator Joins Vicente Sederberg One of Massachusetts’ first cannabis regulators has taken a position at cannabis-focused law firm Vicente Sederberg LLP as its first director of regulatory policy, the firm recently announced. #CBD #Hemp https://www.law360.com/cannabis/articles/1381757?utm_source=rss&utm_medium=rss&utm_campaign=section May 6, 2021 3:45 pm

The Perfect Cannabis and Plantbased Self-Care Products for Mother’s Day

The Perfect Cannabis and Plantbased Self-Care Products for Mother’s Day

These past two years have been an unprecedented whirlwind to say the least.

Many mothers were forced to adjust to the pandemic’s new normal, which includes juggling work, homeschooling, and parental care, without having the ability to destress outside the home. 

This Mother’s Day, you deserve to be pampered like the queen you are. 

Do a D.I.Y home spa treatment, light some candles, unwind with your favorite strain or tasty CBD gummy.

We picked out some of the best Mother’s Day gifts that will make this holiday a day to remember for you, or another mother in your life.

This could be a nurturing friend, your own mom, a surrogate mother, your adopted mother, heck, pamper yourself for being a good mom to your dogs.

Motherhood isn’t just limited to having a child. 

This is a day to celebrate those who have made an impact on our lives and who have supported us through the good and the bad.

What better way to show unconditional love than through a plant that was cultivated to provide relief and comfort?  

 

Willie’s Remedy Teas: $26

 

Willie’s Remedy Teas. Photo courtesy of Willie’s Remedy Teas.

With cannabis legend Willie Nelson’s stamp of approval, you know this tea is going to hit the spot.

Each tea bag is infused with 12.5 mg of organically grown, full-spectrum hemp, which makes it easy to ensure that you’ll get the same calming effect with each cup.

Willie’s Remedy caffeine-free Teas come in a variety of enticing flavors, such as Breakfast Blend, Sweet Spiced Chai, Classic Green, and more.

You’re going to want all the time in the world to enjoy this tea, so sit back, relax, and relish every drop. 

 

Botanika Life Skin Elixir Set + Crystal Roller Kit Box $275

 

Botanika Life Skin Elixer + Crystal Roller. Photo courtesy of Botanika Life.

Get the cucumbers ready!

This is the perfect for those who want to indulge in some high quality selfcare, while also helping out the environment.

Clean face, Clean Earth!

That’s definitely a win. 

The set gives you three all natural, vegan, gluten-free, organic Full Spectrum CBD skin elixirs that you massage over your skin with the Botanika Life Crystal Face Roller.

The elixirs include Vitamin C + Squalane + 1,000MG CBD, Plant Stem Cell + Marula + 1000MG CBD, and their Elite Elixer + 1500MG CBD.

The full spectrum CBD works to stimulate your skin, providing you with a calming and rejuvenating experience that will leave you refreshed and ready to take on the day. 

 

TerraVita CBD Relax CBD Bath Soak $60

 

TerraVita CBD Relax CBD Bath Soak. Photo courtesy of TerraVita.

It wouldn’t be a complete Mother’s Day without a soothing bubble bath.

TerraVita’s Relax bath salts are made with 250mg of premium Broad Spectrum CBD combined with natural salts, botanicals, and natural oils to relieve stress, anxiety, and clear your mind.

Close your eyes, take in the fresh aromas of lavender and coconut, and let any worries you may be facing drift away. 

 

PHYX Sparkling Water (Available in Colorado) $5.95 per bottle

 

PHYX Sparkling Water. Photo courtesy of PHYX.

Bottoms up!

Enjoy a refreshing THC-Infused sparkling water that allows you to feel the benefits of cannabis in minutes due to Phyx’s proprietary nano-emulsified THC technology.

With zero cannabis taste, zero calories and zero sugar, Phyx works as the perfect healthy base for any delicious Mother’s Day cocktail.

Hint: If you’re looking for a cannabis-infused drink recipe, we have your back.

PHYX comes in a variety of delicious flavors, including grapefruit, lime, dragonfruit, and all natural. 

 

New Chapter Hair, Skin & Nails Fermented Biotin & Beauty Herbs Supplement $29

 

Examples of New Chapter supplements. Photo courtesy of New Chapter.

Practicing self-care isn’t just limited to enhancing your emotional wellbeing, though that is an important part of it.

It’s also about taking care of your physical health.

New Chapter’s Hair, Skin & Nails supplements contain an organic superfood blend of Aloe, Chamomile, Maca, and Reishi Mushroom, combined with Biotin to help nourish your hair, and support healthier, youthful skin.

These vegan, gluten-free capsules are made with ingredients you can trust, and are the perfect addition to any self-care routine. 

 

 

Cannaflower Pre-Rolls $25

Cannaflower Sour Space Candy CBD Pre-Rolls. Photo courtesy of Cannaflower.

It wouldn’t be mother’s day without a pre-roll!

Cannaflower’s Sour Space Candy CBD Pre-Rolls are perfect for anyone who wants some calm in their life without feeling dazed, due to the low THC content in the flower.

Sour Space Candy is rich in terpenes b-Caryophyllene and a-Pinene, which work to produce an all-day calming feel.

With how chaotic these past two years have been, there’s nothing more grounding than cannabis.

We could all use a little more calm in our lives.


#CBD #Hemp
https://cannatechtoday.com/products-for-mothers-day/
May 6, 2021 10:00 am

Ex-Calif. Officials Each Get 2 Years In Pot Permit Bribe Row

Ex-Calif. Officials Each Get 2 Years In Pot Permit Bribe Row Two former California city officials on Wednesday were each sentenced to two years in prison for accepting bribes in exchange for expediting a cannabis dispensary permit application, according to a statement from the U.S. Department of Justice. #CBD #Hemp https://www.law360.com/cannabis/articles/1382009?utm_source=rss&utm_medium=rss&utm_campaign=section May 5, 2021 10:52 pm

Pot Connection May Complicate Claims To 'Raw' Brand Name

Pot Connection May Complicate Claims To 'Raw' Brand Name An Arizona federal judge is refusing to end a trademark dispute between a cannabis company and a smoking materials maker over the word “raw,” saying it’s too early to decide if a link to illegal products voided trademark protection. #CBD #Hemp https://www.law360.com/cannabis/articles/1381785?utm_source=rss&utm_medium=rss&utm_campaign=section May 5, 2021 8:51 pm

Fla. Pot Legalization, Taxation Fail In Legislature

Fla. Pot Legalization, Taxation Fail In Legislature Several Florida bills meant to legalize and tax recreational cannabis died in committee, killing legalization hopes in that state this year even as cannabis proposals in other states have made big strides. #CBD #Hemp https://www.law360.com/cannabis/articles/1381825?utm_source=rss&utm_medium=rss&utm_campaign=section May 5, 2021 6:45 pm